Home Cart Sign in  
Chemical Structure| 475207-59-1 Chemical Structure| 475207-59-1

Structure of Sorafenib Tosylate
CAS No.: 475207-59-1

Chemical Structure| 475207-59-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sorafenib Tosylate (Bay 43-9006 Tosylate) is a potent, orally active Raf inhibitor with IC50 values of 6 nM for Raf-1 and 20 nM for B-Raf. Sorafenib Tosylate is a multikinase inhibitor with IC50 values of 90 nM, 15 nM, 20 nM, 57 nM, and 58 nM for VEGFR2, VEGFR3, PDGFRβ, FLT3, and c-Kit, respectively. Sorafenib Tosylate induces autophagy and apoptosis, has anti-tumor activity, and is a ferroptosis activator.

Synonyms: Bay 43-9006 Tosylate; Sorafenib (tosylate); BAY 54-9085

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sorafenib Tosylate

CAS No. :475207-59-1
Formula : C28H24ClF3N4O6S
M.W : 637.03
SMILES Code : O=C(C1=NC=CC(OC2=CC=C(NC(NC3=CC=C(Cl)C(C(F)(F)F)=C3)=O)C=C2)=C1)NC.O=S(C4=CC=C(C)C=C4)(O)=O
Synonyms :
Bay 43-9006 Tosylate; Sorafenib (tosylate); BAY 54-9085
MDL No. :MFCD08235032
InChI Key :IVDHYUQIDRJSTI-UHFFFAOYSA-N
Pubchem ID :406563

Safety of Sorafenib Tosylate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H360-H362-H372-H410
Precautionary Statements:P201-P202-P260-P263-P264-P270-P273-P280-P308+P313-P391-P405-P501
Class:9
UN#:3077
Packing Group:

Related Pathways of Sorafenib Tosylate

RTK
MAPK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Zebrafish liver cells (ZFL) 0.125–1 μM 24, 48, 72 h Sorafenib decreased the viability of ZFL cells in a dose- and time-dependent manner. PMC9965539
PLC/PRF/5 cells 10 μM 36 h To investigate the effect of Sorafenib on oncoVV replication in PLC/PRF/5 cells, the results showed that Sorafenib inhibited oncoVV replication. PMC9965933
Hep3B-R cells 5 μM 2-3 months To study the resistance of Hep3B-R cells to Sorafenib PMC7397405
MV4-11R cells 500 nM To study the resistance of MV4-11R cells to Sorafenib PMC7397405
MV4-11R cells 5550 nM Evaluate the resistance of MV4-11R cells to Sorafenib PMC7397405
Huh7 cells 10 μM 36 h To investigate the effect of Sorafenib on oncoVV replication in Huh7 cells, the results showed that Sorafenib inhibited oncoVV replication. PMC9965933
Hep-3B cells 3 μM 36 h To investigate the effect of Sorafenib on oncoVV replication in Hep-3B cells, the results showed that Sorafenib inhibited oncoVV replication. PMC9965933
SMMC-7721 8 µM 24 h To evaluate the sensitivity of SMMC-7721 cells to Sorafenib, the results showed that 7721SR cells were significantly less sensitive to Sorafenib. PMC9817350
Huh7 4 µM 24 h To evaluate the sensitivity of Huh7 cells to Sorafenib, the results showed that Huh7SR cells were significantly less sensitive to Sorafenib. PMC9817350
PLC/PRF/5 (PLC5) cells 10 μM To study the effect of Sorafenib on PLC5 cells, it was found that the growth inhibition effect of Sorafenib on PLC5 cells was reduced after RFX-1 knockdown. PMC4198826
Huh7 cells 2.5 μM to 10 μM 3 months To study the effect of Sorafenib on Huh7 cells, it was found that sustained Sorafenib treatment led to the development of resistance in Huh7 cells. PMC4198826
TPC-1 cells 1 μmol 48 h To evaluate the effect of Sorafenib alone and in combination with Alisertib on cell proliferation, migration, and invasion. Results showed that Sorafenib alone significantly inhibited the proliferation, migration, and invasion of TPC-1 cells, and the combination with Alisertib had a more pronounced effect. PMC10060208
8305 C cells 1 μmol 48 h To evaluate the effect of Sorafenib alone and in combination with Alisertib on cell proliferation, migration, and invasion. Results showed that Sorafenib alone significantly inhibited the proliferation, migration, and invasion of 8305 C cells, and the combination with Alisertib had a more pronounced effect. PMC10060208
PLC cells 10 μM 24 h To study the effect of Sorafenib on the secretion of GP73 and AFP, results showed that Sorafenib reduced the secretion of GP73 and AFP PMC8516944
HepG2 cells 10 μM 24 h To study the effect of Sorafenib on the interaction between GP73 and AFP, results showed that Sorafenib reduced the intracellular interaction of GP73 and AFP PMC8516944

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Hepatocellular carcinoma model Gavage 20 mg/kg 5 days/week for 21 days To evaluate the antitumor effect of Sorafenib and Orlistat combination therapy on the hepatocellular carcinoma model, the results showed that the combination therapy significantly inhibited tumor growth. PMC9817350
Nude mice Huh7 and Huh7-resistant tumor models Oral 10 mg/kg Every other day for 2 weeks To study the effect of combined Sorafenib and SC-2001 treatment on Huh7 and Huh7-resistant tumors, it was found that the combination therapy significantly inhibited tumor growth. PMC4198826
NSG mice Tumor xenograft model Oral 30 mg/kg Once daily for 12 days To evaluate the effect of Sorafenib alone and in combination with Alisertib on tumor growth. Results showed that Sorafenib alone significantly inhibited tumor growth, and the combination with Alisertib had a more pronounced effect. PMC10060208
Nude mice HCC xenograft model Orally 30 mg/kg Daily for 4 weeks To study the effect of Sorafenib on tumor growth, results showed that Sorafenib significantly inhibited tumor growth, while treatment with AFP or GP73 enhanced tumor growth, and combination treatment synergistically inhibited the antitumor effect of Sorafenib PMC8516944
Balb/c nude mice SK-Hep1OE and SK-Hep1VC cell subcutaneous xenograft model Intraperitoneal injection and oral 10 mg/kg Once daily for 22 days To evaluate the therapeutic effect of Auranofin on Sorafenib-resistant tumors PMC7397405
Balb/c nude mice Subcutaneous xenograft model Oral 10 mg/kg Once daily for 22 days Evaluate the anti-tumor effects of Sorafenib and Auranofin in vivo PMC7397405

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00126503 Chromophobe Renal Cell Carcino... More >>ma Clear Cell Renal Cell Carcinoma Papillary Renal Cell Carcinoma Recurrent Renal Cell Carcinoma Sarcomatoid Renal Cell Carcinoma Stage IV Renal Cell Cancer Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Pennsylvania University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT00126503 - Completed - -
NCT03606590 Hepatocellular Carcinoma Phase 2 Recruiting December 2020 Spain ... More >> Vall d'Hebron Institute of Oncology (VHIO) Recruiting Barcelona, Spain Contact: Teresa Macarulla, Dr.    +34-932748855    tmacarulla@vhio.net    Contact: Raquel García Pelaez    +34-934893000    rgarcia@vhio.net    Principal Investigator: Teresa Macarulla Mercade, Dr.          HM Hospitales - Centro Integral Oncológico Clara Campal Recruiting Madrid, Spain, 28050 Contact: Antonio Cubillo, Dr.       acubillo@hmhospitales.com    Principal Investigator: acubillo@hmhospitales.com acubillo@hmhospitales.com, Dr. Less <<
NCT00964743 - Terminated(Low Accrual) - -
NCT02562755 Hepatocellular Carcinoma (HCC) Phase 3 Recruiting October 2019 -
NCT00635791 Malignant Solid Tumour ... More >> Renal Cell Carcinoma Non Small Cell Lung Carcinoma Less << Phase 1 Completed - United States, Colorado ... More >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 Less <<
NCT00964743 Neoplastic Meningitis Not Applicable Terminated(Low Accrual) - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01025453 Thyroid Cancer Phase 2 Completed - United States, New Jersey ... More >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT01531361 Advanced Malignant Neoplasm ... More >> BRAF Gene Mutation Metastatic Malignant Neoplasm Recurrent Malignant Neoplasm Refractory Malignant Neoplasm Less << Phase 1 Active, not recruiting February 28, 2020 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00639262 Brain Metastases ... More >> Primary Brain Tumors Less << Phase 1 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00131937 - Completed - -
NCT00917462 Esophageal Cancer ... More >> Gastroesophageal Junction Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01497444 Kidney Cancer ... More >> Liver Cancer Less << Phase 1 Active, not recruiting - United States, Arizona ... More >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT01736878 Medullary Thyroid Carcinoma Phase 2 Withdrawn(Study was withdrawn ... More >>due to unanticipated hassle in patient recruitment.) Less << - Germany ... More >> University Hospital Ulm, Clinic for Nuclear Medicine Ulm, Baden-Wuerttemberg, Germany, D-89081 Less <<
NCT00131937 Anaplastic Large Cell Lymphoma... More >> Angioimmunoblastic T-cell Lymphoma Hepatosplenic T-cell Lymphoma Peripheral T-cell Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00956436 Hepatocellular Carcinoma Phase 1 Completed - United States, Colorado ... More >> Resesarch Site Denver, Colorado, United States United States, Florida Resesarch Site Ocoee, Florida, United States United States, Indiana Resesarch Site Indianapolis, Indiana, United States United States, Massachusetts Resesarch Site Boston, Massachusetts, United States United States, New York Resesarch Site New York, New York, United States United States, Virginia Resesarch Site Norfolk, Virginia, United States Singapore Resesarch Site Singapore, Singapore Taiwan Resesarch Site Tainan, Taiwan Resesarch Site Taipei, Taiwan Resesarch Site Tao-Yuan, Taiwan United Kingdom Resesarch Site Edgbaston, Birmingham, United Kingdom Less <<
NCT00862082 Hepatocellular Carcinoma Phase 1 Phase 2 Terminated(PR104 plus sorafeni... More >>b was poorly tolerated in patients with advanced HCC) Less << - United States, Arizona ... More >> University of Arizona Tucson, Arizona, United States, 85724 United States, California Moores UCSD Cancer Center La Jolla, California, United States, 92093 University of California, Irvine Orange, California, United States, 92868 Sharp Clinical Oncology Research San Diego, California, United States, 92123 Pacific Oncology/Hematology San Francisco, California, United States, 94115 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Indiana Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Maryland Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Baltimore, Maryland, United States, 21231 United States, New York Columbia University Medical Center New York, New York, United States, 10032 Hong Kong Prince of Wales Hospital Shatin, New Territories, Hong Kong Singapore Singapore General Hospital Singapore, Singapore Taiwan Chang Gung Memorial Hospital Kaohsiung, Taiwan Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung, Taiwan Chi Mei Medical Center, Liouying T'ai-nan, Taiwan China Medical University Hospital Taichung City, Taiwan Cathay General Hospital Taipei City, Taiwan, 10630 National Taiwan University Hospital Taipei, Taiwan Less <<
NCT02143726 Refractory Hurthle Cell Thyroi... More >>d Cancer Less << Phase 2 Recruiting - United States, Florida ... More >> Mayo Clinic in Florida Suspended Jacksonville, Florida, United States, 32224-9980 United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Site Public Contact    312-695-1301    cancer@northwestern.edu    Principal Investigator: Maria Matsangou          United States, Iowa Siouxland Regional Cancer Center Recruiting Sioux City, Iowa, United States, 51101 Contact: Site Public Contact    712-252-0088       Principal Investigator: Donald B. Wender          United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Site Public Contact    800-865-1125       Principal Investigator: Francis P. Worden          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Site Public Contact    855-776-0015       Principal Investigator: Ashish V. Chintakuntlawar          United States, Nebraska Nebraska Methodist Hospital Recruiting Omaha, Nebraska, United States, 68114 Contact: Site Public Contact    402-354-5144       Principal Investigator: Yungpo B. Su          United States, New Jersey Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Sleepy Hollow Suspended Sleepy Hollow, New York, United States, 10591 United States, North Carolina Southeastern Medical Oncology Center-Clinton Recruiting Clinton, North Carolina, United States, 28328 Contact: Site Public Contact    919-587-9077    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Southeastern Medical Oncology Center-Goldsboro Recruiting Goldsboro, North Carolina, United States, 27534 Contact: Site Public Contact    919-587-9077    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Wayne Memorial Hospital Recruiting Goldsboro, North Carolina, United States, 27534 Contact: Site Public Contact    919-731-6687    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Southeastern Medical Oncology Center-Jacksonville Recruiting Jacksonville, North Carolina, United States, 28546 Contact: Site Public Contact    910-353-0824    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Southeastern Medical Oncology Center-Wilson Suspended Wilson, North Carolina, United States, 27893 United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Site Public Contact    800-293-5066    Jamesline@osumc.edu    Principal Investigator: Bhavana Konda          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Site Public Contact    215-728-4790       Principal Investigator: Jessica R. Bauman          United States, Wisconsin Mercy Health System Recruiting Janesville, Wisconsin, United States, 53547 Contact: Site Public Contact    800-928-1103       Principal Investigator: Emily G. Robinson Less <<
NCT02332031 Drug Interactions Phase 1 Completed - Germany ... More >> Berlin, Germany, 13353 Less <<
NCT01411436 - Completed - Japan ... More >> Many locations, Japan Less <<
NCT01025453 - Completed - -
NCT00862082 - Terminated(PR104 plus sorafeni... More >>b was poorly tolerated in patients with advanced HCC) Less << - -
NCT00893373 Acute Myeloid Leukemia (AML) Phase 2 Completed - Germany ... More >> Sozialstiftung Bamberg Klinikum am Bruderwald Bamberg, Germany, 96049 Klinikum Bayreuth Bayreuth, Germany, 95445 Charite Campus Benjamin Franklin Berlin, Germany Ev. Diakonie-Krankenhaus gGmbH Bremen Bremen, Germany, 28239 University Hospital Dresden Dresden, Germany, 01307 Klinikum Frankfurt (Oder) GmbH Frankfurt (Oder), Germany, 15236 Westpfalz-Klinikum GmbH Kaiserslautern, Germany, 67655 Agaplesion Diakoniekrankenhaus Rotenburg Rotenburg, Germany, 27356 Robert-Bosch-Krankenhaus Stuttgart, Germany, 70376 Less <<
NCT00924807 Prostate Cancer Phase 1 Phase 2 Terminated(Sponsor closed the ... More >>trial) Less << - United States, New York ... More >> St.Luke's-Roosevelt Hospital Center New York, New York, United States, 10019 Less <<
NCT00924807 - Terminated(Sponsor closed the ... More >>trial) Less << - -
NCT00572078 SOLID TUMORS Phase 1 Completed - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT01141309 Thyroid Cancer Phase 2 Active, not recruiting June 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01817751 Glioblastoma ... More >>Recurrent Adult Brain Neoplasm Malignant Glioma WHO Grade III Glioma Less << Phase 2 Recruiting March 31, 2019 United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Recruiting Richmond, Virginia, United States, 23298 Contact: Alison A Ryan, NP    804-628-1936    masseysiit@vcu.edu    Principal Investigator: Mark G Malkin, MD Less <<
NCT01539018 Advanced Hepatocellular Carcin... More >>oma Less << Phase 2 Terminated(After interim resul... More >>ts data showed no evidence of a difference between both groups) Less << - Egypt ... More >> Ain shams university Cairo, Egypt Cairo University Hospitals Cairo, Egypt National cancer institute Cairo, Egypt NHTMRI Cairo, Egypt National Liver Institute Monofeiya, Egypt Less <<
NCT00887107 Thyroid Cancer Phase 2 Completed - Netherlands ... More >> Leiden University Medical Center Leiden, Netherlands, 2300 RC Less <<
NCT01833299 Hepatocellular Carcinoma ... More >> Face Cancer Less << Phase 4 Unknown December 2014 China ... More >> Cancer Centre of Sun Yat-Sen University Recruiting Guangzhou, China, 510060 Contact: min-shan chen, M.D.,Ph.D.    87343117    Chminsh@mail.sysu.edu.cn    Principal Investigator: min-shan chen, M.D.,Ph.D. Less <<
NCT02691780 Refractory Solid Tumors Not Applicable Active, not recruiting December 2018 Korea, Republic of ... More >> Samsung Medical Center Seoul, seoul, korea, Republic of, Korea, Republic of, 135-710 Less <<
NCT01005875 Hepatocellular Carcinoma ... More >> Liver Cancer Less << Not Applicable Terminated(Sponsor(Bayer)did n... More >>ot wish to continue with study due to slow accrual. Therefore, there is insufficient data and will not be any study results/outcomes.) Less << - United States, Alabama ... More >> UAB Birmingham, Alabama, United States, 35294 Less <<
NCT01450384 Unspecified Adult Solid Tumor Phase 1 Completed - United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT00813293 Hepatocellular Cancer Phase 2 Active, not recruiting December 2017 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01093222 Extrahepatic Bile Duct Adenoca... More >>rcinoma Gallbladder Adenocarcinoma Gallbladder Adenocarcinoma With Squamous Metaplasia Hilar Cholangiocarcinoma Recurrent Extrahepatic Bile Duct Carcinoma Recurrent Gallbladder Carcinoma Undifferentiated Gallbladder Carcinoma Unresectable Extrahepatic Bile Duct Carcinoma Unresectable Gallbladder Carcinoma Less << Phase 2 Completed - -
NCT01093222 - Completed - -
NCT02474290 Acute Myeloid Leukemia ... More >> Hematopoietic Stem Cell Transplantation Less << Phase 2 Phase 3 Unknown August 2018 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan    +86-020-61641613    356135708@qq.com    Principal Investigator: Qifa Liu Less <<
NCT01412671 - Completed - Japan ... More >> Multiple Locations, Japan Less <<
NCT00844168 Adult Primary Hepatocellular C... More >>arcinoma Advanced Adult Primary Liver Cancer Localized Resectable Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01005875 - Terminated(Sponsor(Bayer)did n... More >>ot wish to continue with study due to slow accrual. Therefore, there is insufficient data and will not be any study results/outcomes.) Less << - -
NCT00703365 Carcinoma, Hepatocellular Phase 2 Completed - Thailand ... More >> Department of Medicine, Siriraj Hospital Bangkoknoi, Bangkok, Thailand, 10700 Medical Oncology Unit, Chulalongkorn Hospital Patumwan, Bangkok, Thailand, 10330 Horizon Regional Cancer Center, Bamrungrad Hospital Sukhumvit 3, Bangkok, Thailand, 10110 Less <<
NCT01578109 Acute Myeloid Leukemia in Remi... More >>ssion Acute Myeloid Leukemia With FLT3/ITD Mutation Less << Not Applicable Active, not recruiting - United States, Maryland ... More >> University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 Less <<
NCT00126568 Anaplastic Thyroid Cancer ... More >> Recurrent Thyroid Cancer Less << Phase 2 Terminated - United States, Ohio ... More >> Case Western Reserve University Cleveland, Ohio, United States, 44106 Less <<
NCT00093613 Adult Anaplastic Astrocytoma ... More >> Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Less << Phase 1 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland Adult Brain Tumor Consortium Baltimore, Maryland, United States, 21231-1000 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01411423 - Completed - Japan ... More >> Multiple Locations, Japan Less <<
NCT03722498 Hepatocellular Carcinoma Phase 2 Recruiting November 1, 2018 China, Guangdong ... More >> Ming Shi Recruiting Guangzhou, Guangdong, China Contact: Ming Shi, MD    (8620)-87343938    shiming@sysu.edu.cn    Principal Investigator: Ming Shi, MD Less <<
NCT00810394 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 2 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT01328223 - Unknown December 2012 Taiwan ... More >> Shang-Wen Chen Recruiting Taichung, Taiwan, 404 Contact: Shang-Wen Chen, MD    886-4-22052121 ext 7450    vincent1680616@yahoo.com.tw    Sub-Investigator: Yu-Cheng Kuo          Sub-Investigator: Ji-An Liang, MD          Li-Ching Lin Recruiting Tainan, Taiwan, 700 Contact: Li-Ching Lin, MD       liching51@yahoo.com.tw    Jeng-Fong Chiou Recruiting Taipei, Taiwan, 100 Contact: Jeng-Fong Chiou, MD;PhD       sjfchiou@xuite.net Less <<
NCT00126568 - Terminated - -
NCT00810394 - Completed - -
NCT00703638 Breast Cancer ... More >> Colorectal Cancer Head and Neck Cancer Lung Cancer Mesothelioma Pancreatic Cancer Prostate Cancer Sarcoma Less << Phase 1 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01306058 Hepatoma Live... More >>r Neoplasms Adenoma, Liver Cell Carcinoma, Hepatocellular Liver Neoplasms, Experimental Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01561833 T Cell Lymphoma Phase 1 Completed - United States, Connecticut ... More >> Yale Cancer Center New Haven, Connecticut, United States, 06510 Less <<
NCT01306058 - Completed - -
NCT00808145 Hepatocellular Carcinoma Phase 2 Withdrawn(Lack of enrollment, ... More >>many screen failures and non eligible study participants) Less << - United States, Massachusetts ... More >> Lahey Clinic Burlington, Massachusetts, United States, 01805 Less <<
NCT00801801 - Terminated(Sponsors withdrew f... More >>unding; preliminary efficacy data was not encouraging.) Less << - -
NCT00801801 Non Squamous Cell Lung Cancer ... More >> Non Small Cell Lung Cancer Less << Phase 2 Terminated(Sponsors withdrew f... More >>unding; preliminary efficacy data was not encouraging.) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 - 0104 Less <<
NCT00854620 Carcinoma, Renal Cell ... More >> Kidney Disease Kidney Cancer Less << Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT02069145 Hepatocellular Cancer ... More >> Liver Cancer Less << Phase 1 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Indiana Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Massachusetts Massachussetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York Mount Sinai Medical Center New York, New York, United States, 10029 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT01029418 Hepatocellular Carcinoma Phase 1 Phase 2 Terminated(The phase II portio... More >>n was not conducted due to funding issue.) Less << - Singapore ... More >> National University Hospital Singapore Singapore, Singapore, 119074 National Cancer Centre Singapore Singapore, Singapore, 169610 Less <<
NCT00854620 - Completed - -
NCT01861314 Acute Myeloid Leukemia ... More >> Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Active, not recruiting - United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT02530476 Leukemia Acut... More >>e Myeloid Leukemia Less << Phase 1 Phase 2 Active, not recruiting December 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00954278 Carcinoma, Non Small Cell Lung Phase 1 Active, not recruiting December 2018 United States, Wisconsin ... More >> University of Wisconsin - Madison Madison, Wisconsin, United States, 53792 Less <<
NCT01005199 Liver Cancer Phase 2 Completed - Austria ... More >> Medizinische Universität Wien Wien, Austria, 1090 Hungary Szent Laszlo Korhaz Budapest, Hungary, 1097 Switzerland Saint Claraspital AG Basel, Switzerland, CH-4016 Clinical Cancer Research Center at University Hospital Basel Basel, Switzerland, CH-4031 Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland, 6500 Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital Liestal Liestal, Switzerland, CH-4410 CHCVS - Hôpital de Sion Sion, Switzerland, 1950 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 City Hospital Triemli Zurich, Switzerland, CH-8063 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT02185560 - Recruiting June 30, 2021 Japan ... More >> Recruiting Multiple Locations, Japan Less <<
NCT01334710 - Terminated(safety issue observ... More >>ed on another hepatocellular study using OSI906) Less << - -
NCT03211416 Advanced Adult Hepatocellular ... More >>Carcinoma Child-Pugh Class A Stage III Hepatocellular Carcinoma Stage IIIA Hepatocellular Carcinoma Stage IIIB Hepatocellular Carcinoma Stage IIIC Hepatocellular Carcinoma Stage IV Hepatocellular Carcinoma Stage IVA Hepatocellular Carcinoma Stage IVB Hepatocellular Carcinoma Less << Phase 1 Phase 2 Recruiting October 11, 2019 United States, New York ... More >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Roswell Park    877-275-7724    ASKRPCI@roswellpark.org    Principal Investigator: Renuka V. Iyer Less <<
NCT01398501 Acute Myeloid Leukemia Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02214 Less <<
NCT00875745 Leukemia, Myeloid, Acute ... More >> Leukemia, Promyelocytic, Acute Myelodysplastic Syndromes Less << Phase 1 Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT01338857 neurofibromatosis1 (NF1) ... More >> Recurrent or Progressive Optic Pathway Gliomas (OPG) Recurrent or Progressive Low-grade Glioma Less << Phase 2 Terminated(Sorafenib ineffecti... More >>ve for tx of recurrent or progressive PLGA) Less << - United States, New York ... More >> New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders New York, New York, United States, 10016 Less <<
NCT01334710 Liver Cancer Phase 2 Terminated(safety issue observ... More >>ed on another hepatocellular study using OSI906) Less << - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00880542 - Terminated(The study lost fund... More >>ing.) Less << - -
NCT00880542 Sarcoma Phase 2 Terminated(The study lost fund... More >>ing.) Less << - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT01851408 Melanoma Recu... More >>rrent Melanoma Stage III Melanoma Stage IV Melanoma Less << Phase 2 Withdrawn(No progression of Ph... More >>ase 1 trial to Phase 2.) Less << - -
NCT01338857 - Terminated(Sorafenib ineffecti... More >>ve for tx of recurrent or progressive PLGA) Less << - -
NCT00767468 Liver Cancer Phase 1 Terminated(Funding unavailable... More >>) Less << - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT01730937 Adult Primary Hepatocellular C... More >>arcinoma Advanced Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer Less << Phase 3 Recruiting June 2025 -
NCT00933777 Unspecified Adult Solid Tumor,... More >> Protocol Specific Non-Small Cell Lung Cancer Less << Phase 1 Completed - Germany ... More >> Center for Integrated Oncology, Dep.I of Internal Medicine, University Hospital Cologne Cologne, Germany Less <<
NCT00544609 Bladder Cancer Phase 1 Completed - Spain ... More >> Hospital Clínic i Provincial de Barcelona Barcelona, Spain Hospital de la Santa Creu i Sant Pau Barcelona, Spain Institut Català d' Oncología Barcelona, Spain Less <<
NCT01342627 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Terminated(low enrollment rate... More >>) Less << - Italy ... More >> Centro di Riferimento Oncologico Aviano, Pordenone, Italy, 33081 Less <<
NCT00480389 Renal Cell Carcinoma ... More >> Metastatic Disease Less << Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital, University Health Network Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT02599337 Fasting Phase 1 Completed - Canada, Quebec ... More >> Inventiv Health Clinique Inc. Québec, Quebec, Canada, G1P 0A2 Less <<
NCT00390325 Hereditary Thyroid Gland Medul... More >>lary Carcinoma|Locally Advanced Thyroid Gland Medullary Carcinoma|Multiple Endocrine Neoplasia Type 2A|Multiple Endocrine Neoplasia Type 2B|Recurrent Thyroid Gland Medullary Carcinoma|Sporadic Thyroid Gland Medullary Carcinoma|Stage III Thyroid Gland Medullary Carcinoma AJCC v7|Stage IV Thyroid Gland Medullary Carcinoma AJCC v7|Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7|Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7|Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7 Less << PHASE2 COMPLETED 2022-12-22 Washington University School o... More >>f Medicine, Saint Louis, Missouri, 63110, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States Less <<
NCT01556815 PHENYTOIN/SORAFENIB [VA Drug I... More >>nteraction] Liver Neoplasms Carcinoma, Hepatocellular Digestive System Neoplasms Neoplasms by Site Liver Diseases Adenocarcinoma Carcinoma Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type DOXORUBICIN/TRASTUZUMAB [VA Drug Interaction] HBV Less << Phase 2 Unknown May 2015 China, Shandong ... More >> Shandong Cancer Hospital and Institute Not yet recruiting Jinan, Shandong, China, 250117 Contact: Wenbo Shao, MD, Ph D    +8653167626412    shaowenbomd@gmail.com    Principal Investigator: Jinlong Song, MD          Sub-Investigator: Wenbo Shao, MD, Ph D Less <<
NCT01906216 Hepatocellular Carcinoma Phase 2 Phase 3 Recruiting December 2018 China, Shaanxi ... More >> Xijing Hospital of Digestive Disease Recruiting Xi`an, Shaanxi, China, 710032 Contact: Wei Bai, MD    +8615991771343       Contact: Yan Zhao, MD    +8613571884093 Less <<
NCT01444807 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Recruiting September 2019 Italy ... More >> Istituto Tumori Milano Recruiting Milan, Mi, Italy, 20156 Contact: Giuseppe Procopio, MD    +390223902557    Giuseppe.Procopio@istitutotumori.mi.it    Contact: Elena Verzoni, MD    +390223902557    elena.verzoni@istitutotumori.mi.it    Principal Investigator: Giuseppe Procopio, MD          Cinzia Ortega Recruiting Alba, Italy Alessandra Bearz Recruiting Aviano, Italy Alfredo Berruti Recruiting Brescia, Italy Saverio Cinieri Recruiting Brindisi, Italy Francesco Atzori Recruiting Cagliari, Italy Rodolfo Passalaqua Recruiting Cremona, Italy Francesco Di Costanzo Recruiting Firenze, Italy Vincenzo Emanuele Chiuri Recruiting Lecce, Italy Alessandra Mosca Recruiting Novara, Italy Vittorio Gebbia Recruiting Palermo, Italy Enrico Cortesi Recruiting Roma, Italy Francesco Cognetti Recruiting Roma, Italy Contact: Michele Milella          Franco Morelli Recruiting San Giovanni Rotondo, Italy Less <<
NCT02196857 Leukemia Phase 2 Active, not recruiting February 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01303341 Advanced Malignant Solid Neopl... More >>asm Recurrent Melanoma Refractory Malignant Solid Neoplasm Stage III Cutaneous Melanoma AJCC v7 Stage IIIA Cutaneous Melanoma AJCC v7 Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIC Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7 Less << Phase 1 Active, not recruiting - United States, New Jersey ... More >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT01507064 Hepatocellular Carcinoma Phase 2 Completed - Italy ... More >> UOSC Epatologia - Cardarelli Hospital Napoli, Italy, 80131 Less <<
NCT03582618 Hepatocellular Carcinoma ... More >> Advanced Cancer Less << Phase 2 Recruiting June 2021 United States, California ... More >> Innovative Clinical Research Institute Recruiting Whittier, California, United States, 90603 United States, South Carolina Charleston Hematology Oncology Associates Recruiting Charleston, South Carolina, United States, 29403 Taiwan National Cheng Kung University Hospital Not yet recruiting Tainan, Taiwan, 704 Less <<
NCT02298348 Neuroblastoma Phase 1 Active, not recruiting May 2019 United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Colorado Children Hospital of Colorado Aurora, Colorado, United States, 80045 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago, Comer Children's Hospital Chicago, Illinois, United States, 60637 United States, Massachusetts Childrens Hospital Boston, Dana-Farber Cancer Institute. Boston, Massachusetts, United States, 02115 United States, Michigan C.S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Texas Cook Children's Healthcare System Fort Worth, Texas, United States, 76104 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT02311205 Hepatocellular Carcinoma ... More >> Metastasis Less << Phase 2 Active, not recruiting June 2018 Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT00846131 Hepatocellular Carcinoma Phase 1 Completed - United States, Illinois ... More >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Less <<
NCT00997022 Hepatocellular Cancer Phase 1 Completed - United States, California ... More >> University of Southern California Los Angeles, California, United States, 90089 University of California, Los Angeles Los Angeles, California, United States, 90095 United States, New York Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT01254890 - Completed - -
NCT01510756 Chronic Lymphocytic Leukemia Phase 2 Terminated(slow enrollment) - United States, California ... More >> UCSD Medical Center La Jolla, California, United States, 92093 Less <<
NCT01510756 - Terminated(slow enrollment) - -
NCT01471353 Colorectal Cancer Metastatic Phase 2 Completed - United States, Florida ... More >> UF Health Cancer Center Gainesville, Florida, United States, 32610 Less <<
NCT01254890 Leukemia Phase 1 Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00780169 Metastatic Colorectal Cancer Phase 1 Completed - Canada, Ontario ... More >> The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT00478114 Renal Cell Carcinoma Phase 3 Completed - Thailand ... More >> Siriraj Hospital, Department of Medicine Bangkoknoi, Bangkok, Thailand, 10700 Less <<
NCT01471353 - Completed - -
NCT03535259 Hepatocellular Carcinoma, Radi... More >>otherapy, Sorafenib Less << Phase 2 Recruiting April 1, 2021 China, Beijing ... More >> Bo Chen Recruiting Beijing, Beijing, China, 100021 Contact: Bo Chen, MD    008613240000876    chenboo@outlook.com    Contact: Yexiong Li, MD    00861087788860    yexiong12@163.com    Principal Investigator: Yexiong Li, MD          Principal Investigator: Bo Chen, MD          Sub-Investigator: Huiying Zeng, MD          Sub-Investigator: Liming Wang, MD Less <<
NCT02560779 Hepatocellular Carcinoma Phase 1 Phase 2 Recruiting November 2020 United States, Alabama ... More >> University of Alabama Recruiting Birmingham, Alabama, United States, 35294-3300 United States, California City of Hope Withdrawn Duarte, California, United States, 91010 United States, Maryland National Cancer Institute Withdrawn Bethesda, Maryland, United States, 20892 United States, Ohio University Hospitals Recruiting Cleveland, Ohio, United States, 44106 United States, Texas MD Anderson Recruiting Houston, Texas, United States, 77030-4009 Less <<
NCT02021929 Hepatopulmonary Syndrome Phase 2 Terminated - United States, Arizona ... More >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, Illinois Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 United States, Minnesota Mayo Clinic - Rochester Rochester, Minnesota, United States, 55905 United States, New York Columbia University-NewYork-Presbyterian Hospital New York, New York, United States, 10032 United States, Pennsylvania University of Pennsylvania - Perelman Center Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29424 United States, Texas University of Texas Health Science Center at Houston Medical School Houston, Texas, United States, 77030 Less <<
NCT01075113 Liver Cancer Phase 1 Active, not recruiting January 31, 2023 United States, Virginia ... More >> Hunter Holmes McGuire VA Medical Center Richmond, Virginia, United States, 23249 Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT02867280 Hepatocellular Carcinoma ... More >> Recurrence Less << Phase 3 Recruiting June 2023 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Minshan Cchen, M.D.    8620-87343117    chenmsh@sysucc.org.cn    Contact: Li Xu, M.D.       xuli@sysucc.org.cn    Principal Investigator: Minshan Chen, M.D. Less <<
NCT01203787 Hepatocellular Carcinoma Phase 4 Completed - United States, Florida ... More >> University of Florida Hepatology Gainesville, Florida, United States, 32610-0277 Mayo Clinic Jacksonville, Florida, United States, 32224 Florida Hospital Transplant Center Orlando, Florida, United States, 32804 Tampa General Hospital Tampa, Florida, United States, 33606 United States, Illinois Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Pennsylvania Drexel University College of Medicine Philadelphia, Pennsylvania, United States, 19107 United States, Texas University of Texas Health Science Center Houston Houston, Texas, United States, 77030 Brooke Army Medical Center San Antonio, Texas, United States, 78234 Less <<
NCT01203787 - Completed - -
NCT02072486 Advanced Adult Hepatocellular ... More >>Carcinoma Localized Non-Resectable Adult Hepatocellular Carcinoma Stage III Childhood Hepatocellular Carcinoma Stage IIIA Hepatocellular Carcinoma Stage IIIB Hepatocellular Carcinoma Stage IIIC Hepatocellular Carcinoma Stage IV Childhood Hepatocellular Carcinoma Stage IVA Hepatocellular Carcinoma Stage IVB Hepatocellular Carcinoma Less << Not Applicable Active, not recruiting December 3, 2018 United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT03565536 Thyroid Cancer, Anaplastic Phase 2 Recruiting October 30, 2019 China, Fujian ... More >> Fujian Medical University Union Hospital Recruiting FuZhou, Fujian, China, 350001 Contact: bo wang, md    13705947900    wangbo@fjmu.edu.cn Less <<
NCT01425216 Keloids Phase 2 Terminated(IND application was... More >> not approved by the US FDA - Project was never started) Less << - United States, New York ... More >> Michael H. Tirgan, MD New York, New York, United States, 10023 Less <<
NCT01900002 Liver Cancer Phase 2 Active, not recruiting September 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02122003 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Terminated(availability of new... More >> and more promising therapeutic agents than expected in the experimentation in question) Less << - Italy ... More >> Istituto Tumori Milan, Mi, Italy, 20156 Less <<
NCT02733809 Hepatocellular Carcinoma Phase 4 Recruiting December 2024 Saudi Arabia ... More >> King Saud University Medical City Recruiting Riyadh, Saudi Arabia, 7805 Contact: Weam S Husseim    +966541480459    wshussain@ksu.edu.sa    Principal Investigator: Dr. Mazen M Hassanain, MBBS FRCSC FACS PhD          Sub-Investigator: Prof. Ayman A Abdo, MD, FRCPC, FACP          Sub-Investigator: Dr. Khalid A Alswat, MD, ABIM, MRCP,FACP          Sub-Investigator: Prof. Waleed K Alhamoudi          Principal Investigator: Dr. Shouki M Bazarbashi Less <<
NCT02636426 Neoplasms Phase 1 Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Noord-Holland, Netherlands, 1081 HV Less <<
NCT02288507 Hepatocellular Cancer Phase 1 Withdrawn(Closed due to no acc... More >>rual) Less << - United States, Hawaii ... More >> University of Hawaii Honolulu, Hawaii, United States, 96813 Less <<
NCT02084732 Thyroid Cancer Phase 2 Unknown June 2018 Colombia ... More >> Instituto Nacional de Cancerología Recruiting Bogotá, Cundinamarca, Colombia, 00000 Contact: Yeinnyer C. Muleth, BSc    3340106    ymuleth@cancer.gov.co    Principal Investigator: Luis F Fierro, Md          Sub-Investigator: Gloria Garavito, Md          Sub-Investigator: Andres A Cuellar, Md          Sub-Investigator: Jose A. Carreño, Md          Sub-Investigator: Juan S Castillo, Md Less <<
NCT01801163 Hepatocellular Carcinoma Phase 1 Withdrawn(Trial had no patient... More >>s accrued while open) Less << - United States, Indiana ... More >> Indiana University Indianapolis, Indiana, United States, 46202 Less <<
NCT00825734 Metastatic Breast Cancer Phase 1 Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Ft. Myers, Florida, United States, 33916 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 RHHP/ Hope Cancer Center Terre Haute, Indiana, United States, 47802 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 United States, Louisiana Hematology Oncology Clinic, LLP Baton Rouge, Louisiana, United States, 70806 United States, Maine Mercy Hospital Portland, Maine, United States, 04101 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63044 United States, New Hampshire Portsmouth Regional Hospital Portsmouth, New Hampshire, United States, 03801 United States, New Jersey Hematology-Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07962 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates Columbia, South Carolina, United States, 29210 Spartanburg Regional Medical Center Spartanburg, South Carolina, United States United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00095966 Adenocarcinoma of the Pancreas... More >> Recurrent Pancreatic Cancer Stage II Pancreatic Cancer Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT00217646 Adult Acute Basophilic Leukemi... More >>a|Adult Acute Eosinophilic Leukemia|Adult Acute Megakaryoblastic Leukemia|Adult Acute Monoblastic Leukemia|Adult Acute Monocytic Leukemia|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With Maturation|Adult Acute Myeloid Leukemia With Minimal Differentiation|Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1|Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL|Adult Acute Myeloid Leukemia Without Maturation|Adult Acute Myelomonocytic Leukemia|Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA|Adult Erythroleukemia|Adult Pure Erythroid Leukemia|Alkylating Agent-Related Acute Myeloid Leukemia|Blastic Phase|de Novo Myelodysplastic Syndrome|Previously Treated Myelodysplastic Syndrome|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndrome Less << PHASE1 COMPLETED - M D Anderson Cancer Center, Ho... More >>uston, Texas, 77030, United States Less <<
NCT01076010 Advanced Renal Cell Carcinoma Phase 3 Completed - -
NCT01290926 Colorectal Cancer Phase 2 Completed - Belgium ... More >> Cliniques Universitaires Saint Luc Woluwe Saint Lambert, Bruxelles, Belgium, 1200 Universiteit Ziekenhuis Antwerpen Antwerpen, Belgium Institut Jules Bordet Brussels, Belgium, 1000 Hopital Erasme Brussels, Belgium, 1070 Entité Jolimontoise La Louviere, Belgium Hopitaux St Joseph Liege, Belgium, 4000 CHU Ambroise Paré Mons, Belgium, 7000 Less <<
NCT03674060 Healthy, Male Phase 1 Not yet recruiting February 2019 -
NCT00825734 - Completed - -
NCT01932177 Metastatic or Locally Advanced... More >> Solid Tumors Less << Phase 1 Unknown October 2015 France ... More >> Hospices Civils de Lyon Recruiting Lyon, France, 69002 Less <<
NCT00287495 Kaposi's Sarcoma ... More >> HHV-8 KSHV Less << Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02259647 Hepatocellular Carcinoma Not Applicable Unknown June 2016 India ... More >> Institute of Liver & Biliary Sciences Recruiting New Delhi, Delhi, India, 110070 Contact: Dr Devraj R, MD    011-46300000    drdevurgowda@gmail.com    Principal Investigator: Dr Devraja R, MD Less <<
NCT00712790 Hepatocellular Carcinoma Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seoul, Korea, Republic of Malaysia Selayang Hospital Selangor, Malaysia Myanmar Yangon GI & Liver Centre Yangon, Myanmar Singapore Singapore General Hospital Singapore, Singapore, 169608 National Cancer Centre Singapore, Singapore, 169610 Less <<
NCT02575339 Hepatocellular Carcinoma ... More >> Liver Cancer HCC Less << Phase 1 Phase 2 Active, not recruiting June 2020 United States, Illinois ... More >> Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 University of Illinois Cancer Center Chicago, Illinois, United States, 60612 United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, North Carolina University of Noth Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27514 United States, Pennsylvania Penn State Cancer Institute Hershey, Pennsylvania, United States, 17033 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53705 Less <<
NCT00562913 Cancer Phase 1 Completed - Canada, Alberta ... More >> Edmonton, Alberta, Canada, T6G 1Z2 Canada, Quebec Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT03439891 Stage III Hepatocellular Carci... More >>noma AJCC v8 Stage IIIA Hepatocellular Carcinoma AJCC v8 Stage IIIB Hepatocellular Carcinoma AJCC v7 Stage IIIC Hepatocellular Carcinoma AJCC v7 Stage IV Hepatocellular Carcinoma AJCC v8 Stage IVA Hepatocellular Carcinoma AJCC v8 Stage IVB Hepatocellular Carcinoma AJCC v8 Less << Phase 2 Recruiting December 31, 2020 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94158 Contact: Robin K. Kelley    877-827-3222    cancertrials@ucsf.edu    Principal Investigator: Robin K. Kelley Less <<
NCT03412773 Hepatocellular Carcinoma (HCC) Phase 3 Recruiting May 2022 -
NCT00586105 Carcinoma, Renal Cell Phase 3 Completed - China, Jiangsu ... More >> Nanjing, Jiangsu, China, 210003 China Beijing, China, 100021 Shanghai, China, 200032 Shanghai, China, 200127 Taiwan Tainan, Taiwan, 70428 Taipei, Taiwan, 10002 Taipei, Taiwan, 112 Taoyuan, Taiwan, 333 Less <<
NCT01434602 Brain Tumor G... More >>lioblastoma Anaplastic Glioma Less << Phase 1 Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02358395 Hepatocellular Carcinoma Phase 1 Completed - Japan ... More >> 4 Sites Tokyo,etc, Japan Less <<
NCT01445080 Leukemia With... More >> AML and FLT3-ITD Mutations Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00586105 - Completed - -
NCT01253070 Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia (Megakaryoblastic) With t(1;22)(p13.3;q13.1); RBM15-MKL1 Acute Myeloid Leukemia With a Variant RARA Translocation Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214 Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-KMT2A Acute Myeloid Leukemia With Variant MLL Translocations Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Active, not recruiting - -
NCT01253070 - Active, not recruiting - -
NCT00999843 Hepatocellular Carcinoma Phase 1 Phase 2 Unknown October 2012 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Less <<
NCT00981162 Acinar Cell Adenocarcinoma of ... More >>the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Colorado ... More >> University of Colorado at Denver Health Sciences Center Aurora, Colorado, United States, 80045 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT01030783 Advanced Renal Cell Carcinoma Phase 3 Completed - -
NCT00101400 Breast Neoplasms ... More >> Breast Cancer Less << Phase 2 Completed - Germany ... More >> Stuttgart, Baden-Württemberg, Germany, 70199 München, Bayern, Germany, 80637 Frankfurt, Hessen, Germany, 60590 Italy Bologna, Italy, 40138 Milano, Italy, 20133 Milano, Italy, 20162 Parma, Italy, 43100 Less <<
NCT00373373 Acute Myeloid Leukemia Phase 2 Completed - Germany ... More >> Charité Campus Benjamin Franklin, Med. Klinik III Berlin, Germany, 12203 Klinikum Chemnitz GmbH, Klinik für Innere Medizin III Chemnitz, Germany, 09113 Universitätsklinikum Carl Gustav Carus der TU Dresden, Medizinische Klinik I Dresden, Germany, 01307 St. Johannes Hospital, Medizinische Klinik II Duisburg, Germany, 47166 Universitätsklinikum Essen, Zentrum für Innere Medizin, Medizinische Klinik und Poliklinik für Hämatologie Essen, Germany, 45147 Klinikum der J. W. Goethe-Universität Frankfurt am Main, Medizinische Klinik II Frankfurt / Main, Germany, 60590 Allgemeines Krankenhaus St. Georg, Hämatologische Abteilung Hamburg, Germany, 20099 Universitätsklinikum Heidelberg, Med. Klinik V Heidelberg, Germany, D-69120 Klinikum der Universität zu Köln, Klinik I für Innere Medizin Köln, Germany, 50937 Klinikum der Johannes Gutenberg Universität, 3. Medizinische Klinik und Poliklinik Mainz, Germany, 55101 Philipps Universität, Abteilung für Hämatologie, Onkologie und Immunologie Marburg, Germany, 35043 Klinik für Hämatologie und Onkologie Klinikum Minden Minden, Germany, 32423 TU München, Medizinische Klinik III München, Germany, 81675 Universitätsklinikum Münster, Medizinische Klinik A Münster, Germany, 48149 Klinikum Nürnberg, 5. Medizinische Klinik Einheit für Knochenmarktransplantation Nürnberg, Germany, 90419 Universität Regensburg, Abteilung für Hämatologie und Internistische Onkologie Regensburg, Germany, 93042 Robert-Bosch Krankenhaus Stuttgart Stuttgart, Germany, 70376 Julius-Maximilians-Universität Würzburg, Medizinische Klinik und Poliklinik II Würzburg, Germany, 97979 Less <<
NCT00589550 Kidney Cancer Phase 1 Terminated(low accrual) - United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT03178656 Portal Vein Tumor Thrombus Phase 4 Recruiting December 15, 2019 China, Hubei ... More >> Hepatic surgery center, Tong ji Hospital Recruiting Wuhan, Hubei, China, 430030 Contact: Xiaoping Chen, Doctor    8602783662851    chenxp@medmail.com.cn    Contact: Qiong Gong, Doctor    8618086496360    dtjgq486@hust.edu.cn    Principal Investigator: peng zhu, doctor Less <<
NCT00647426 Non-Small Cell Lung Cancer Phase 2 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00606125 Neoplasms Phase 1 Completed - United States, Connecticut ... More >> New Haven, Connecticut, United States, 06511-5991 United States, Texas San Antonio, Texas, United States, 78229-3307 Less <<
NCT02450149 Refractory Solid Tumors Not Applicable Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, seoul, korea, Republic of, Korea, Republic of, 135-710 Less <<
NCT00589550 - Terminated(low accrual) - -
NCT01534260 Acute Myeloid Leukemia Phase 1 Phase 2 Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00461851 Bladder Cancer Phase 2 Completed - United States, Connecticut ... More >> Yale University, Comprehensive Cancer Center New Haven, Connecticut, United States, 06520 Less <<
NCT00101400 - Completed - -
NCT00461851 - Completed - -
NCT00096395 Recurrent Ovarian Epithelial C... More >>ancer Recurrent Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01534260 - Completed - -
NCT00828074 - Completed - -
NCT01187212 Malignant Neoplasm of Stomach ... More >> Effects of Chemotherapy Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Songpa-gu, Seoul, Korea, Republic of, 138-736 Less <<
NCT00411671 Lung Cancer Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01098760 Hepatocellular Carcinoma Phase 4 Completed - Taiwan ... More >> Chia Yi, Taiwan, 613 Hualien county, Taiwan, 970 Kaohsiung City, Taiwan, 807 Kaohsiung City, Taiwan, 8330 Taichung City, Taiwan Taipei City,, Taiwan Taoyuan, Taiwan, 33305 Less <<
NCT00411671 - Completed - -
NCT00828074 Breast Cancer Phase 1 Phase 2 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 South Pasadena Cancer Center Pasadena, California, United States, 91030 Less <<
NCT00098540 Recurrent Non-small Cell Lung ... More >>Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Completed - United States, Minnesota ... More >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 Less <<
NCT02774187 Hepatocellular Carcinoma Phase 3 Active, not recruiting August 2018 China, Guangdong ... More >> Dongguan People 's Hospital Dongguan, Guangdong, China, 523059 Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China, 510060 The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Guangzhou Twelfth People 's Hospita Guangzhou, Guangdong, China, 510620 The Kaiping Center's Hospital Kaiping, Guangdong, China, 529300 China, Hunan First Affiliated Hospital of University Of South China Hengyang, Hunan, China, 421001 China, Shanxi First Affiliated Hospital Of Xi'an Jiaotong University Xi'an, Shanxi, China, 710061 Less <<
NCT02425605 Hepatocellular Carcinoma Phase 2 Unknown January 2018 Korea, Republic of ... More >> Department of Internal Medicine, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 120-752 Contact: BeomKyung Kim, M.D., Ph.D.    +82-2-2228-1930    beomkkim@yuhs.ac    Contact: Wonseok Kang, M.D., Ph.D.       WSKANG79@yuhs.ac Less <<
NCT01605734 PHENYTOIN/SORAFENIB [VA Drug I... More >>nteraction] Carcinoma, Hepatocellular Less << Phase 2 Unknown December 2015 China, Shandong ... More >> Shandong Medical Imaging Research Institute Not yet recruiting Jinan, Shandong, China, 250021 Contact: Jun Tang, MD    +8613964031909    tangjun7925032@163.com    Principal Investigator: Jun Tang, MD          Qilu Hospital of Shandong University Not yet recruiting Jinan, Shandong, China, 250114 Contact: Caixia Li, MD    +8613505312972    Lilyshanda88@hotmail.com    Principal Investigator: Caixia Li, MD          Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 the Affiliated Hospital of Medical College Qingdao University Not yet recruiting Qingdao, Shandong, China, 266003 Contact: Zixiang Li, MD    +8618669739263    zixiangli@yahoo.com.cn    Principal Investigator: Zixiang Li, MD          Yantai Yuhuangding Hospital Not yet recruiting Yantai, Shandong, China, 264000 Contact: Yanbo Zheng, MD    +8613805356068    13805356068@163.com    Principal Investigator: Yanbo Zheng Less <<
NCT02748304 Hepatocellular Carcinoma Not Applicable Recruiting June 2021 China ... More >> Huashan hospital Recruiting Shanghai, China, 200040 Contact: Lu Lu, MD    862152887175    lulu@huashan.org.cn Less <<
NCT00722072 Breast Cancer Phase 2 Terminated(Sponsor pulled fund... More >>ing and low accrual) Less << - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT01724606 Breast Cancer ... More >> Brain Metastases Less << Phase 1 Recruiting November 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States Contact: Andrew Seidman, MD    646-888-5445       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Andrew Seidman, MD    646-888-5445       United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Andrew Seidman, MD    646-422-4333       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Andrew Seidman, MD    646-888-5445       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Andrew Seidman, MD    646-888-5445       Contact: Kathryn Beal, MD    212-639-5159       Principal Investigator: Andrew Seidman, MD          Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Andrew Seidman, MD    646-888-5445 Less <<
NCT00722072 - Terminated(Sponsor pulled fund... More >>ing and low accrual) Less << - -
NCT00112671 Metastatic Transitional Cell C... More >>ancer of the Renal Pelvis and Ureter Recurrent Bladder Cancer Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter Regional Transitional Cell Cancer of the Renal Pelvis and Ureter Stage III Bladder Cancer Stage IV Bladder Cancer Transitional Cell Carcinoma of the Bladder Less << Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00112671 - Completed - -
NCT00329719 Adult Glioblastoma ... More >> Adult Gliosarcoma Recurrent Adult Brain Neoplasm Less << Phase 1 Phase 2 Completed - -
NCT01470495 HCC Radiofreq... More >>uency Ablation Sorafenib Less << Not Applicable Recruiting December 2018 China, Chongqing ... More >> Institute of hepatobiliary surgery,southwest hospital Recruiting Chongqing, Chongqing, China, 400038 Contact: feng xiaobin, MD    +86-23-13228683243    fengxiaobin200708@yahoo.com.cn    Principal Investigator: feng xiaobin, MD Less <<
NCT01100242 - Terminated(Low accrual) - -
NCT00349206 Melanoma Recu... More >>rrent Melanoma Stage III Melanoma Stage IV Melanoma Less << Phase 1 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00329719 - Completed - -
NCT01005797 Renal Cancer ... More >>Non Small Cell Lung Cancer (NSCLC) Soft Tissue Sarcoma Less << Phase 1 Completed - United States, South Carolina ... More >> Medical University of South Carolina Hollings Cancer Center Charleston, South Carolina, United States, 29425 Less <<
NCT00112905 Adenocarcinoma of the Bladder ... More >> Distal Urethral Cancer Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Proximal Urethral Cancer Recurrent Bladder Cancer Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter Recurrent Urethral Cancer Regional Transitional Cell Cancer of the Renal Pelvis and Ureter Squamous Cell Carcinoma of the Bladder Stage III Bladder Cancer Stage IV Bladder Cancer Transitional Cell Carcinoma of the Bladder Urethral Cancer Associated With Invasive Bladder Cancer Less << Phase 2 Terminated - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00759928 Refractory Solid Tumors Phase 1 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33916 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT00131989 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less <<
NCT00119249 Stage III Melanoma ... More >> Stage IV Melanoma Less << Phase 2 Completed - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467-2490 Less <<
NCT02624700 Breast Cancer ... More >> Metastatic Breast Cancer Recurrent Breast Cancer Less << Phase 2 Recruiting April 1, 2025 United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Recruiting Richmond, Virginia, United States, 23298 Contact: Alison Ryan, NP    804-628-1936    masseysiit@vcu.edu    Contact: Andrew S Poklepovic, MD    804-628-2321    andrew.poklepovic@vcuhealth.org    Principal Investigator: Andrew S Poklepovic, MD Less <<
NCT01100242 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Terminated(Low accrual) - United States, New Mexico ... More >> University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 The Cancer Center at Presbyterian Albuquerque, New Mexico, United States, 87110 Memorial Medical Center- Cancer Center Las Cruces, New Mexico, United States, 88011 Less <<
NCT00557830 Renal Cell Carcinoma Phase 2 Terminated(The study was close... More >>d to enrollment when it became clear that enrollment was too slow to complete the full enrollment target within the time frame allowed.) Less << - United States, Arkansas ... More >> Clopton Clinic Jonesboro, Arkansas, United States, 72401 United States, California Wilshire Oncology Medical Group, Inc. La Verne, California, United States, 91750 United States, Florida Advanced Medical Specialties Miami, Florida, United States, 33176 United States, Georgia Northeast Georgia Cancer Care Athens, Georgia, United States, 30607 Peachtree Hematology Oncology Consultants Atlanta, Georgia, United States, 30309 Central Georgia Cancer Care Macon, Georgia, United States, 31201 Northwest Georgia Oncology Centers Marietta, Georgia, United States, 30060 United States, Illinois Mid-Illinois Hematology and Oncology Associates, Ltd. Normal, Illinois, United States, 61761 United States, Montana Hematology Oncology Centers of the Northern Rockies Billings, Montana, United States, 59101 United States, North Carolina Gaston Hematology and Oncology Gastonia, North Carolina, United States, 28054 United States, Oregon Pacific Oncology, PC Beaverton, Oregon, United States, 97006 United States, Pennsylvania The Lancaster Cancer Center, Ltd Lancaster, Pennsylvania, United States, 17605 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 Less <<
NCT00112905 - Terminated - -
NCT00618982 Carcinoma, Renal Cell Phase 2 Completed - France ... More >> Bordeaux, France, 33000 La Roche Sur Yon, France, 85925 Marseille, France, 13385 Nantes, France, 44805 Paris Cedex 10, France, 75475 Tours, France, 37044 Germany Tübingen, Baden-Württemberg, Germany, 72076 Marburg, Hessen, Germany, 35043 Hannover, Niedersachsen, Germany, 30625 Mainz, Rheinland-Pfalz, Germany, 55131 Jena, Thüringen, Germany, 07740 Italy Aviano, Pordenone, Italy, 33081 Milano, Italy, 20133 Pavia, Italy, 27100 Poland Olsztyn, Poland, 10-226 Warszawa, Poland, 02-781 Warszawa, Poland, 04-141 Wroclaw, Poland, 50 - 556 United Kingdom Greater Manchester, Manchester, United Kingdom, M20 4BX Cardiff, South Glamorgan, United Kingdom, CF14 7TB Glasgow, United Kingdom, G12 0YN London, United Kingdom, SW3 6JJ Less <<
NCT00618982 - Completed - -
NCT00785226 Advanced Cancer Phase 1 Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and LAC/USC Medical Center Los Angeles, California, United States, 90033 United States, Nevada Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89169 United States, New York New York Oncology Hematology, PC Albany, New York, United States, 12206 Roswell Park Cancer Institute Buffalo, New York, United States, 14263 James P. Wilmot Cancer Center Rochester, New York, United States, 14642 United States, Pennsylvania UPenn Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Greenville Hospital System University Medical Center, (ITOR) Greenville, South Carolina, United States, 29605 United States, Texas Texas Oncology - Baylor Charles A. Simmons Cancer Center Dallas, Texas, United States, 75246 Texas Oncology-Tyler Tyler, Texas, United States, 75702 Canada, Ontario Toronto General Hospital Toronto, Ontario, Canada, M5G 2N2 Less <<
NCT01608139 Advanced Cancers Phase 1 Withdrawn - -
NCT00557830 - Terminated(The study was close... More >>d to enrollment when it became clear that enrollment was too slow to complete the full enrollment target within the time frame allowed.) Less << - -
NCT00392821 - Completed - -
NCT00096512 Metastatic Squamous Neck Cance... More >>r With Occult Primary Squamous Cell Carcinoma Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Salivary Gland Squamous Cell Carcinoma Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IVA Salivary Gland Cancer Stage IVA Squamous Cell Carcinoma of the Larynx Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVA Verrucous Carcinoma of the Larynx Stage IVA Verrucous Carcinoma of the Oral Cavity Stage IVB Salivary Gland Cancer Stage IVB Squamous Cell Carcinoma of the Larynx Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVB Verrucous Carcinoma of the Larynx Stage IVB Verrucous Carcinoma of the Oral Cavity Stage IVC Salivary Gland Cancer Stage IVC Squamous Cell Carcinoma of the Larynx Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVC Squamous Cell Carcinoma of the Oropharynx Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVC Verrucous Carcinoma of the Larynx Stage IVC Verrucous Carcinoma of the Oral Cavity Tongue Cancer Untreated Metastatic Squamous Neck Cancer With Occult Primary Less << Phase 2 Completed - United States, Texas ... More >> Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States, 78245 Less <<
NCT00613145 Refractory Malignancy Phase 1 Completed - United States, Tennessee ... More >> Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00839111 Colorectal Neoplasms Phase 2 Unknown November 2010 China, Shanghai ... More >> Cancer Hospital,Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Yanfei Liu, Master    +862164175590 ext 1107 Less <<
NCT01934829 Hepatocellular Carcinoma Phase 2 Completed - China, Beijing ... More >> 301 Military Hospital, Beijing, China Beijing, Beijing, China, 100039 302 Military Hospital, Beijing, China Beijing, Beijing, China, 100039 China, Fujian Union Hospital of Fujian Medical University, Fujian, China Fuzhou, Fujian, China, 350001 China, Guangdong Guangdong Provincial People's Hospital, Guangdong, China Guangzhou, Guangdong, China, 510080 The Third Affiliated Hospital of Sun Yat-sen University, Guangdong, China Guangzhou, Guangdong, China, 510630 China, Heilongjiang Heilongjiang Provincial Cancer Hospital, Heilongjiang, China Haerbin, Heilongjiang, China, 150081 China, Jiangsu The 81 Hospital of the Chinese People's Liberation Army, Nanjing, China Nanjing, Jiangsu, China, 210002 China, Jilin Jilin Provincial Tumor Hospital, Jilin, China Changchun, Jilin, China, 130012 China, Shanghai Zhongshan Hospital, Fudan University, Shanghai Shanghai, Shanghai, China, 200032 Eastern Hepatobiliary Surgery Hospital of the Second Military Medical University, Shanghai, China Shanghai, Shanghai, China, 200438 China, Tianjin Tianjin Cancer Hospital, Tianjin, China Tianjin, Tianjin, China, 300060 Less <<
NCT02292173 Hepatocellular Cancer ... More >> Liver Cancer Less << Phase 1 Active, not recruiting April 2020 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00392821 Kidney Cancer Phase 1 Phase 2 Completed - United States, Florida ... More >> Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 Norton Cancer Institute Louisville, Kentucky, United States, 40207 United States, Missouri Research Medical Center Kansas City, Missouri, United States, 64132 United States, New Jersey Hematology Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07960 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT01226056 Advanced Solid Tumors Phase 1 Phase 2 Suspended(toxicity (protocol a... More >>mendment under approval)) Less << December 2012 Italy ... More >> Istituto Europeo di Oncologia, Milano, Italy, 20141 Less <<
NCT00253578 Refractory Multiple Myeloma Phase 2 Completed - United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less <<
NCT00826540 Recurrent Colon Cancer ... More >> Recurrent Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 2 Completed - -
NCT00126594 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Carcinoma Stage IV Renal Cell Cancer Less << Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00826540 - Completed - -
NCT00837148 - Completed - -
NCT00126594 - Completed - -
NCT00844688 Hepatocellular Carcinoma Phase 2 Unknown December 2009 Pakistan ... More >> Combined Military Hospital Recruiting Rawalpindi, Punjab, Pakistan, 46000 Principal Investigator: Naeem Naqi, MBBS,FCPS Less <<
NCT00098254 Non-Small-Cell Lung Carcinoma Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00098254 - Completed - -
NCT00933816 Hepatocellular Carcinoma Phase 1 Phase 2 Completed - Japan ... More >> Kurume University Medical Center Kurume, Fukuoka, Japan, 839-0863 Ogaki Municipal Hospital Oogaki, Gifu, Japan, 503-8502 Kinki University School of Medicine Osaka-Sayama, Osaka, Japan, 589-8511 Less <<
NCT02747537 Pediatric Solid Tumors Phase 2 Recruiting February 29, 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Alok Kothari, M.D.    314-454-6018    alok@wustl.edu    Principal Investigator: Alok Kothari, M.D. Less <<
NCT01128998 Advanced Solid Tumors Phase 1 Completed - Taiwan ... More >> National Cheng-Kung University Hospital Tainan City, Taiwan, 704 Less <<
NCT00844883 Hepatocellular Carcinoma ... More >> Hepatoma Less << Phase 2 Completed - United States, Maryland ... More >> The Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Less <<
NCT00278382 Anaplastic Large Cell Lymphoma... More >> Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Mantle Cell Lymphoma Less << Phase 2 Completed - United States, Maryland ... More >> University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201-1595 Less <<
NCT00844883 - Completed - -
NCT00093626 Primary Peritoneal Carcinoma ... More >> Recurrent Ovarian Carcinoma Less << Phase 2 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00118170 Extranodal Marginal Zone B-cel... More >>l Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Multiple Myeloma Splenic Marginal Zone Lymphoma Stage II Multiple Myeloma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Multiple Myeloma Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Waldenstr?m Macroglobulinemia Less << Phase 1 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B (CALGB) Research Base Chicago, Illinois, United States, 60604-1104 Less <<
NCT01217034 Hepatocellular Carcinoma ... More >> Unresectable Hepatocellular Carcinoma Carcinoma, Hepatocellular Liver Neoplasm Less << Phase 2 Active, not recruiting March 2018 Japan ... More >> Kinki University Hospital Osaka-Sayama, Osaka, Japan, 589-8511 Less <<
NCT01982097 - Completed - Russian Federation ... More >> Multiple Locations, Russian Federation Less <<
NCT00448149 Carcinoma, Renal Cell Phase 1 Phase 2 Completed - United States, Texas ... More >> The Methodist Hospital Research Institute Houston, Texas, United States, 77030 Less <<
NCT00837148 Sarcoma Synov... More >>ial Sarcoma Leiomyosarcoma Malignant Peripheral Nerve Sheath Tumor Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00922584 Non-Small Cell Lung Cancer Phase 2 Completed - China, Guangdong ... More >> WuYiLong Guangzhou, Guangdong, China, 510080 Less <<
NCT00562523 Neoplasms Phase 1 Completed - United States, Florida ... More >> Tampa, Florida, United States, 33612 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT01337492 Carcinoma, Hepatocellular Early Phase 1 Terminated(slow accrual) - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00414388 Prostate Cancer Phase 1 Phase 2 Completed - United States, Illinois ... More >> Onocology Specialists, S.C Niles, Illinois, United States, 60714 Oncology Specialists, S.C Park Ridge, Illinois, United States, 60068 Less <<
NCT00622479 Carcinoma, Renal Cell Phase 1 Terminated - United States, Arizona ... More >> Scottsdale, Arizona, United States, 85259 United States, Florida Jacksonville, Florida, United States, 32224 United States, Illinois Maywood, Illinois, United States, 60153 United States, Michigan Detroit, Michigan, United States, 48201 United States, Minnesota Rochester, Minnesota, United States, 55905 United States, New Jersey Hackensack, New Jersey, United States, 07601 United States, New York Stony Brook, New York, United States, 11794-944 Less <<
NCT01276210 Tumors Metastatic to Brain Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00622466 Breast Cancer Phase 2 Unknown December 2015 United States, Texas ... More >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT00955721 Cholangiocarcinoma ... More >> Biliary Tract Cancer Gallbladder Cancer Less << Phase 1 Phase 2 Terminated(Lack of Funding) - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 Less <<
NCT01271504 Hepatocellular Carcinoma Phase 1 Phase 2 Completed - United States, Arizona ... More >> Tucson, Arizona, United States, 85715 United States, Florida Fort Myers, Florida, United States, 33905 Saint Petersburg, Florida, United States, 33705 United States, North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Cincinnati, Ohio, United States, 45267 Toledo, Ohio, United States, 43623 United States, Tennessee Nashville, Tennessee, United States, 37203 Belgium Brussels, Belgium, 1070 Bruxelles, Belgium, 1200 Leuven, Belgium, 3000 Italy Rozzano, Milano, Italy, 20089 Modena, Italy, 40124 Pavia, Italy, 27100 Spain Madrid, Spain, 28007 Madrid, Spain, 28034 Madrid, Spain, 28046 Madrid, Spain, 28050 Ukraine Dnipropetrovsk, Ukraine, 49102 Donetsk, Ukraine, 83092 Kharkiv, Ukraine, 61037 Lviv, Ukraine, 79031 United Kingdom London, Greater London, United Kingdom, WC1E 6BT Manchester, Greater Manchester, United Kingdom, M20 4BX Glasgow, Strathclyde, United Kingdom, G12 OYN Less <<
NCT00955721 - Terminated(Lack of Funding) - -
NCT01383343 Recurrent Colon Carcinoma ... More >> Recurrent Rectal Carcinoma Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Phase 1 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01091207 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135710 Less <<
NCT01714609 - Completed - -
NCT00609934 Renal Cell Carcinoma Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hosptial Toronto, Ontario, Canada, M5G2M9 Less <<
NCT00827177 Advanced Solid Tumors Phase 1 Completed - United States, Massachusetts ... More >> Boston, Massachusetts, United States, 02111 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Tennessee Nashville, Tennessee, United States, 37232 Italy Rozzano, Italy, 20089 Less <<
NCT01557127 - Completed - Poland ... More >> Many Locations, Poland Less <<
NCT00618384 Hepatocellular Carcinoma Phase 2 Terminated - Germany ... More >> Universitätsklinikum Tübingen Innere Medizin I Tübingen, BW, Germany, 72076 Medizinische Universitätsklinik Ulm Innere Medizin I Ulm, BW, Germany, 89081 Klinikum der Universität Großhardern Muenchen, BY, Germany, 81377 Klinikum der Johann-Goethe-Universität Frankfurt, HE, Germany, 60590 Universitätsklinikum Hamburg-Eppendorf Zentrum für Innere Medizin Hamburg, HH, Germany, 20246 Johannes-Gutenberg-Universität Medizinische Klinik Mainz, RP, Germany, 55131 Less <<
NCT01502410 Childhood Hepatocellular Carci... More >>noma Papillary Thyroid Cancer Previously Treated Childhood Rhabdomyosarcoma Recurrent Childhood Liver Cancer Recurrent Childhood Rhabdomyosarcoma Recurrent Thyroid Cancer Recurrent Wilms Tumor and Other Childhood Kidney Tumors Less << Phase 2 Completed - -
NCT01714609 Clinically Significant Portal ... More >>Hypertension Less << Phase 2 Completed - United States, Connecticut ... More >> Yale Cancer Center New Haven, Connecticut, United States, 06520 VA Medical Center West Haven West Haven, Connecticut, United States, 06516 United States, Massachusetts Brigham & Womens Boston, Massachusetts, United States, 02115 United States, New York New York University Langone Medical Center New York, New York, United States, 10016 United States, Pennsylvania University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, United States, 19104 United States, Texas The University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 Less <<
NCT00414388 - Completed - -
NCT00303797 Refractory Chronic Lymphocytic... More >> Leukemia Refractory Multiple Myeloma Stage III Multiple Myeloma Stage IV Chronic Lymphocytic Leukemia Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01502410 - Completed - -
NCT00786110 Adrenocortical Carcinoma Phase 2 Unknown October 2010 Italy ... More >> Department of Clinical and Biological Sciences, University of Turin Recruiting Orbassano, Italy Contact: Paola Perotti    : +390119026 ext Ext. 017       Principal Investigator: Alfredo Berruti          Azienda Ospedaliera di Padova Not yet recruiting Padova, Italy Contact: Franco Mantero          Sub-Investigator: Franco Mantero          Azienda Ospedaliera Università di Palermo Not yet recruiting Palermo, Italy Sub-Investigator: Vittorio Gebbia          Policlinico Universitario Campus Biomedico- Roma Not yet recruiting Roma, Italy Contact: Daniele Santini          Sub-Investigator: Daniele Santini          Ist. Clin.Humanitas Not yet recruiting Rozzano, Italy Contact: Carlo Carnaghi          Sub-Investigator: Carlo Carnaghi Less <<
NCT00492297 - Completed - -
NCT00105443 Carcinoma, Hepatocellular Phase 3 Completed - -
NCT00384969 Renal Cell Carcinoma Phase 1 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94115 Less <<
NCT00747799 Nasopharyngeal Neoplasms Phase 2 Completed - China, Guangdong ... More >> Cancer Center of Sun-Yat Sen University Guangzhou, Guangdong, China, 510000 Less <<
NCT00105443 - Completed - -
NCT00301847 Kidney Cancer ... More >> Metastatic Cancer Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States, 62526 Evanston Northwestern Health Care - Evanston Hospital Evanston, Illinois, United States, 60201-1781 Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States, 60153 Oncology Hematology Associates of Central Illinois, PC - Peoria Peoria, Illinois, United States, 61615-7828 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62701 United States, Indiana Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States, 46885-5099 CCOP - Northern Indiana CR Consortium South Bend, Indiana, United States, 46601 United States, Michigan Oncology Care Associates, PLLC Saint Joseph, Michigan, United States, 49085 United States, Missouri David C. Pratt Cancer Center at St. John's Mercy Saint Louis, Missouri, United States, 63141 United States, Wisconsin Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01004978 Hepatocellular Carcinoma ... More >> Unresectable Hepatocellular Carcinoma Less << Phase 3 Active, not recruiting - -
NCT00873002 Liver Cancer Phase 1 Terminated(Dose Limiting Toxic... More >>ity) Less << - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00984282 Thyroid Neoplasms Phase 3 Completed - -
NCT02024087 Advanced Adult Hepatocellular ... More >>Carcinoma Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> The University of Chicago Medical Center Chicago, Illinois, United States United States, Kansas University of Kansas Medical Center (KUMC) Westwood, Kansas, United States United States, Massachusetts Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States University of Rochester Rochester, New York, United States United States, Ohio University of Cincinnati Cancer Institute Cincinnati, Ohio, United States Less <<
NCT00492297 Melanoma Phase 2 Completed - France ... More >> Bordeaux, France, 33000 Lyon Cedex, France, 39373 Toulouse, France, 31052 Villejuif, France, 94805 United Kingdom Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Southampton, Hampshire, United Kingdom, SO16 6YD Northwood, Middlesex, United Kingdom, HA6 2RN Sutton, Surrey, United Kingdom, SM2 5PT London, United Kingdom, NW3 2QG London, United Kingdom, SE1 7EH London, United Kingdom, SW3 6JJ Manchester, United Kingdom, M20 4BX Less <<
NCT01903694 Child-Pugh A Hepatocellular Ca... More >>rcinoma Less << Phase 3 Completed - France ... More >> CHU de Dijon Dijon, France, 21079 Less <<
NCT01223027 Metastatic Renal Cell Carcinom... More >>a Less << Phase 3 Completed - -
NCT00093457 Prostate Cancer Phase 2 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Ontario Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada, N6A 4L6 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT03247088 Acute Myeloid Leukemia Phase 1 Phase 2 Recruiting July 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       CR_Study_Registration@mdanderson.org Less <<
NCT01223027 - Completed - -
NCT00632541 Metastatic Breast Cancer Phase 2 Terminated(Significant Toxicit... More >>ies Experienced) Less << - United States, Illinois ... More >> Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Quality Cancer Center (MCGOP) Indianapolis, Indiana, United States, 46202 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Horizon Oncology Center Lafayette, Indiana, United States, 47905 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 United States, Ohio Ireland Cancer Center - University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 Less <<
NCT00632541 - Terminated(Significant Toxicit... More >>ies Experienced) Less << - -
NCT01335074 Hepatocellular Carcinoma Phase 1 Phase 2 Withdrawn - Germany ... More >> University Hospital Giessen and Marburg Marburg, Germany, 35043 Less <<
NCT00259129 Neoplasms Phase 1 Completed - United States, Massachusetts ... More >> Boston, Massachusetts, United States, 02115 United States, Texas San Antonio, Texas, United States, 78229 Less <<
NCT01078961 Melanoma Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00607438 Breast Cancer Phase 2 Terminated(Low accrual) - United States, Ohio ... More >> Veeda Oncology Columbus, Ohio, United States, 43215 Less <<
NCT00941967 Liver Cancer Phase 2 Unknown - France ... More >> Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Recruiting Montpellier, France, 34295 Contact: Eric Assenat, MD    33-4-6761-2593 Less <<
NCT00492752 Carcinoma, Hepatocellular Phase 3 Completed - China, Anhui ... More >> Hefei, Anhui, China, 230022 China, Guangdong Guangzhou, Guangdong, China, 510060 Guangzhou, Guangdong, China, 510515 China, Hubei Wuhan, Hubei, China, 430030 China, Jiangsu Nanjing, Jiangsu, China, 210003 Nanjing, Jiangsu, China, 210009 China, Liaoning Dalian, Liaoning, China, 116011 Dalian, Liaoning, China, 116027 China, Zhejiang Hangzhou, Zhejiang, China, 310016 China Beijing, China, 100021 Beijing, China, 100039 Chongqing, China, 400038 Shanghai, China, 200003 Shanghai, China, 200032 Tianjin, China Korea, Republic of Seoul, Seoul Teugbyeolsi, Korea, Republic of, 152-703 Daegu, Korea, Republic of, 702-701 Seoul, Korea, Republic of, 138-736 Taiwan Changhua, Taiwan, 500 Tainan, Taiwan, 736 Taipei, Taiwan, 10016 Taipei, Taiwan, 251 Taoyuan, Taiwan, 333 Less <<
NCT00121264 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT02988440 Hepatocellular Carcinoma Phase 1 Recruiting August 16, 2019 United States, Michigan ... More >> Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Colette Zack       zackc@karmanos.org    Principal Investigator: Philip A. Philip          Canada, Quebec Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H3T 1E2 France Novartis Investigative Site Terminated Clichy, France, 92110 Germany Novartis Investigative Site Completed Essen, Germany, 45147 Hong Kong Novartis Investigative Site Active, not recruiting Hong Kong, Hong Kong Italy Novartis Investigative Site Recruiting Rozzano, MI, Italy, 20089 Japan Novartis Investigative Site Active, not recruiting Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Active, not recruiting Yokohama city, Kanagawa, Japan, 232 0024 Spain Novartis Investigative Site Completed Pamplona, Navarra, Spain, 31008 Taiwan Novartis Investigative Site Active, not recruiting Taipei, Taiwan, 10002 Less <<
NCT00712855 Hepatocellular Carcinoma Phase 1 Completed - United States, California ... More >> Cedars-Sinai Health System Los Angeles, California, United States, 90048 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Florida University of Florida Gainesville, Florida, United States, 32610 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania University of Pennsylvania- Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00621686 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - -
NCT00134069 Recurrent Colon Cancer ... More >> Recurrent Rectal Cancer Stage III Colon Cancer Stage III Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 1 Completed - United States, Colorado ... More >> University of Colorado at Denver Health Sciences Center Aurora, Colorado, United States, 80045 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less <<
NCT00452218 Pulmonary Arterial Hypertensio... More >>n Less << Phase 1 Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00984282 - Completed - -
NCT01715441 Metastatic Colorectal Cancer P... More >>atients With KRAS Mutated Tumors Less << Phase 2 Unknown September 2015 France ... More >> Hôpital AVICENNE Recruiting Bobigny, France, 93009 Contact: Thomas APARICIO, MD       Thomas.aparicio@avc.aphp.fr    Principal Investigator: Thomas APARICIO, MD          Centre François Baclesse Recruiting Caen, France, 14076 Contact: Marie-Pierre GALAIS, MD          Principal Investigator: Marie-Pierre GALAIS, MD          Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Antoine ADENIS, MD       a-adenis@o-lambret.fr    Principal Investigator: Antoine ADENIS, MD          Centre Léon Bérard Recruiting Lyon, France, 69373 Contact: Françoise DESSEIGNE, MD          Principal Investigator: Françoise DESSEIGNE, MD          Hôpital LA TIMONE Recruiting Marseille, France, 13365 Contact: Jean-François SEITZ, MD       Jean-françois.seitz@ap-hm.fr    Principal Investigator: Jean-François SEITZ, MD          CRLC Val d'Aurelle-Paul Lamarque Recruiting Montpellier, France, 34298 Contact: Emmanuelle SAMALIN, MD          Principal Investigator: Emmanuelle SAMALIN, MD          C.H.U. de REIMS Recruiting Reims, France, 51092 Contact: Olivier BOUCHE, MD       Obouche@chu-reims.fr    Principal Investigator: Olivier BOUCHE, MD          CHU Charles Nicolle Recruiting Rouen, France, 76038 Contact: Frédéric Di FIORE, MD    33 2.32.88.81.01    Frederic.Di-Fiore@chu-rouen.fr    Principal Investigator: Frédéric Di FIORE, MD          Institut de Cancérologie de l'Ouest - René Gauducheau Recruiting St. Herblain, France, 44805 Contact: Jaafa BENNOUNA, MD       Jaafa.bennouna@ico.unicancer.fr    Principal Investigator: Jaafa BENNOUNA, MD Less <<
NCT00573690 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT00436579 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Terminated - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00699374 Carcinoma, Hepatocellular Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00101114 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << Phase 2 Completed - United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less <<
NCT00492752 - Completed - -
NCT00456716 Lung Cancer Phase 2 Completed - United States, Washington ... More >> Swedish Cancer Institute Seattle, Washington, United States, 98104 Less <<
NCT00699374 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00619242 Esophageal Cancer Not Applicable Terminated(Low accrual) - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00619242 - Terminated(Low accrual) - -
NCT01839630 - Completed - China ... More >> Multiple Locations, China Less <<
NCT02114658 Thyroid Carcinoma Phase 2 Completed - Japan ... More >> Kobe, Hyogo, Japan, 650-0011 Matsumoto, Nagano, Japan, 390-8621 Bunkyo-ku, Tokyo, Japan, 113-8603 Koto-ku, Tokyo, Japan, 135-8550 Osaka, Japan, 545-8586 Less <<
NCT00536575 - Completed - -
NCT01158287 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - Ireland ... More >> Bon Secours Hospital Cork, Ireland Cork University Hospital Cork, Ireland Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital Dublin, Ireland, 24 Mater Misericordiae University Hospital Dublin, Ireland, 7 St. James's Hospital Dublin, Ireland, 8 Beaumont Hospital Dublin, Ireland, 9 University College Hospital Galway, Ireland Waterford Regional Hospital Waterford, Ireland Less <<
NCT00600015 - Completed - -
NCT01840592 Hepatocellular Carcinoma Phase 2 Active, not recruiting April 2019 United States, New Jersey ... More >> Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT00098618 Clear Cell Renal Cell Carcinom... More >>a Papillary Renal Cell Carcinoma Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << Phase 2 Terminated - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00621686 - Completed - -
NCT03009461 HepatoCellular Carcinoma ... More >> Portal Vein Thrombosis Less << Phase 2 Recruiting December 2019 China, Beijing ... More >> Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Xiaodong Wang, MD    008610-88196476    wangxde@gmail.com    Sub-Investigator: Guang Cao, MD          Sub-Investigator: Hui Chen, MD          Sub-Investigator: Jianhai Guo, MD          Sub-Investigator: Haifeng Xu, MD          Sub-Investigator: Peng Liu, MD          Sub-Investigator: Jungang Hu, MD Less <<
NCT00536575 Multiple Myeloma Phase 1 Phase 2 Completed - United States, Maryland ... More >> Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00889057 Osteosarcoma Phase 2 Completed - Italy ... More >> I.R.C.C. - Unit of Medical Oncology Candiolo, Torino, Italy, 10060 Istituti Ortopedici Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors Bologna, Italy, 40136 Istituto Nazionale Tumori - Unit of Medical Oncology Milano, Italy, 20133 Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology Torino, Italy, 10126 Less <<
NCT00727532 Hereditary Clear Cell Renal Ce... More >>ll Carcinoma Kidney Cancer Less << Not Applicable Terminated(Low Accrual) June 2015 United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT00600015 Non-Small Cell Lung Cancer Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kansas Kansas City Cancer Centers Overland Park, Kansas, United States, 66210 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, North Carolina Cancer Care of Western North Carolina Asheville, North Carolina, United States, 28801 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 Mid Ohio Oncology/Hematology, Inc./ The Mark H. Zangmeister Center Columbus, Ohio, United States, 43219 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Family Cancer Center Collierville, Tennessee, United States, 38017 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Texas Coastal Bend Cancer Center Corpus Christi, Texas, United States, 78463 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT00665990 Refractory Solid Tumors ... More >> Leukemia Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01126645 Hepatocellular Carcinoma Phase 2 Unknown March 2018 Germany ... More >> University of Magdeburg Magdeburg, Germany, 39120 Less <<
NCT00217399 Recurrent Breast Cancer ... More >> Stage IV Breast Cancer Less << Phase 1 Phase 2 Completed - United States, District of Col... More >>umbia Lombardi Comprehensive Cancer Center at Georgetown University Washington, District of Columbia, United States, 20057 Less <<
NCT00217399 - Completed - -
NCT01518413 Rhabdomyosarcoma and Other Sof... More >>t Tissue Sarcomas Ewing's Sarcoma Family of Tumors Osteosarcoma Neuroblastoma Brain Tumors Less << Phase 1 Completed - United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Massachusetts Children's Hospital Boston/Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Pennsylvania The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03097848 HCC Not Applicable Recruiting December 31, 2018 China, Chongqing ... More >> Southwest Hospital Recruiting Chongqing, Chongqing, China, 400038 Contact: kuansheng Ma, MD Less <<
NCT00255658 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Texas ... More >> Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00908167 Acute Myeloid Leukemia ... More >> Infantile Leukemia (Both AML and ALL) Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasms Biphenotypic Leukemia Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00114244 Stage IV Pancreatic Cancer Phase 2 Completed - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Less <<
NCT00217620 Sarcoma Phase 2 Completed - -
NCT00217620 - Completed - -
NCT01258608 Carcinoma, Hepatocellular Phase 2 Completed - -
NCT00510250 Cancer of the Cervix Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00114244 - Completed - -
NCT01272557 Liver Carcinoma Phase 2 Unknown December 2014 Germany ... More >> Medizinische Klinik und Poliklinik, Heinrich-Heine-Universität Düsseldorf, Germany, 40225 Martin-Luther-University Halle-Wittenberg Halle (Saale), Germany, D-06099 Universitätsklinikum des Saarlande Homburg/Saar, Germany, 66421 Ortenau Klinikum Lahr-Ettenheim Lahr, Germany, 77933 Universitätsklinikum Leipzig Leipzig, Germany, 04013 Klinikum Ludwigsburg Ludwigsburg, Germany, 71640 Less <<
NCT00390611 - Completed - -
NCT00848640 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Completed - Egypt ... More >> Egyptian Foundation For Cancer Research Cairo, Egypt, 11553 Less <<
NCT01141478 Carcinoma, Hepatocellular Not Applicable Unknown June 2018 United States, California ... More >> Loma Linda University Medical Center Recruiting Loma Linda, California, United States, 92354 Less <<
NCT01933945 - Completed - -
NCT00678288 Carcinoma, Renal Cell Phase 2 Terminated - Austria ... More >> Salzburg, Austria, 5020 Wien, Austria, 1090 France Avignon, France, 84000 Bayonne, France, 64100 Bordeaux, France, 33000 Marseille, France, 13015 Marseille, France, 13385 Nantes, France, 44020 Paris, France, 75014 Paris, France, 75651 Reims, France, 51100 Strasbourg, France, 67000 Toulouse, France, 31052 Vandoeuvre Les Nancy, France, 54000 Ireland Cork, Ireland Dublin, Ireland, 24 Italy Aviano, Pordenone, Italy, 33081 Legnago, Verona, Italy, 37045 Napoli, Italy, 80131 Pavia, Italy, 27100 Perugia, Italy, 06156 Reggio Emilia, Italy, 42100 Poland Gdansk, Poland, 80-219 Lublin, Poland, 20-090 Warszawa, Poland, 04-141 Wroclaw, Poland, 50 - 556 Spain Barcelona, Spain, 08035 Madrid, Spain, 28041 Madrid, Spain, 28046 Oviedo, Spain, 33006 Pamplona, Spain, 31008 Valencia, Spain, 46009 United Kingdom Northwood, Middlesex, United Kingdom, HA6 2RN Newcastle Upon Tyne, Tyne and Wear, United Kingdom, NE4 6BE London, United Kingdom, SW3 6JJ Less <<
NCT00533585 Lung Cancer Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00634634 Metastatic Breast Cancer Phase 1 Phase 2 Active, not recruiting May 2019 United States, District of Col... More >>umbia Georgetown University Hospital Washington, District of Columbia, United States, 20007 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 Cooper Hospital/University Medical Center Voorhees, New Jersey, United States, 08690 Less <<
NCT03518502 Hepatocellular Carcinoma ... More >> Metastasis Less << Phase 4 Recruiting February 28, 2022 Korea, Republic of ... More >> Korea University Ansan Hospital Recruiting Ansan, Gyeonggi-do, Korea, Republic of, 425-707 Contact: Hyung Joon Yim, M.D.    82-31-412-6565    gudwns21@korea.ac.kr    Contact: Sang Jun Suh, M.D.    82-31-412-4926    mothpickle@naver.com    Principal Investigator: Hyung Joon Yim, M.D.          Sub-Investigator: Sang Jun Suh, M.D.          Sub-Investigator: Young Kul Jung, M.D.          Soonchunghyang University Bucheon Hospital Recruiting Bucheon, Gyeonggi-do, Korea, Republic of Contact: Young-Seok Kim          Keimyung University Dongsan Hospital Recruiting Daegu, Korea, Republic of Contact: Woo Jin Chung          Chonnam National University Hwasoon Hospital Recruiting Gwangju, Korea, Republic of Contact: Sung-Bum Cho, M.D.          Seoul Saint Marry Hospital, the Catholic University of Korea Recruiting Seoul, Korea, Republic of Contact: Si-Hyun Bae          Severance Hospital, Yonsei University Recruiting Seoul, Korea, Republic of Contact: Jun Yong Park, M.D. Less <<
NCT00390611 Ovarian Cancer Phase 2 Completed - United States, Arkansas ... More >> Northeast Arkansas Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Holy Cross Hospital Ft. Lauderdale, Florida, United States, 33308 Gulfcoast Oncology Associates St. Petersburg, Florida, United States, 33705 United States, Georgia Medical College of Georgia Cancer Specialists Augusta, Georgia, United States, 30912 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Michigan St. Joseph Mercy Hospital Ann Arbor, Michigan, United States, 48106 Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Valley Clinical Research Chattanooga, Tennessee, United States, 37411 Family Cancer Center Collierville, Tennessee, United States, 38017 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Center Newport News, Virginia, United States, 23601 Less <<
NCT00971126 Hepatocellular Carcinoma Phase 1 Phase 2 Terminated(Two patients in the... More >> first dose level be counted as reaching DLT. DSMB recommend terminated early this trial.) Less << - Taiwan ... More >> Ghang-Gung Memorial Hospital at Chia-Yi Chia-Yi, Taiwan, 613 Less <<
NCT01585870 Neoplasms Phase 1 Completed - France ... More >> Toulouse, France, 31052 Germany Freiburg, Baden-Württemberg, Germany, 79106 Heidelberg, Baden-Württemberg, Germany, 69120 Berlin, Germany, 10117 Less <<
NCT02354898 Advanced Solid Tumors ... More >> Hepatocellular Carcinoma Less << Phase 1 Completed - Japan ... More >> 5 Sites Chiba, Etc., Japan Less <<
NCT00610246 Cancer Phase 1 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT02187081 HCC Not Applicable Recruiting December 2018 China, Chongqing ... More >> Southwest Hospital Recruiting Chongqing, Chongqing, China, 400038 Contact: Xiaobin Feng          Principal Investigator: Kuansheng Ma, Ph.D Less <<
NCT02627963 Carcinoma, Renal Cell Phase 3 Active, not recruiting December 2019 -
NCT01194869 - Terminated(Slow accrual, avail... More >>ability of other clinical options) Less << - -
NCT00300885 Carcinoma, Non-Small Cell Lung Phase 3 Terminated(Based on the result... More >>s of the interim analysis, it was determined that the study would not meet its primary efficacy endpoint and the study was terminated early.) Less << - -
NCT02989870 HepatoCellular Carcinoma ... More >> Unresectable HepatoCellular Carcinoma Liver Cancer Less << Phase 1 Withdrawn(No Interest. Investi... More >>gator was unable to enroll any participants on study.) Less << - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00300885 - Terminated(Based on the result... More >>s of the interim analysis, it was determined that the study would not meet its primary efficacy endpoint and the study was terminated early.) Less << - -
NCT01908322 - Completed - Germany ... More >> Many Locations, Germany Less <<
NCT01194869 Breast Cancer Phase 2 Terminated(Slow accrual, avail... More >>ability of other clinical options) Less << - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00943449 Hepatocellular Carcinoma Phase 2 Completed - Germany ... More >> ONKOPLUS Beratung und Hilfe für Menschen mit Krebs Berlin, Germany, 14195 Universitätsklinikum Essen (Innere Klinik/Tumorforschung und Zentrum für Innere Medizin) Essen, Germany, 45147 Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg (Klinik und Poliklinik für Innere Medizin I) Halle, Germany, 06120 Universitätsklinikum Hamburg-Eppendorf (I. Medizinische Klinik und Poliklinik) Hamburg, Germany, 20246 Universitätsklinikum Heidelberg (Medizinische Universitätsklinik/Innere Medizin IV/Nationales Centrum für Tumorerkrankungen) Heidelberg, Germany, 69120 Johannes Gutenberg-Universität Mainz (I. Medizinische Klinik und Poliklinik) Mainz, Germany, 55131 Klinikum rechts der Isar der Technischen Universität München (Medizinische Klinik und Poliklinik II/Gastroenterologie) Munich, Germany, 81675 Universitätsklinikum Tübingen (Medizinische Klinik/Innere Medizin I) Tübingen, Germany, 72076 Italy l'Azienda Ospedaliero-Universitaria di Bologna-Policlinico S. Orsola Malpighi Bologna, Italy, 40138 l'Università degli Studi di Genova (Dipartimento di Medicina Interna e Specialità Mediche) Genova, Italy, 16132 Istituto Europea di Oncologia EIO Milano, Italy, 20141 A.O.R.N. Monaldi-Cotugno-CTO Napoli, Italy, 80131 l'Azienda Ospedaliera di Padova and l'Istituto Oncologico Veneto IOV Padova, Italy l'Ente "Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone" Palermo, Italy, 12990127 L'Istituto Clinico Humanitas-Humanitas Mirasole S.p.A. Rozzano-Milano, Italy, 20089 Less <<
NCT00101413 Cancer Carcin... More >>oma, Non-Small Cell Lung Less << Phase 2 Completed - United States, Texas ... More >> Houston, Texas, United States, 77030 Germany Großhansdorf, Schleswig-Holstein, Germany, 22927 Less <<
NCT00101413 - Completed - -
NCT00466232 Small Cell Carcinoma ... More >> Lung Cancer Less << Phase 1 Completed - United States, Minnesota ... More >> Park Nicollet Institute St. Louis Park, Minnesota, United States, 55416 Less <<
NCT00869570 Colorectal Cancer Phase 1 Phase 2 Completed - Hungary ... More >> Szent Laszlo Korhaz Budapest, Hungary, 1097 Switzerland Saint Claraspital AG Basel, Switzerland, CH-4016 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland, 6500 Inselspital, Bern Bern, Switzerland, CH-3010 Spitalzentrum Biel Biel, Switzerland, CH-2501 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Hopital Cantonal Universitaire de Geneva HUG Geneva, Switzerland, CH-1211 Kantonsspital Luzern Luzern, Switzerland, 6000 OnkoZentrum Luzern at Klinik St. Anna Luzern, Switzerland, 6006 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 SpitalSTS AG Simmental-Thun-Saanenland Thun, Switzerland, 3600 Kantonsspital Winterthur Winterthur, Switzerland, CH-8400 Onkozentrum - Klinik im Park Zurich, Switzerland, 8002 Onkozentrum Hirslanden Zurich, Switzerland, CH-8008 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Stadtspital Triemli Zürich, Switzerland, 8063 Less <<
NCT00542971 - Completed - -
NCT00734526 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Terminated - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01915602 Carcinoma, Hepatocellular Phase 2 Completed - -
NCT00542971 AML Acute Mye... More >>loid Leukemia Myelodysplastic Disorders Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00245102 Adult Angiosarcoma ... More >> Adult Epithelioid Sarcoma Adult Leiomyosarcoma Adult Malignant Fibrous Histiocytoma Adult Neurofibrosarcoma Adult Synovial Sarcoma Ovarian Sarcoma Recurrent Adult Soft Tissue Sarcoma Recurrent Uterine Sarcoma Stage III Adult Soft Tissue Sarcoma Stage III Uterine Sarcoma Stage IV Adult Soft Tissue Sarcoma Stage IV Uterine Sarcoma Uterine Carcinosarcoma Uterine Leiomyosarcoma Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00095693 Anaplastic Thyroid Cancer ... More >> Insular Thyroid Cancer Recurrent Thyroid Cancer Stage III Follicular Thyroid Cancer Stage III Papillary Thyroid Cancer Stage IV Follicular Thyroid Cancer Stage IV Papillary Thyroid Cancer Less << Phase 2 Terminated - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00238121 Recurrent Uterine Sarcoma ... More >> Stage III Uterine Sarcoma Stage IV Uterine Sarcoma Uterine Carcinosarcoma Less << Phase 2 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 University of Southern California Los Angeles, California, United States, 90033-0804 United States, Illinois Decatur Memorial Hospital Decatur, Illinois, United States, 62526 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 60702 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston General Hospital Kingston, Ontario, Canada, K7L 5P9 University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00245102 - Completed - -
NCT00678288 - Terminated - -
NCT00722969 Non-Small Cell Lung Cancer Phase 2 Unknown April 2009 Netherlands ... More >> VU university medical center Amsterdam, Netherlands, 1007 MB Netherlands Cancer Institute Amsterdam, Netherlands University Medical Center Groningen Groningen, Netherlands University Hospital Maastricht Maastricht, Netherlands Less <<
NCT01047891 Ovarian Cancer Phase 2 Completed - Germany ... More >> Charité Campus Virchow-Klinikum Berlin, Germany, 13355 Less <<
NCT02537158 Hepatocellular Carcinoma Not Applicable Unknown July 2018 China ... More >> Cancer Hospital and Institute, Chinese Academy of Medical Sciences Recruiting Bei jing, China, 100026 Contact: Xinyu Bi, Doctor    86-13911792177    beexy1971@163.com Less <<
NCT00863746 Carcinoma Non... More >>-Small-Cell Lung Less << Phase 3 Completed - -
NCT00863746 - Completed - -
NCT00238121 - Completed - -
NCT00418496 Renal Cancer ... More >>Melanoma Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00595985 Gastric Cancer Phase 2 Terminated(low response rate, ... More >>no evidence of PFS or OS improved.) Less << January 2009 China, Shanghai ... More >> Fudan University Cancer Hospital ShangHai, Shanghai, China, 200032 Less <<
NCT00474929 - Active, not recruiting - -
NCT03644511 - Not yet recruiting December 31, 2021 Germany ... More >> Many Locations Not yet recruiting Multiple Locations, Germany Less <<
NCT02050919 Pleomorphic Rhabdomyosarcoma ... More >> Stage IIB Adult Soft Tissue Sarcoma AJCC v7 Stage III Adult Soft Tissue Sarcoma AJCC v7 Stage IV Adult Soft Tissue Sarcoma AJCC v7 Less << Phase 2 Active, not recruiting December 31, 2018 United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less <<
NCT01182272 Liver Cancer Phase 2 Unknown - France ... More >> Hopital Beaujon Recruiting Clichy, France, 92110 Contact: Contact Person    33-1-4087-5614    sandrine.faivre@bjn.aphp.fr Less <<
NCT00474929 Lymphoma Mult... More >>iple Myeloma and Plasma Cell Neoplasm Less << Phase 1 Phase 2 Active, not recruiting January 2019 United States, Iowa ... More >> Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242-1002 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT00602862 Clear Cell Renal Cell Carcinom... More >>a Less << Not Applicable Completed - Netherlands ... More >> Radboud University Nijmegen Medical Center Nijmegen, Gelderland, Netherlands, 6500 HB Less <<
NCT00714948 - Terminated(Lack of accrual) - -
NCT00326495 - Completed - -
NCT01844947 Urothelial Carcinoma ... More >> Bladder Cancer Renal Pelvis Cancer Ureter Cancer Urethra Cancer Less << Phase 1 Completed - Denmark ... More >> Department of Oncology, Aarhus University Hospital Aarhus, Denmark, DK-8200 Department of Oncology, Rigshospitalet Copenhagen, Denmark, DK-2100 Sweden Department of Oncology, Karolinska University Hospital Stockholm, Sweden, SE-171 76 Less <<
NCT00714948 Bladder Cancer ... More >> URINARY BLADDER Less << Phase 2 Terminated(Lack of accrual) - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00326495 Metastatic Colorectal Cancer Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02642913 Hepatocellular Carcinoma Phase 1 Phase 2 Recruiting December 2019 United States, California ... More >> University of California San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Robin K Kelley, MD    415-353-9888       United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Benjamin Tan, MD    314-747-7222       Principal Investigator: Benjamin Tan, MD          United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263-0001 Contact: Iyer Renuka, MD    716-845-2300       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: James Harding, MD    646-888-4314       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: James Harding, MD    646-888-4314       Contact: Ghassan Abou-Alfa, MD    646-888-4184 Less <<
NCT01033240 Advanced Hepatocellular Carcin... More >>oma Liver Cancer Hepatic Cancer Liver Neoplasms Less << Phase 2 Completed - United States, California ... More >> Kenmar Research Group Los Angeles, California, United States, 90057 United States, District of Columbia Georgetown-Lombardi Cancer Center Washington DC, District of Columbia, United States, 20007 United States, New York The Mount Sinai Medical Center New York, New York, United States, 10029 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Japan Kurume University Hospital Kurume-shi, Fukuoka, Japan, 830-0011 Hiroshima University Hiroshima-city, Hiroshima, Japan Kanazawa University Kanazawa, Ishikawa, Japan Kinki University Hospital Osaka, Osaka-sayama, Japan, 589-8511 Osaka Med Center Cancer and Cardiovascular Disease Higashinari-ku, Osaka, Japan, 537-8511 Yamaguchi University Hospital Ube, Yamaguchi, Japan Chiba University Hospital Chiba, Japan, 260-8677 Okayama University Hospital Okayama, Japan, 700-8558 Musashino Red-Cross Hospital Tokyo, Japan, 180-8610 Korea, Republic of Samsung Medical Center Gangnam-gu, Seoul, Korea, Republic of, 135-710 Keimyung University Dongsan Hospital Daegu, Korea, Republic of, 700-712 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Severance Hospital Seoul, Korea, Republic of, 120-752 Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Catholic Univ. of Korea, Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-701 Asan Medical Center Seoul, Korea, Republic of, 138-736 Taiwan Chang Gung Memorial Hospital Putz, Chiayi, Taiwan Kaohiung Chang Gung Hospital Kaohsiung, Niaosung Hsiang, Taiwan Chi-Mei Medical Center Liouying, Tainan County, Taiwan, 736 Changhua Christian Hospital Changhua, Taiwan, 500 Kaohslung Medical University Hospital Kaohsiung, Taiwan, 807 National Cheng-Kung University Hospital Tainan city, Taiwan, 704 National Taiwan University Hospital Taipei, Taiwan Chang Gung Medical Foundation-Linkuo Taoyuan, Taiwan, 33305 Less <<
NCT03775395 Hepatocellular Carcinoma Phase 3 Recruiting December 1, 2021 China, Guangdong ... More >> Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    8620-87343115    shiming@mail.sysu.edu.cn Less <<
NCT00389285 Carcinoma, Renal Cell Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35294 United States, Arizona Premiere Oncology of Arizona Scottsdale, Arizona, United States, 85260 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT00661375 Carcinoma, Renal Cell Phase 2 Completed - -
NCT00606866 Metastatic Renal Cell Carcinom... More >>a Less << Phase 3 Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00812175 - Completed - -
NCT00454194 Lung Cancer Phase 2 Completed - -
NCT03764293 Locally Advanced or Metastatic... More >> and Unresectable HCC Less << Phase 3 Not yet recruiting December 2021 -
NCT01761266 Hepatocellular Carcinoma (HCC) Phase 3 Active, not recruiting March 2019 -
NCT02400788 Hepatocellular Carcinoma Phase 1 Phase 2 Completed - Japan ... More >> Chiba, Japan Ishikawa, Japan Kanagawa, Japan Kochi, Japan Kyoto, Japan Osaka, Japan Saga, Japan Shizuoka, Japan Tokyo, Japan Korea, Republic of Busan, Korea, Republic of Daegu, Korea, Republic of Seoul, Korea, Republic of Less <<
NCT00547443 Lung Cancer Phase 1 Phase 2 Terminated(Withdrawn as the sp... More >>onsor has stopped the drug for NSCLC population) Less << - United States, Texas ... More >> Arlington Cancer Center - Arlington Arlington, Texas, United States, 76012-2510 Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Less <<
NCT03164382 Liver Cancer ... More >>Hepatic Carcinoma Less << Phase 3 Recruiting December 31, 2022 China, Guangdong ... More >> Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Recruiting Guangzhou, Guangdong, China, 500060 Contact: Ming Zhao, MD    86-20-87343272    zhaoming@sysucc.org.cn Less <<
NCT01481805 - Completed - Korea, Republic of ... More >> Samsung medical Center Seoul, Korea, Republic of Less <<
NCT00454194 - Completed - -
NCT01170104 Hepatocellular Carcinoma Phase 2 Unknown June 2013 Korea, Republic of ... More >> Chung-Ang University Hospital Recruiting Dongjak, Seoul, Korea, Republic of, 156-755 Contact: Joung-Soon Jang, M.D.    82-2-6299-1427    alsaba@daum.net    Contact: In Gyu Hwang, M.D.    82-2-748-9786    higyu72@yahoo.co.kr    Principal Investigator: Joung-Soon Jang, M.D.          Sub-Investigator: Hyung Joon Kim, M.D.          Sub-Investigator: Hyun Woong Lee, M.D.          Sub-Investigator: In Gyu Hwang, M.D. Less <<
NCT00919061 Extrahepatic Bile Duct Cancer ... More >> Gallbladder Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00919061 - Completed - -
NCT01234337 Breast Cancer Phase 3 Completed - -
NCT01761266 - Active, not recruiting - -
NCT01042041 Hepatocellular Carcinoma ... More >> Liver Cancer Localized Unresectable Liver Cancer Less << Phase 1 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01687673 Hepatocellular Carcinoma Phase 2 Active, not recruiting September 2017 United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 United States, Illinois Robert H Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 Less <<
NCT01234337 - Completed - -
NCT01320111 Metastatic Breast Cancer Phase 2 Completed - Germany ... More >> Germany Multiple Sites All Over Germany Recruiting Multiple Sites, Germany Contact: iOMEDICO AG Freiburg, Germany, 79108 Less <<
NCT02460991 Hepatocellular Carcinoma ... More >> Hepatoma Liver Cell Carcinoma Less << Phase 3 Terminated(Slow enrollment) - United States, Alabama ... More >> University of Alabama Hospital Birmingham, Alabama, United States, 35233 United States, California University of Southern California Los Angeles, California, United States, 90033 United States, Kentucky University of Louisville Louisville, Kentucky, United States, 40202 United States, Maryland University of Maryland Medical Center Baltimore, Maryland, United States, 21201 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00619541 Hepatocellular Carcinoma Phase 2 Completed - Italy ... More >> Dipartimento di Oncologia, dei Trapianti e delle Nuove Tecnologie in Medicina ... Indirizzo: via Roma, 55 - 56100 Pisa Tel. 050-2218690 - Fax. 050-2218685 Pisa, Italy, 56100 Less <<
NCT00516828 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Phase 2 Completed - Canada, Nova Scotia ... More >> QEII Health Sciences Center Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 Less <<
NCT02460991 - Terminated(Slow enrollment) - -
NCT00726986 Lung Cancer Phase 2 Terminated(Extreme toxicity) - United States, New York ... More >> Columbia Presbyterian New York, New York, United States, 10032 United States, Ohio Lake/University Ireland Cancer Center Cleveland, Ohio, United States, 44060 Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 MetroHealth Medical Center Cleveland, Ohio, United States, 44109 CCF-Fairview Hospital Cleveland, Ohio, United States, 44111 UHHS Chagrin Highlands Medical Center Cleveland, Ohio, United States, 44122 Southwest General Health Center Cleveland, Ohio, United States, 44130 UHHS Westlake Medical Center Cleveland, Ohio, United States, 44145 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 UH-Monarch Mayfield Heights, Ohio, United States, 44124 UH-Firelands Sandusky, Ohio, United States, 44870 Less <<
NCT02728050 Acute Biphenotypic Leukemia ... More >> Acute Myeloid Leukemia de Novo Myelodysplastic Syndrome High Risk Myelodysplastic Syndrome Myelodysplastic Syndrome Myeloproliferative Neoplasm Less << Phase 1 Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Anna Halpern    206-314-5944    halpern2@uw.edu    Principal Investigator: Anna Halpern Less <<
NCT03113604 - Withdrawn(The study has been s... More >>topped because no one is) Less << - France ... More >> CHU Amiens Picardie Amiens, Picardie, France, 80054 Less <<
NCT00726986 - Terminated(Extreme toxicity) - -
NCT02576509 Hepatocellular Carcinoma Phase 3 Active, not recruiting July 14, 2020 -
NCT00526799 Ovarian Cancer Phase 1 Phase 2 Terminated(Study closed to acc... More >>rual due unfavorable interim analysis) Less << - United States, Illinois ... More >> Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 St. Vincent Hospital Cynecologic Oncology Indianapolis, Indiana, United States, 46260 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 United States, New York Schwartz Gynecologic Oncology, PLLC Brightwaters, New York, United States, 11718 Less <<
NCT00478374 Hepatocellular Carcinoma Phase 1 Completed - Switzerland ... More >> Inselspital Bern, Switzerland, 3010 Less <<
NCT00526799 - Terminated(Study closed to acc... More >>rual due unfavorable interim analysis) Less << - -
NCT00509613 Advanced Solid Tumor ... More >> Refractory to Standard Therapies Less << Phase 1 Completed - Netherlands ... More >> UMC St Radboud Nijmegen, Netherlands Less <<
NCT00823290 Hepatocellular Carcinoma Phase 1 Unknown December 2010 Germany ... More >> Department of Medicine 1, University Hospital Erlangen Recruiting Erlangen, Germany, 91054 Contact: Matthias Ocker, MD    +49-6421-58 ext 68931    Matthias.Ocker@staff.uni-marburg.de    Contact: Susanne Gahr, MD    +49-9131-85 ext 35000    susanne.gahr@uk-erlangen.de    Principal Investigator: Deike Strobel, MD Less <<
NCT00544817 Glioblastoma Multiforme Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas South Texas Oncology and Hematology San Antonio, Texas, United States, 78258 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT01897038 Carcinoma, Hepatocellular Phase 1 Completed - United States, Florida ... More >> Sarasota, Florida, United States, 34232 United States, Maryland Baltimore, Maryland, United States, 21231 United States, New York New York, New York, United States, 10065 United States, Tennessee Nashville, Tennessee, United States, 37203 United States, Texas Houston, Texas, United States, 77030 Hong Kong Pokfulam, Hong Kong Singapore Singapore, Singapore, 119228 Singapore, Singapore, 169610 Taiwan Tainan, Taiwan, 00704 Taipei, Taiwan, 100 Less <<
NCT00544817 - Completed - -
NCT03434379 Carcinoma, Hepatocellular Phase 3 Recruiting June 29, 2022 -
NCT02270788 Acute Myeloid Leukemia Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00329641 - Completed - -
NCT00329641 Ciliary Body and Choroid Melan... More >>oma, Medium/Large Size Extraocular Extension Melanoma Iris Melanoma Metastatic Intraocular Melanoma Recurrent Intraocular Melanoma Less << Phase 2 Completed - United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less <<
NCT00609401 Metastatic Disease ... More >> Renal Cell Carcinoma Less << Phase 2 Completed - Italy ... More >> Istituto Tumori Milano, Italy Less <<
NCT00939627 Metastatic Squamous Neck Cance... More >>r With Occult Primary Squamous Cell Carcinoma Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Salivary Gland Squamous Cell Carcinoma Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IVA Salivary Gland Cancer Stage IVA Squamous Cell Carcinoma of the Larynx Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVA Verrucous Carcinoma of the Larynx Stage IVA Verrucous Carcinoma of the Oral Cavity Stage IVB Salivary Gland Cancer Stage IVB Squamous Cell Carcinoma of the Larynx Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVB Verrucous Carcinoma of the Larynx Stage IVB Verrucous Carcinoma of the Oral Cavity Stage IVC Salivary Gland Cancer Stage IVC Squamous Cell Carcinoma of the Larynx Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVC Squamous Cell Carcinoma of the Oropharynx Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVC Verrucous Carcinoma of the Larynx Stage IVC Verrucous Carcinoma of the Oral Cavity Tongue Cancer Untreated Metastatic Squamous Neck Cancer With Occult Primary Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 Suburban Hospital Bethesda, Maryland, United States, 20814 United States, Montana Billings Clinic Billings, Montana, United States, 59107-7000 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467-2490 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT00586495 - Completed - -
NCT00939627 - Completed - -
NCT00586495 Carcinoma, Renal Cell Phase 2 Completed - Japan ... More >> Asahi, Chiba, Japan, 289-2511 Matsuyama, Ehime, Japan, 791-0280 Kurume, Fukuoka, Japan, 830-0011 Isesaki, Gunma, Japan, 372-0817 Maebashi, Gunma, Japan, 371-8511 Sapporo, Hokkaido, Japan, 003-0804 Sapporo, Hokkaido, Japan, 060-8543 Sapporo, Hokkaido, Japan, 060-8648 Sunagawa, Hokkaido, Japan, 073-0196 Tsukuba, Ibaraki, Japan, 305-8576 Morioka, Iwate, Japan, 020-8505 Tsu, Mie, Japan, 514-8507 Natori, Miyagi, Japan, 981-1293 Kashihara, Nara, Japan, 634-8522 Kurashiki, Okayama, Japan, 710-8602 Osakasayama, Osaka, Japan, 589-8511 Suita, Osaka, Japan, 565-0871 Hidaka, Saitama, Japan, 350-1298 Irima-gun, Saitama, Japan, 350-0495 Tokorozawa, Saitama, Japan, 359-8513 Hamamatsu, Shizuoka, Japan, 431-3192 Sunto, Shizuoka, Japan, 411-8777 Utsunomiya, Tochigi, Japan, 320-0834 Arakawa-ku, Tokyo, Japan, 116-8567 Bunkyo-ku, Tokyo, Japan, 113-8655 Chuo-ku, Tokyo, Japan, 104-0045 Itabashi-ku, Tokyo, Japan, 173-0003 Shinjuku-ku, Tokyo, Japan, 162-8666 Ube, Yamaguchi, Japan, 755-8505 Akita, Japan, 010-8543 Chiba, Japan, 260-8677 Chiba, Japan, 260-8717 Fukuoka, Japan, 812-0033 Fukuoka, Japan, 812-8582 Kagoshima, Japan, 890-8520 Kyoto, Japan, 602-8566 Kyoto, Japan, 606-8507 Okayama, Japan, 700-8558 Osaka, Japan, 537-8511 Tokushima, Japan, 770-8503 Yamagata, Japan, 990-9585 Less <<
NCT01751763 - Completed - China ... More >> Many Locations, China Less <<
NCT00096434 Male Breast Cancer ... More >> Recurrent Breast Cancer Stage IV Breast Cancer Less << Phase 2 Completed - United States, Minnesota ... More >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 Less <<
NCT01405573 Advanced Adult Hepatocellular ... More >>Carcinoma Less << Phase 3 Terminated(lack of enrolment) - Italy ... More >> Azienda Ospedaliera G. Rummo Benevento, BN, Italy Policlinico Giaccone Palermo, PA, Italy, 90127 S. Orsola-Malpighi Bologna, Italy Ospedale Ramazzini di Carpi Carpi, Italy Osp. Civile Infermi Faenza, Italy Azienda Ospedaliera Careggi Firenze, Italy IRCCS-Azienda Ospedaliera Universitaria San Martino-IST Genova, Italy AO C. Poma Mantova, Italy Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Meldola, Italy A.O.U. G.Martino- Policlinico Universita di Messina Messina, Italy Istituto Nazionale Tumori Milano, Italy A.O.U. Federico II Napoli, Italy AOU II Università di Napoli Napoli, Italy Istituto Nazionale dei Tumori Napoli, Italy Ospedale Cardarelli Napoli, Italy Azienda Ospedaliera Universitaria di Padova Padova, Italy Istituto Oncologico Veneto Padova, Italy A.O. Ospedali Riuniti Villa Sofia-Cervello Palermo, Italy Azienda Ospedaliero Universitaria di Parma Parma, Italy Ospedale Guglielmo da Saliceto Piacenza, Italy, Italy AO S. Carlo Potenza, Italy Policlinico Universitario Tor Vergata Roma, Italy Oncologia IRCCS - Casa Sollilevo Sofferenza S. Giovanni Rotondo, Italy Azienda Ospedaliera Universitaria Arcispedal, U.O. di Oncologia Clinica Sant'Anna di Ferrara, Italy A.O. Trevigilio - Caravaggio Trevigilio, Italy Less <<
NCT01078311 - Unknown February 2014 Australia, New South Wales ... More >> Westmead Hospital Recruiting Westmead, New South Wales, Australia, 2145 Less <<
NCT00602576 Melanoma (Skin) Phase 2 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT02981498 Hepatocellular Carcinoma Phase 2 Recruiting April 2017 China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD       Shiming@sysu.edu.cn Less <<
NCT02129322 Hepatocellular Carcinoma Phase 2 Not yet recruiting December 2019 China ... More >> First affiliated hospital, Zhejiang University Not yet recruiting Hangzhou, China Contact: Weijiafang fang          Principal Investigator: Weijia fang, MD Less <<
NCT03622541 FLT3-ITD Mutation ... More >> AML Less << Phase 2 Recruiting November 2019 Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Chunxiao Zhang, SC    852-22554361    chunxiao@hku.hk Less <<
NCT00874874 Sarcoma Phase 2 Unknown - France ... More >> Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Nicolas Penel, MD    33-3-20-295-920 Less <<
NCT00498836 Malignant Melanoma Phase 2 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas Cancer Therapy and Research Center, Institute for Drug Development San Antonio, Texas, United States, 78229 Norway The Norwegian Radium Hospital Oslo, Norway, NO-0310 Sweden Lund University Hospital Lund, Sweden, SE-221 85 Umeå University Hospital Umeå, Sweden Uppsala University Hospital Uppsala, Sweden, SE-751 85 Less <<
NCT00466752 Adenocarcinoma of the Prostate... More >> Stage II Prostate Cancer Stage III Prostate Cancer Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00466752 - Completed - -
NCT02908165 Hepatocellular Carcinoma Phase 2 Withdrawn(A future study will ... More >>be taking place using the same patient population.) Less << June 2020 United States, Connecticut ... More >> Smilow Cancer Center New Haven, Connecticut, United States, 06510 Less <<
NCT01348503 Hepatocellular Carcinoma Phase 1 Terminated(Treatment was ineff... More >>ective) Less << - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00387751 - Completed - -
NCT00473486 Carcinoma, Non-Small-Cell Lung Phase 1 Phase 2 Terminated(Sorafenib administe... More >>red in the combination with pemetrexed-carboplatin appears to enhance thrombocytopenia compared to historical data.) Less << - Germany ... More >> University of Muenster, Dept. of Medicine, Hematology / Oncology Muenster, Germany, 48145 Less <<
NCT02599090 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Withdrawn(Multi phase study di... More >>d not progress to Phase II. Phase I registered as NCT00734526.) Less << - -
NCT01204177 Carcinoma, Hepatocellular Phase 2 Completed - Hong Kong ... More >> Shatin, New Territories, Hong Kong Hong Kong, Hong Kong Korea, Republic of Jung-gu, Daegu Gwang''yeogsi, Korea, Republic of, 700-721 Goyang-si, Gyeonggido, Korea, Republic of, 410-769 Busan, Korea, Republic of, 602-739 Seoul, Korea, Republic of, 110-744 Seoul, Korea, Republic of, 120-752 Seoul, Korea, Republic of, 135-710 Seoul, Korea, Republic of, 138-736 Singapore Singapore, Singapore, 228510 Singapore, Singapore, 258499 Taiwan Kaohsiung, Taiwan, 833 Tainan, Taiwan, 736 Tainan, Taiwan Taipei, Taiwan, 100 Less <<
NCT00791778 Ovarian Neoplasms Phase 2 Completed - -
NCT00789763 Pancreatic Cancer Phase 1 Completed - Spain ... More >> Hospital de La Santa Creu I Sant Pau Barcelona, Spain, 08025 Hospital Clinic I Provincial Barcelona, Spain, 08036 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Universitario La Fe Valencia, Spain, 46009 Less <<
NCT00387751 Recurrent Melanoma ... More >> Stage III Skin Melanoma Stage IV Skin Melanoma Less << Phase 2 Completed - United States, Texas ... More >> Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00791778 - Completed - -
NCT01829035 Advanced Adult Hepatocellular ... More >>Carcinoma Less << Phase 3 Completed - Korea, Republic of ... More >> National Cancer Center, Korea Seoul, Korea, Republic of Less <<
NCT00430235 Adenocarcinoma of the Prostate Phase 2 Completed - Canada, British Columbia ... More >> BC Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Less <<
NCT00867321 - Completed - -
NCT00619996 Prostate Cancer Phase 2 Completed - Italy ... More >> Dipartimento di Oncologia, dei Trapianti e delle Nuove Tecnologie in Medicina ... Indirizzo: via Roma, 55 - 56100 Pisa Tel. 050-2218690 - Fax. 050-2218685 Pisa, Italy, 56100 Less <<
NCT00119639 Kidney Diseases Phase 1 Completed - -
NCT00867321 Liver Cancer Phase 1 Phase 2 Completed - -
NCT00398814 Renal Cancer ... More >>Tumors Less << Phase 1 Completed - -
NCT00881751 - Completed - -
NCT01616186 Locally Metastatic Malignant N... More >>eoplasm Less << Phase 2 Withdrawn April 2016 -
NCT00941863 Carcinoma Phase 1 Completed - United States, Pennsylvania ... More >> Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Nashville, Tennessee, United States, 37232 United States, Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT00881751 Liver Cancer Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90033-0804 California Pacific Medical Center San Francisco, California, United States, 94115 United States, New York Columbia University/ New York Presbyterian Hospital New York, New York, United States, 10032 United States, South Carolina Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Tennessee Oncology, PLLCat Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 United States, Virginia UVA Cancer Center Charlottesville, Virginia, United States, 22908 Less <<
NCT01265576 HCC Phase 2 Unknown April 2016 United States, California ... More >> Vicus Clinical Site Berkeley, California, United States, 94704 United States, Georgia Vicus Clinical Site Atlanta, Georgia, United States, 30318 United States, New Jersey Vicus Clinical Site New Brunswick, New Jersey, United States Vicus Clinical Site Newark, New Jersey, United States, 07103 Vicus Clinical Site Paterson, New Jersey, United States, 07503 United States, New York Vicus Clinical Site Buffalo, New York, United States, 14263 Vicus Clinical Site New York, New York, United States, 10016 United States, Pennsylvania Vicus Clinical Site Philadelphia, Pennsylvania, United States United States, Texas Vicus Clinical Site Houston, Texas, United States, 77024 Vicus Clinical Site Houston, Texas, United States, 77030 Less <<
NCT01377025 Uveal Melanoma Phase 2 Unknown June 2017 Germany ... More >> Universitätsmedizin Berlin, Charité Campus Benjamin Franklin Berlin, Germany, 12203 Universitätsklinikum Erlangen Erlangen, Germany, 91052 Univesitätsklinikum Essen Essen, Germany, 45147 Less <<
NCT00941863 - Completed - -
NCT00494299 Carcinoma, Hepatocellular Phase 3 Completed - -
NCT00494299 - Completed - -
NCT01353794 - Withdrawn April 2018 -
NCT00752063 Advanced Hepatocellular Carcin... More >>oma Metastatic Hepatocellular Carcinoma Less << Phase 2 Unknown December 2008 China ... More >> Queen Mary Hospital Recruiting Hong Kong, China Contact: Ida Choi, MPhil    (852)28553635    cychoia@hkucc.hku.hk    Principal Investigator: Ronnie Poon, MD Less <<
NCT00424385 Prostate Cancer Phase 1 Completed - United States, Illinois ... More >> Oncology Specialists, S.C Niles, Illinois, United States, 60714 Oncology Specialists, S.C Park Ridge, Illinois, United States, 60068 Less <<
NCT01508364 - Completed - Germany ... More >> Many Locations, Germany Less <<
NCT00281957 Recurrent Melanoma ... More >> Stage IV Melanoma Less << Phase 2 Completed - -
NCT00424385 - Completed - -
NCT00281957 - Completed - -
NCT00889343 Colorectal Neoplasms Phase 2 Terminated - -
NCT01418729 Advanced Hepatocarcinoma Phase 2 Completed - Spain ... More >> Hospital Donostia, Instituto Biodonostia San Sebastian, Gipuzkoa, Spain, 20014 Less <<
NCT00855218 - Completed - -
NCT01264705 Hepatocellular Carcinoma ... More >> Liver Cancer Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT00788099 Advanced Solid Tumors ... More >> Lymphomas Less << Phase 1 Completed - United States, New Jersey ... More >> The Cancer Institute of New Jersey (CINJ) New Brunswick, New Jersey, United States, 08901 France Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT00828594 Hepatocellular Carcinoma Phase 1 Terminated - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 UCLA Department of Medicine Los Angeles, California, United States, 90005 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of Netherlands Novartis Investigative Site Amsterdam, Netherlands Spain Novartis Investigative Site Barcelona, Spain Novartis Invstigative Site Madrid, Spain Taiwan Novartis Investigative Site Tainan, Taiwan Less <<
NCT00110019 - Completed - -
NCT01131689 Hepatocellular Carcinoma Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT00627835 Locally Advanced Squamous Cell... More >> Carcinomas of the Head and Neck (SCCHN) Less << Phase 1 Withdrawn(Site decided not to ... More >>open this study) Less << - Canada, British Columbia ... More >> BC Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Less <<
NCT02564666 Hepatocellular Carcinoma Not Applicable Unknown December 2017 Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00110019 Mucosal Melanoma ... More >> Recurrent Melanoma Stage IIIA Skin Melanoma Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma Less << Phase 3 Completed - -
NCT03456401 Renal Cancer Cell Phase 2 Terminated(availability of new... More >> and more promising therapeutic agents than expected in the experimentation in question) Less << - Italy ... More >> Istituto Tumori Milan, Mi, Italy, 20156 Less <<
NCT00989469 Metastatic Colorectal Cancer Phase 1 Phase 2 Completed - France ... More >> Centre Oscar Lambret Lille, France Hopital Saint Eloi Montpellier, France Centre Rene Gauducheau Nantes, France Centre Antoine Lacassagne Nice, France CHU Robert Debre Reims, France Less <<
NCT00855218 Carcinoma, Hepatocellular Phase 2 Completed - -
NCT00494182 Metastatic Head and Neck Squam... More >>ous Cell Carcinoma Metastatic Squamous Cell Carcinoma of the Hypopharynx Metastatic Squamous Cell Carcinoma of the Larynx Metastatic Squamous Cell Carcinoma of the Oral Cavity Metastatic Squamous Cell Carcinoma of the Oropharynx Recurrent Head and Neck Squamous Cell Carcinoma Recurrent Hypopharyngeal Squamous Cell Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma Recurrent Oral Cavity Squamous Cell Carcinoma Recurrent Oropharyngeal Squamous Cell Carcinoma Less << Phase 2 Active, not recruiting April 30, 2019 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00657254 Neoplasm Meta... More >>stasis Less << Phase 2 Completed - United States, Massachusetts ... More >> Boston, Massachusetts, United States, 02115-6084 Belgium Bruxelles - Brussel, Belgium, 1000 Canada, Ontario Hamilton, Ontario, Canada, L8V 5C2 Toronto, Ontario, Canada, M5G 2M9 Germany Essen, Nordrhein-Westfalen, Germany, 45147 Herne, Nordrhein-Westfalen, Germany, 44625 Less <<
NCT00044512 Carcinoma, Hepatocellular Phase 2 Completed - United States, California ... More >> Los Angeles, California, United States, 90057 United States, New York New York, New York, United States, 10021-6007 Belgium Bruxelles - Brussel, Belgium, 1000 Bruxelles - Brussel, Belgium, 1070 Bruxelles - Brussel, Belgium, 1090 Gent, Belgium, 9000 Leuven, Belgium, 3000 France Lille Cedex, France, 59020 Marseille, France, 13005 Paris, France, 75020 Rennes Cedex, France, 35062 Saint Herblain, France, 44805 Israel Haifa, Israel, 31096 Jerusalem, Israel, 91120 Petach Tikva, Israel, 49100 Rehovot, Israel, 76100 Tel Aviv, Israel, 64239 Tel Hashomer, Israel, 52621 Italy Rozzano, Milano, Italy, 20089 Forlì, Italy, 47100 Milano, Italy, 20122 Pisa, Italy, 56126 Verona, Italy, 37126 Less <<
NCT00378703 - Completed - -
NCT01775501 Hepatocellular Cancer Phase 2 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02125 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT00253370 Adenocarcinoma of the Gastroes... More >>ophageal Junction Metastatic Gastric Cancer Advanced Unresectable Gastric Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00901901 Carcinoma, Hepatocellular Phase 3 Completed - -
NCT00378703 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Carcinoma Stage IV Renal Cell Cancer AJCC v7 Less << Phase 2 Completed - -
NCT00901901 - Completed - -
NCT00954135 Breast Cancer Phase 2 Unknown December 2010 Italy ... More >> Breast Unit Azienda Ospedaliera Istituti Ospitalieri Cremona, Italy Azienda Ospedaliera S.Luigi Orbassano Orbassano, Italy Less <<
NCT00238212 Adenocarcinoma of the Extrahep... More >>atic Bile Duct Adenocarcinoma of the Gallbladder Adenocarcinoma With Squamous Metaplasia of the Gallbladder Cholangiocarcinoma of the Extrahepatic Bile Duct Cholangiocarcinoma of the Gallbladder Recurrent Extrahepatic Bile Duct Cancer Recurrent Gallbladder Cancer Squamous Cell Carcinoma of the Gallbladder Unresectable Extrahepatic Bile Duct Cancer Unresectable Gallbladder Cancer Less << Phase 2 Completed - United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less <<
NCT00253370 - Completed - -
NCT00126620 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - Canada, Ontario ... More >> Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01482442 Liver Carcinoma Phase 3 Completed - France ... More >> CHU Amiens #2 Amiens, France, 80054 CHU Angers #3 Angers, France, 49933 CHRU Besançon Hôpital Jean Minjoz #21 Besançon, France, 25030 Hôpital Jean Verdier #25 Bondy, France, 93140 Hôpital Côte de Nacre #4 Caen, France, 14033 Hôpital Antoine Béclère #29 Clamart, France, 92140 Hopital beaujon #1 Clichy, France, 92110 Henri Mondor #24 Créteil, France, 94000 CHU Dijon Hôpital Bocage #22 Dijon, France, 21000 CHU Grenoble #5 Grenoble, France, 38043 Hôpital Edouard Herriot #6 Lyon, France, 69003 Lyon La croix Rousse #27 Lyon, France, 69004 Institut Paoli Calmettes #7 Marseille, France, 13009 CHU Marseille Hôpital La Timone #23 Marseille, France, 13385 Hôpital Saint Eloi #8 Montpellier, France, 34295 Hôpital de Brabois #9 Nancy, France, 54511 Hotel Dieu #10 Nantes, France, 44093 Hôpital de L'Archet #11 Nice, France, 06002 Hôpital Européen Georges Pompidou #13 Paris, France, 75908 Hôpital Haut Leveque #14 Pessac, France, 33604 CHU Poitiers La Milétrie Poitiers, France, 86021 CHU Robert Debré #28 Reims, France, 51100 CHU Saint Etienne Hôpital Nord #17 Saint-Priest en Jarez, France, 42270 Hôpital de Hautepierre #18 Strasbourg, France, 67098 Paul Brousse #19 Villejuif, France, 94275 Institut Gustave Roussy #20 Villejuif, France, 94805 Less <<
NCT00121251 Recurrent Renal Cell Carcinoma... More >> Stage III Renal Cell Cancer AJCC v7 Stage IV Renal Cell Cancer AJCC v7 Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467 Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, New York, United States, 10016 Mount Sinai Hospital New York, New York, United States, 10029 Weill Medical College of Cornell University New York, New York, United States, 10065 Less <<
NCT00692770 Carcinoma, Hepatocellular Phase 3 Completed - -
NCT01171482 Carcinoma, Hepatocellular Phase 2 Terminated(There were problems... More >> with national reimbursement policies.) Less << - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00692770 - Completed - -
NCT00758381 Locally Advanced Pancreatic Ca... More >>ncer Less << Phase 2 Unknown August 2009 Italy ... More >> A.O. Treviglio-Caravaggio, P.le Ospedale n1 Recruiting Treviglio, Bergamo, Italy, 24047 Sub-Investigator: sandro Barni, MD          Ospedale S.Orsola Fatebenefratelli Active, not recruiting Brescia, BS, Italy, 15100 A.O. Ospedale S.Martino Recruiting Genova, GE, Italy, 16132 Sub-Investigator: Alberto Sobrero, MD          A.O. san Paolo Recruiting Milano, MI, Italy, 20100 Sub-Investigator: Paolo Foa, MD          Casa di Cura Igea Not yet recruiting Milano, MI, Italy, 20100 Sub-Investigator: Gianfranco Pancera, MD          Ospedale S.Carlo Borromeo Not yet recruiting Milano, MI, Italy, 20123 Sub-Investigator: Donata Tabiadon, MD          A.O. S.Gerardo Recruiting Monza, MI, Italy, 20052 Sub-Investigator: Paolo Bidoli, MD          A.O. Universitaria Ospedali Riuniti Umberto I Recruiting Ancona, Italy, 60020 Principal Investigator: Stefano Cascinu, M.Pr          Ospedali Riuniti, Largo Barozzi, 1 Recruiting Bergamo, Italy, 24128 Principal Investigator: Roberto Labianca, MD          A.O.Policlinico S.Orsola Malpighi Active, not recruiting Bologna, Italy, 40138 A.O. Careggi-Università, Viale Pieraccini, 17 Recruiting Firenze, Italy, 50139 Sub-Investigator: Francesco Di Costanzo, MD          Ospedale Galliera Active, not recruiting Genova, Italy, 16132 A.O. Carlo Poma - Via Albertoni, 1 Recruiting Mantova, Italy, 46100 Sub-Investigator: Enrico Aitini, MD          A.O. Cà Granda, Piazza Ospedale Maggiore, 3 Recruiting Milano, Italy, 20162 Sub-Investigator: Salvatore Siena, MPr          Policlinico di modena Active, not recruiting Modena, Italy, 41100 Università Campus Biomedico, Via Emilio Longoni, 83 Active, not recruiting Roma, Italy, 00155 A.O. S.Giovanni Calabita Fatebenefratelli Active, not recruiting Roma, Italy, 00186 Less <<
NCT00044512 - Completed - -
NCT02156297 - Recruiting August 2019 China, Jiangsu ... More >> The First Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215006 Contact: Jia Chen, M.D.    +86 512 67781856    c_jerry_j@163.com    Principal Investigator: Depei Wu, M.D., Ph.D.          Sub-Investigator: Jia Chen, M.D. Less <<
NCT00199160 Head and Neck Neoplasms Phase 2 Completed - Belgium ... More >> Jules Bordet Institute Brussels, Belgium, 1000 Less <<
NCT01069328 Carcinoma, Non-Small-Cell Lung... More >> Lung Cancer Less << Phase 1 Completed - United States, Minnesota ... More >> Rochester, Minnesota, United States, 55905 United States, Texas Houston, Texas, United States, 77030 Less <<
NCT01387555 Hepatocellular Carcinoma ... More >> Liver Cancer HCC Less << Phase 2 Completed - -
NCT01183663 Advanced Cancers Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00573755 Breast Cancer Phase 2 Terminated(lack of participant... More >> accrual) Less << - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 55259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01308723 Carcinoma, Hepatocellular Phase 1 Completed - Singapore ... More >> Singapore, Singapore, 119228 Singapore, Singapore, 169610 Less <<
NCT00573755 - Terminated(lack of participant... More >> accrual) Less << - -
NCT00732914 Renal Cell Carcinoma Phase 3 Completed - Germany ... More >> Urologische Klinik Mannheim, Baden-Wuerttemberg, Germany, 68167 Less <<
NCT00095459 Neoplasms Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00483301 Malignant Melanoma Phase 2 Completed - United States, California ... More >> Dr. Steven O'Day Los Angeles, California, United States, 90025 United States, Florida Mt. Sinai Medical Center Miami Beach, Florida, United States, 33140 Less <<
NCT02101593 Hepatocellular Carcinoma Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Less <<
NCT00858871 Hepato Cellular Carcinoma (HCC... More >>) Less << Phase 3 Completed - -
NCT01324076 Liver Cancer Phase 3 Unknown - United Kingdom ... More >> Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Recruiting Birmingham, England, United Kingdom, B15 2TH Contact: Contact Person    44-121-472-1311       Bristol Royal Infirmary Recruiting Bristol, England, United Kingdom, BS2 8HW Contact: Contact Person    44-117-923-0000       Aintree University Hospital Recruiting Liverpool, England, United Kingdom, L9 7AL Contact: Contact Person    44-151-525-5980       Royal Free Hospital Recruiting London, England, United Kingdom, NW3 2QG Contact: Contact Person    44-20-7794-0500       King's College Hospital Recruiting London, England, United Kingdom, SE5 9RS Contact: Contact Person    44-20-3299-9000       Royal Marsden - London Recruiting London, England, United Kingdom, SW3 6JJ Contact: Contact Person    44-20-7352-8171       Queen's Medical Centre Recruiting Nottingham, England, United Kingdom, NG7 2UH Contact: Contact Person    44-115-924-9924       Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Contact Person    44-23-8079-8751 Less <<
NCT00474786 Renal Cell Carcinoma Phase 3 Completed - -
NCT02616692 - Completed - Japan ... More >> Many Locations, Japan Less <<
NCT01222676 Bladder Cancer Phase 2 Unknown - Italy ... More >> Fondazione Istituto Nazionale dei Tumori Recruiting Milan, Italy, 20133 Contact: Contact Person    39-2-2390-2359    roberto.salvioni@istitutotumori.mi.it Less <<
NCT00623402 Melanoma Phase 2 Completed - Germany ... More >> Dpt. of Dermatology, Humboldt University Berlin, Germany, 10117 Dept. of Dermatology, Elbe Klinikum Buxtehude, Germany, 21614 Dpt. of Dermatology, University of Hannover Hannover, Germany, 30449 Dpt. of Dermatology, University of Homburg/Saar Homburg/Saar, Germany, 66421 Dpt. of Dermatology; UK-SH Campus Kiel, Germany Kiel, Germany, D-24105 Dpt. of Dermatology, University of Cologne Koeln, Germany, D-50937 Dpt. of Dermatology, University of Mannheim Mannheim, Germany, 68163 Dpt. of Dermatology, Ludwig-Maximilian-University München, Germany, 80337 Dpt. of Dermatology, University of Tübingen Tübingen, Germany, 72076 Dpt. of Dermatology, University of Würzburg Würzburg, Germany, 97080 Less <<
NCT03340636 - Not yet recruiting March 2019 France ... More >> Caen University Hospital Not yet recruiting Caen, France Contact: Dupont Benoit, MD, PhD    02.31 06 45 40 ext +33    dupont-be@chu-caen.fr    Principal Investigator: benoit Dupont, Md, PhD Less <<
NCT00417248 Non-Small Cell Lung Cancer Phase 1 Phase 2 Terminated(Negative sorafenib ... More >>results from ESCAPE trial and safety concerns of regimen) Less << - United States, Illinois ... More >> Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Center for Cancer Care at Goshen Health System Goshen, Indiana, United States, 46527 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Horizon Oncology Center Lafayette, Indiana, United States, 47905 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 United States, Ohio Oncology Partners Network Cincinnati, Ohio, United States, 45247 Less <<
NCT01246843 - Completed - Netherlands ... More >> University Medical Centre Nijmegen Nijmegen, Gelderland, Netherlands, 6500 HB Less <<
NCT01897610 Advanced Hepatocellular Carcin... More >>oma Less << Phase 2 Completed - Korea, Republic of ... More >> Inha University Hospital Incheon, Korea, Republic of, 400-711 Yonsei University Health System Seoul, Korea, Republic of, 120-752 Korea University Anam Hospital Seoul, Korea, Republic of, 136-750 The Catholic University of Korea, Seoul ST. Mary's Hospital Seoul, Korea, Republic of, 137-701 Less <<
NCT03212625 Hepatocellular Carcinoma Phase 4 Active, not recruiting January 31, 2019 Korea, Republic of ... More >> Korea University Guro Hospital Seoul, Korea, Republic of, 08308 Less <<
NCT00406601 Sarcoma, Soft Tissue Phase 2 Completed - Italy ... More >> Istituto Clinico Humanitas Rozzano, Milan, Italy, 20089 Less <<
NCT00474786 - Completed - -
NCT00565968 Melanoma (Skin) Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01409499 Hepatectomy H... More >>epatocellular Carcinoma Sorafenib Less << Phase 4 Completed - China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT03755791 Hepatocellular Carcinoma Phase 3 Recruiting December 1, 2021 United States, California ... More >> Exelixis Clinical Site #2 Recruiting Rialto, California, United States, 92377 Contact: Exelixis    888-393-5494    druginfo@exelixis.com    United States, Nevada Exelixis Clinical Site #1 Recruiting Las Vegas, Nevada, United States, 89169 Contact: Exelixis    888-393-5494    druginfo@exelixis.com Less <<
NCT00490685 Carcinoma, Hepatocellular Phase 2 Completed - Italy ... More >> Istituto Clinico Humanitas Rozzano, Milan, Italy, 20089 Less <<
NCT00330421 - Completed - -
NCT01988493 Carcinoma, Hepatocellular Phase 1 Phase 2 Active, not recruiting October 18, 2018 -
NCT00330421 Metastatic Ewing Sarcoma/Perip... More >>heral Primitive Neuroectodermal Tumor Metastatic Osteosarcoma Recurrent Adult Soft Tissue Sarcoma Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Osteosarcoma Stage I Adult Soft Tissue Sarcoma Stage II Adult Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00417248 - Terminated(Negative sorafenib ... More >>results from ESCAPE trial and safety concerns of regimen) Less << - -
NCT00352859 Carcinoma, Renal Cell Phase 4 Terminated - United States, Missouri ... More >> Kansas City, Missouri, United States Less <<
NCT02645981 HCC Phase 2 Phase 3 Active, not recruiting August 2019 China, Jiangsu ... More >> The PLA 81 Hospital Nanjing, Jiangsu, China, 025 China, Sichuan West China Hospital Sichuan University Chengdu, Sichuan, China, 610042 Less <<
NCT00496301 Carcinoma, Renal Cell Phase 2 Completed - Spain ... More >> Hospital del Mar Barcelona, Spain, 08003 Hospital Vall d´Hebron Barcelona, Spain, 08035 Hospital de Basurto Bilbao, Spain, 48013 Hospital Santiago de Compostela Coruña, Spain, 15706 Hospital Josep Trueta Gerona, Spain, 17007 Hospital Juan Ramón Jiménez Huelva, Spain, 21005 Hospital Clínico Virgen de la Victoria Málaga, Spain, 29010 Clínica Universitaria de Navarra Pamplona, Spain, 31008 Hospital Virgen Macarena Sevilla, Spain, 41009 Hospital Xeral Cies Vigo, Spain, 36204 Less <<
NCT01887717 Hepatocellular Carcinoma Phase 3 Terminated(Poor Accrual.) - United States, Illinois ... More >> Northwestern Medical Faculty Foundation, Div of Hematology/Oncology Chicago, Illinois, United States, 60611 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 Belgium Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 France Paoli-Calmettes Institute Marseille, France, 13273 Italy UO Radiologia, Ospedali Riuniti di Bergamo Bergamo, Italy, 24128 Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy, 40138 ASO-Santa Croce e Carle di Cuneo Cuneo, Italy, 12100 Fondazione IRCCS Ca Grande Milano, Italy, 20122 S.C Radiologia Interventistica, A.O.Ospedale Niguarda Ca Granda Milano, Italy, 20162 Fondazione Istituto Nazionale Tumori di Milano Milano, Italy, I-20133 Azienda Ospedaliera Ospedali Riuniti "Villa Sofia-Cervello" Palermo, Italy, 90147 University of Pisa Pisa, Italy, 56100 Policlinico A. Gemelli Rome, Italy, 8 - 00168 Spain Hospital Clínic Barcelona. IDIBAPS. CIBEREHD. Liver Unit Barcelona, Spain, 08036 Bulevar Sur s/n Madrid, Spain, 28041 Hospital Universitario Puerta de Hierro, Gastroenterology & Hepatology Dept Madrid, Spain, 28222 Hospital Universitari i Politecnic la Fe Valencia, Spain, 46026 United Kingdom University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom, B15 2WB Royal Free London NHS Foundation Trust London, United Kingdom, NW3 2QG Less <<
NCT02349867 Pancreatic Adenocarcinoma ... More >> Stage IA Pancreatic Cancer Stage IB Pancreatic Cancer Stage IIA Pancreatic Cancer Stage IIB Pancreatic Cancer Stage III Pancreatic Cancer Recurrent Pancreatic Carcinoma Less << Phase 1 Recruiting May 31, 2022 United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Recruiting Richmond, Virginia, United States, 23298 Contact: Andrew Poklepovic, MD    804-628-2321    andrew.poklepovic@vcuhealth.org    Contact: Katherine Thompson, CRN    804-628-0960    masseysiit@vcu.edu    Principal Investigator: Andrew Poklepovic, MD Less <<
NCT01012011 - Completed - Korea, Republic of ... More >> Many Locations, Korea, Republic of Less <<
NCT00544167 - Completed - -
NCT00544167 Breast Cancer Not Applicable Completed - United States, Florida ... More >> Integrated Community Oncology Network Jacksonville, Florida, United States, 32256 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less <<
NCT02786342 - Recruiting January 2019 Italy ... More >> Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Recruiting Meldola, FC, Italy, 47014 Contact: Andrea Casadei-Gardini, MD          Oncologia medica , PO FAENZA, Ausl della Romagna Recruiting Faenza, RA, Italy, 48018 Contact: Stefano Tamberi, MD          Ospedale Civile degli Infermi Recruiting Rimini, RM, Italy, 47921 Contact: Emiliano Tamburini, MD Less <<
NCT00449033 - Completed - -
NCT00499525 Breast Cancer Phase 2 Active, not recruiting December 2021 -
NCT00449033 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - -
NCT01806740 Hepatocellular Carcinoma Phase 4 Active, not recruiting April 2018 Korea, Republic of ... More >> Guerbet Korea Seoul, Gangnam Gu, Korea, Republic of, 135-920 Less <<
NCT00696696 - Completed - -
NCT00696696 Pancreatic Cancer Phase 2 Completed - United States, California ... More >> Desert Regional Medical Center Palm Springs, California, United States, 92262 United States, New York Bellevue Hospital New York, New York, United States, 10016 New York University Cancer Center New York, New York, United States, 10016 Less <<
NCT03406364 Solid Tumor Phase 1 Phase 2 Recruiting December 31, 2019 Taiwan ... More >> Tri-Service General Hospital Recruiting Taipei, Nehu District, Taiwan, 114 Contact: Candace Liu    +886-2-8792-3100 ext 19391    candaceliu@metagone.com.tw Less <<
NCT00452387 - Terminated(Early stopping rule... More >>) Less << - -
NCT00794859 Mesothelioma Phase 2 Unknown - United Kingdom ... More >> Guy's and St Thomas' NHS Foundation Trust London, United Kingdom, SE1 9RT Less <<
NCT00452387 Metastatic Prostate Cancer Phase 2 Terminated(Early stopping rule... More >>) Less << - United States, California ... More >> Wilshire Oncology Medical Group, Inc. La Verne, California, United States, 91750 United States, Georgia Peachtree Hematology Oncology Consultants Atlanta, Georgia, United States, 30309 Central Georgia Cancer Care Macon, Georgia, United States, 31201 Northwest Georgia Oncology Centers Marietta, Georgia, United States, 30060 United States, Montana Hematology Oncology Centers of the Northern Rockies, PC Billings, Montana, United States, 59101 United States, Ohio Mid-Ohio Oncology/Hematology, Inc. Columbus, Ohio, United States, 43213 United States, Pennsylvania Lancaster Cancer Center Lancaster, Pennsylvania, United States, 17605 Pennsylvania Oncology Hematmology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 United States, Virginia Cancer Specialists of Tidewater Chesapeake, Virginia, United States, 23320 Less <<
NCT00541021 Pancreatic Cancer Phase 3 Unknown - France ... More >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Recruiting Marseille, France, 13273 Contact: Frederic Viret, MD    33-4-91-22-35-37    viretf@marseille.fnclcc.fr Less <<
NCT01004003 Carcinoma, Hepatocellular Phase 2 Completed - Austria ... More >> 1199.37.43001 Boehringer Ingelheim Investigational Site Wien, Austria 1199.37.43002 Boehringer Ingelheim Investigational Site Wien, Austria France 1199.37.33001 Boehringer Ingelheim Investigational Site Paris, France 1199.37.33002 Boehringer Ingelheim Investigational Site Paris, France Germany 1199.37.49008 Boehringer Ingelheim Investigational Site Berlin, Germany 1199.37.49009 Boehringer Ingelheim Investigational Site Erlangen, Germany 1199.37.49002 Boehringer Ingelheim Investigational Site Freiburg, Germany 1199.37.49001 Boehringer Ingelheim Investigational Site Hannover, Germany 1199.37.49010 Boehringer Ingelheim Investigational Site Heidelberg, Germany 1199.37.49005 Boehringer Ingelheim Investigational Site Jena, Germany 1199.37.49004 Boehringer Ingelheim Investigational Site Magdeburg, Germany 1199.37.49003 Boehringer Ingelheim Investigational Site München, Germany 1199.37.49006 Boehringer Ingelheim Investigational Site Tübingen, Germany Hungary 1199.37.36001 Boehringer Ingelheim Investigational Site Debrecen, Hungary Netherlands 1199.37.31002 Boehringer Ingelheim Investigational Site Leiden, Netherlands 1199.37.31001 Boehringer Ingelheim Investigational Site Utrecht, Netherlands Poland 1199.37.48002 Boehringer Ingelheim Investigational Site Olsztyn, Poland 1199.37.48003 Boehringer Ingelheim Investigational Site Warsaw, Poland 1199.37.48001 Boehringer Ingelheim Investigational Site Warszawa, Poland Romania 1199.37.40002 Boehringer Ingelheim Investigational Site Bucharest, Romania 1199.37.40003 Boehringer Ingelheim Investigational Site Cluj-Napoca, Romania United Kingdom 1199.37.44001 Boehringer Ingelheim Investigational Site Edgbaston, Birmingham, United Kingdom 1199.37.44005 Boehringer Ingelheim Investigational Site Glasgow, United Kingdom 1199.37.44008 Boehringer Ingelheim Investigational Site Liverpool, United Kingdom 1199.37.44002 Boehringer Ingelheim Investigational Site London, United Kingdom 1199.37.44003 Boehringer Ingelheim Investigational Site London, United Kingdom 1199.37.44006 Boehringer Ingelheim Investigational Site Manchester, United Kingdom 1199.37.44004 Boehringer Ingelheim Investigational Site Nottingham, United Kingdom Less <<
NCT00661830 Adenocarcinoma Phase 2 Completed - Germany ... More >> Klinikum der Johannes Gutenberg-Universität Mainz, I. Med. Klinik Mainz, Rheinland-Pfalz, Germany, 55131 Universitätsklinikum Jena, Klinik für Innere Medizin, Innere Medizin II D-07740 Jena, Germany Universitätsklinikum Hamburg-Eppendorf, I. Med. Klinik, Zentrum für Innere Medizin, Martinistr. 3 D-20248 Hamburg, Germany Klinikum Fulda gAG, Tumorklinik, Pacelliallee 4 D-36043 Fulda, Germany Klinikum der Johann-Wolfgang Goethe-Universität, Innere Medizin I, Theodor-Stern-Kai 7 D-60590 Frankfurt, Germany Universitätsklinikum des Saarlandes, Klinik für Innere Medizin II, Kirrberger Str., Gebäude 41 D-66421 Homburg/Saar, Germany Klinikum der Universität München, Medizinische Klinik II, Marchioninistr. 15 D-81377 München, Germany Klinikum rechts der Isar, TU München, II. Medizinische Klinik und Poliklinik, Ismaningerstr. 22 D-81675 München, Germany II. Med. Klinik, Leopoldina-Krankenhaus der Stadt Schweinfurt, Gustav-Adolf-Str. 8 D-97422 Schweinfurt, Germany Klinikum Esslingen Esslingen, Germany, 73730 Universitätsklinikum Halle, Innere Medizin I Halle, Germany, 06120 Less <<
NCT03578874 Hepatocellular Carcinoma Phase 2 Recruiting December 31, 2021 Hong Kong ... More >> Queen Mary Hospital Recruiting Hong Kong, Hong Kong Contact: Thomas Yau          Principal Investigator: Thomas Yau, MD Less <<
NCT00538005 Melanoma (Skin) Phase 1 Phase 2 Unknown - United States, California ... More >> San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas Recruiting Encinitas, California, United States, 92024 Contact: Edward F. McClay, MD    760-452-3340    emcclay@pacificoncology.com Less <<
NCT00792350 - Completed - Austria ... More >> Many Locations, Austria Germany Many Locations, Germany Less <<
NCT01004003 - Completed - -
NCT00895674 - Completed - -
NCT00661830 - Completed - -
NCT00872014 Advanced Hepatocellular Carcin... More >>oma Inoperable Hepatocellular Carcinoma Less << Phase 2 Completed - -
NCT02856126 Hepatocellular Carcinoma Phase 3 Recruiting August 2018 China, Guangdong ... More >> Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Wusheng Yu, MD    13827285010    yuwusheng1998@126.com    Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    8620-87343115    shiming@mail.sysu.edu.cn    The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Guosheng Tan, MD    13725254145    tgs1976@163.com    Guangzhou Twelfth People 's Hospital Recruiting Guangzhou, Guangdong, China, 510620 Contact: Yuanmin Zhou, MD    15521278919    13430288977@139.com    Principal Investigator: Jinghua Chen, MD          Kaiping Central Hospital Recruiting Kaiping, Guangdong, China, 529300 Contact: Shijie Zhang, MD    13717287622    Shijie_9262511@163.com    China, Hunan The First Affiliated Hospital of University Of South China Recruiting Hengyang, Hunan, China, 421001 Contact: Xiaoping Wu, MD    13975486015    wxp19730806@sina.com    China, Shanxi The First Affiliated Hospital Of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710061 Contact: Xin Zheng, MD    13649265446    183421344@qq.com Less <<
NCT00976170 Hepatocellular Carcinoma Phase 1 Completed - United States, California ... More >> California Pacific Medical Center San Francisco, California, United States, 94115 United States, Florida University of Miami Miami, Florida, United States United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Taiwan National Cheng Kung University Hospital Tainan, Taiwan National Taiwan Univercity Hospital Taipei, Taiwan Less <<
NCT01232296 - Completed - -
NCT01011010 Liver Cancer Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT01009593 Hepatocellular Carcinoma Non-r... More >>esectable Hepatocellular Carcinoma Recurrent Carcinoma, Hepatocellular Liver Diseases Neoplasms by Histologic Type Digestive System Neoplasms Carcinoma Liver Neoplasms Neoplasms Neoplasms by Site Digestive System Diseases Adenocarcinoma Neoplasms, Glandular and Epithelial Less << Phase 3 Terminated(See termination rea... More >>son in detailed description) Less << - -
NCT01187199 Advanced Cancer Phase 1 Active, not recruiting August 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01232296 Hepatocellular Carcinoma Phase 2 Completed - China, Jiangsu ... More >> Novartis Investigative Site Nanjing, Jiangsu, China, 210002 China, Shanxi Novartis Investigative Site Xi'an, Shanxi, China, 710032 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310016 China Novartis Investigative Site Beijing, China, 100039 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Novartis Investigative Site Shatin, New Territories, Hong Kong Japan Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 232-0024 Novartis Investigative Site OsakaSayama, Osaka, Japan, 589-8511 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03722 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Republic of, 136-705 Singapore Novartis Investigative Site Singapore, Singapore, 308433 Taiwan Novartis Investigative Site Taipei, Taiwan, ROC, Taiwan, 112 Novartis Investigative Site Kuei-Shan Chiang, Taoyuan/ Taiwan ROC, Taiwan, 33305 Novartis Investigative Site Taichung, Taiwan, 40705 Novartis Investigative Site Taipei, Taiwan, 10048 Thailand Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Bangkok, Thailand, 10700 Novartis Investigative Site Chiang Mai, Thailand, 50200 Novartis Investigative Site Khon Kaen, Thailand, 40002 Novartis Investigative Site Songkla, Thailand, 90110 Less <<
NCT00687674 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 1 Phase 2 Terminated(Due to study design... More >> (and toxicity), this trial closed to accrual prior to opening the phase II portion.) Less << - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01703455 Salivary Gland Cancer Phase 2 Unknown January 2013 Italy ... More >> IRCCS Istituto Nazionale Tumori Milano, Italy, 20133 Less <<
NCT00687674 - Terminated(Due to study design... More >> (and toxicity), this trial closed to accrual prior to opening the phase II portion.) Less << - -
NCT00634751 Pancreatic Neoplasms ... More >> Bile Duct Neoplasms Less << Phase 1 Phase 2 Completed - United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT00589420 Prostate Cancer Phase 2 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104-4283 Contact: Clinical Trials Office - Abramson Cancer Center of the Univers    800-474-9892 Less <<
NCT00875615 Liver Cancer Phase 2 Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT00634751 - Completed - -
NCT00771147 - Completed - Belgium ... More >> Many Locations, Belgium Less <<
NCT01157013 Hepatocellular Carcinoma Not Applicable Completed - Spain ... More >> Miguel Servet University Hospital Zaragoza, Aragon, Spain, 50009 Less <<
NCT00875615 - Completed - -
NCT00990860 Hepatocellular Carcinoma Phase 2 Unknown - Taiwan ... More >> E-Da hospital Kaohsiung, Taiwan Veterans General Hospital- Kaochiung Kaoshiung, Taiwan Veterans General Hospital- Taichung Taichung, Taiwan National Cheng Kung University Hospital Tainan, Taiwan Mackay Memorial Hospital Taipei, Taiwan Tri- Service General Hospital Taipei, Taiwan Veterans General Hospital- Taipei Taipei, Taiwan Chang-Gung Memorial Hospital- LinKou TaoYuan Hsien, Taiwan Less <<
NCT00492258 Kidney Cancer Phase 3 Completed - United Kingdom ... More >> Royal Bournemouth Hospital Bournemouth, England, United Kingdom, BH7 7DW Bristol Haematology and Oncology Centre Bristol, England, United Kingdom, BS2 8ED Queen's Hospital Burton-upon-Trent, England, United Kingdom, DE13 0RB Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Gloucestershire Oncology Centre at Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN Derbyshire Royal Infirmary Derby, England, United Kingdom, DE1 2QY Dorset County Hospital Dorchester, England, United Kingdom, DT1 2JY Gloucestershire Royal Hospital Gloucester, England, United Kingdom, GL1 3NN Diana Princess of Wales Hospital Grimsby, England, United Kingdom, DN33 2BA Princess Royal Hospital at Hull and East Yorkshire NHS Trust Hull, England, United Kingdom, HU8 9HE Ipswich Hospital Ipswich, England, United Kingdom, IP4 5PD Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Lincoln County Hospital Lincoln, England, United Kingdom, LN2 5QY Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Guy's Hospital London, England, United Kingdom, SE1 9RT Royal Marsden - London London, England, United Kingdom, SW3 6JJ Charing Cross Hospital London, England, United Kingdom, W6 8RF Maidstone Hospital Maidstone, England, United Kingdom, ME16 9QQ Christie Hospital Manchester, England, United Kingdom, M20 4BX Clatterbridge Centre for Oncology Merseyside, England, United Kingdom, CH63 4JY James Cook University Hospital Middlesbrough, England, United Kingdom, TS4 3BW Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle-Upon-Tyne, England, United Kingdom, NE4 6BE Mount Vernon Cancer Centre at Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Dorset Cancer Centre Poole Dorset, England, United Kingdom, BH15 2JB Portsmouth Oncology Centre at Saint Mary's Hospital Portsmouth Hants, England, United Kingdom, PO3 6AD Whiston Hospital Prescot Merseyside, England, United Kingdom, L35 5DR Berkshire Cancer Centre at Royal Berkshire Hospital Reading, England, United Kingdom, RG1 5AN Scarborough General Hospital Scarborough, England, United Kingdom, YO12 6QL Scunthorpe General Hospital Scunthorpe, England, United Kingdom, DN15 7BH Cancer Research Centre at Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Wexham Park Hospital Slough, Berkshire, England, United Kingdom, SL2 4HL Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD University Hospital of North Staffordshire Stoke-On-Trent, England, United Kingdom, ST4 7LN Torbay Hospital Torquay, England, United Kingdom, TQ2 7AA Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Less <<
NCT01371981 Acute Myeloid Leukemia ... More >> Leukemia Cutis Myeloid Neoplasm Myeloid Sarcoma Untreated Adult Acute Myeloid Leukemia Untreated Childhood Myeloid Neoplasm Less << Phase 3 Active, not recruiting - -
NCT00111020 Carcinoma, Renal Cell Phase 3 Completed - -
NCT01728948 - Completed - China ... More >> Many Locations, China Less <<
NCT00663741 Gastric Cancer Phase 1 Completed - Japan ... More >> Kashiwa, Chiba, Japan, 277-8577 Kobe, Hyogo, Japan, 650-0017 Chuo-ku, Tokyo, Japan, 104-0045 Less <<
NCT01215266 Bladder Cancer Phase 2 Terminated(Slow recruitment) - -
NCT02240433 Hepatocellular Carcinoma Phase 1 Active, not recruiting February 11, 2019 Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 277 8577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 241-8515 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suita-shi, Japan, 565-0871 Less <<
NCT00073307 Carcinoma, Renal Cell Phase 3 Completed - -
NCT00096200 Recurrent Fallopian Tube Carci... More >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Less << Phase 2 Completed - United States, Florida ... More >> Moffitt Cancer Center at Tampa General Hospital Tampa, Florida, United States, 33612 Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Lake University Ireland Cancer Center Mentor, Ohio, United States, 44060 United States, Virginia Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT00492986 Carcinoma, Renal Cell Phase 3 Completed - -
NCT00073307 - Completed - -
NCT00079612 Carcinoma, Renal Cell Phase 2 Completed - United States, Illinois ... More >> Chicago, Illinois, United States, 60637 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas Houston, Texas, United States, 77030 San Antonio, Texas, United States, 78229 United Kingdom London, Greater London, United Kingdom, SW3 6JJ Glasgow, Strathclyde, United Kingdom, G11 6NT Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT00445588 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00445588 - Completed - -
NCT00661180 Chronic Myelogenous Leukemia Phase 2 Completed - United States, Oregon ... More >> Portland, Oregon, United States, 97239 France Lyon Cedex, France, 69437 Paris, France, 75010 Poitiers Cedex, France, 86021 Less <<
NCT02517736 Uveal Melanoma Phase 2 Completed - France ... More >> Service d'ophtalmologie, CHU de Caen Caen, France, 14000 Less <<
NCT00096200 - Completed - -
NCT00822848 Sarcoma Phase 1 Completed - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00837876 - Completed - -
NCT00558636 Carcinoma, Non-Small-Cell Lung Phase 3 Terminated(Terminated early wh... More >>en the results from Study NCT00300885 showed an overall lack of efficacy in NSCLC and increased mortality in subjects with squamous subtype.) Less << - China, Guangdong ... More >> Guangzhou, Guangdong, China, 510060 Guangzhou, Guangdong, China, 510515 China, Hong Kong Shatin, Hong Kong, China China, Jiangsu Nanjing, Jiangsu, China, 210003 China, Zhejiang Hangzhou, Zhejiang, China, (310022), Hangzhou, Zhejiang, China, 310016 China Beijing, China, 100021 Beijing, China, 100142 Beijing, China, 100730 Chongqing, China, 400038 Shanghai, China, 200032 Shanghai, China, 200433 India Mumbai, Maharashtra, India, 400012 New- Delhi, India, 110008 Korea, Republic of Gyeonggi-do, Korea, Republic of, 410-769 Seoul, Korea, Republic of, 136-705 Singapore Singapore, Singapore, 119228 Singapore, Singapore, 169610 Taiwan Changhua, Taiwan, 500 Taipei, Taiwan, 100 Thailand Bangkok, Thailand, 10330 Bangkok, Thailand Less <<
NCT00876382 - Completed - United States, Arkansas ... More >> Northeast Arkansas Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Gulfcoast Oncology Associates St. Petersburg, Florida, United States, 33705 United States, Georgia Medical Oncology Associates of Augusta Augusta, Georgia, United States, 30901 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Mississippi Jackson Oncology Associates Jackson, Mississippi, United States, 39202 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00558636 - Terminated(Terminated early wh... More >>en the results from Study NCT00300885 showed an overall lack of efficacy in NSCLC and increased mortality in subjects with squamous subtype.) Less << - -
NCT00837876 Pancreatic Cancer Phase 2 Completed - United States, Kentucky ... More >> Purchase Cancer Group - Paducah Paducah, Kentucky, United States, 42002 United States, Tennessee Erlanger Cancer Center at Erlanger Hospital - Baroness Chattanooga, Tennessee, United States, 37403 Baptist Regional Cancer Center at Baptist Riverside Knoxville, Tennessee, United States, 37901 Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT01466504 - Terminated(Accrual did not mee... More >>t expectations. Over nearly 2 years just 4 subjects were treated on study. The goal of 30 subjects was not attainable.) Less << - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756 United States, Vermont White River Junction VA Medical Center White River Junction, Vermont, United States, 05009 Less <<
NCT01124669 - Completed - -
NCT03236649 Hepatocellular Carcinoma (HCC) Phase 3 Not yet recruiting August 2019 -
NCT02977754 - Recruiting March 2019 Italy ... More >> Istituto Clinico Humanitas Recruiting Rozzano, Milano, Italy, 20089 Contact: Egesta Lopci, MD    +39 0282247542 Less <<
NCT01664182 Stage III Renal Cell Cancer AJ... More >>CC v7 Stage IV Renal Cell Cancer AJCC v7 Less << Phase 2 Active, not recruiting - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 City of Hope South Pasadena South Pasadena, California, United States, 91030 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Metro Minnesota Community Oncology Research Consortium Saint Louis Park, Minnesota, United States, 55416 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Virginia VCU Massey Cancer Center at Hanover Medical Park Mechanicsville, Virginia, United States, 23116 Less <<
NCT01245582 Hepatic Neoplasm Malignant Phase 3 Withdrawn August 2015 -
NCT00919009 Carcinoma, Hepatocellular Phase 2 Completed - Korea, Republic of ... More >> National Cancer Center Seoul, Korea, Republic of Less <<
NCT01262482 Advanced or Metastatic Gastric... More >> or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment) Less << Phase 2 Completed - Spain ... More >> Hospital Clinic de Barcelona Barcelona, Spain Hospital Sant Pau Barcelona, Spain H. Josep Trueta Girona, Spain Centro Oncológico M.D. Anderson Spain Madrid, Spain Hospital de Fuenlabrada Madrid, Spain Hospital La Paz Madrid, Spain Hospital Althaia Manresa, Spain Clínica Universitaria de Navarra Pamplona, Spain Hospital Parc Taulí Sabadell, Spain Hospital General de Valencia Valencia, Spain Less <<
NCT00449280 Advanced Solid Tumor Phase 1 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00464919 Hepatocellular Carcinoma Phase 2 Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT00522301 - Terminated - -
NCT00117637 Carcinoma, Renal Cell Phase 2 Completed - -
NCT00865709 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT00522301 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 2 Terminated - United States, New York ... More >> Memorial Sloan - Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00117637 - Completed - -
NCT01754987 Metastatic Hepatocellular Carc... More >>inoma Advanced Liver Cancer Less << Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00335764 - Completed - -
NCT00335764 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Less << Phase 1 Phase 2 Completed - United States, California ... More >> University of California at Los Angeles Los Angeles, California, United States, 90095 University of California San Francisco San Francisco, California, United States, 94115 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00865709 - Completed - -
NCT03140332 Hepatocellular Carcinoma ... More >> Perfusion Scanner Less << Not Applicable Recruiting February 27, 2020 France ... More >> CHU Amiens Picardie Recruiting Amiens, Picardie, France, 80054 Contact: Vincent HAUTEFEUILLE, Dr    +33322668206    hautefeuille.vincent@chu-amiens.fr Less <<
NCT01754987 - Completed - -
NCT02560012 Carcinoma, Renal Cell Phase 2 Terminated(Loss of laboratory ... More >>performing molecular analysis) Less << - United States, Texas ... More >> UTHealth Memorial Hermann Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00410124 Metastatic Renal Cell Carcinom... More >>a Less << Phase 3 Completed - -
NCT00410124 - Completed - -
NCT02779283 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Less << Phase 1 Recruiting June 1, 2019 United States, Oregon ... More >> OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Stephen E. Spurgeon    503-494-8950    spurgeos@ohsu.edu    Principal Investigator: Stephen E. Spurgeon Less <<
NCT02013089 Gastrointestinal Cancers Not Applicable Unknown December 2017 China, Guangdong ... More >> Gastrointestinal Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanghong Deng, PhD    008613925106525    13925106525@163.com    Principal Investigator: Yanhong Deng, PhD Less <<
NCT02559778 Neuroblastoma Phase 2 Recruiting September 2026 -
NCT03533582 Childhood Hepatocellular Carci... More >>noma Childhood Malignant Liver Neoplasm Elevated Alpha-Fetoprotein Hepatoblastoma SMARCB1 Gene Mutation Less << Phase 2 Phase 3 Recruiting March 31, 2025 -
NCT01556490 Unresectable Hepatocellular Ca... More >>rcinoma Less << Phase 3 Active, not recruiting April 2019 -
NCT02187302 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Completed - -
NCT02940496 Malignant Neoplasms of Digesti... More >>ve Organs Advanced Liver Cancer Less << Phase 1 Phase 2 Active, not recruiting December 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00495872 Solid Tumors Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01731158 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Unknown May 2016 Germany ... More >> Charité Berlin Berlin, Germany University Hospital Bonn Bonn, Germany University Hospital Dresden Dresden, Germany University Hospital Düsseldorf Düsseldorf, Germany Waldkrankenhaus St. Marien Erlangen, Germany University Hospital Essen Essen, Germany University Hospital Frankfurt Frankfurt, Germany University Hospital Freiburg Freiburg, Germany University Hospital Göttingen Göttingen, Germany Oncological Practice Hannover Hannover, Germany University Hospital Hannover Hannover, Germany University Hospital Magdeburg Magdeburg, Germany University Hospital Tübingen Tübingen, Germany Less <<
NCT02184416 - Recruiting July 20, 2019 -
NCT03642236 FLT3-ITD Mutation ... More >> Acute Myeloid Leukemia Brutons Tyrosine Kinase Less << Phase 2 Phase 3 Enrolling by invitation September 2023 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China, 510515 Less <<
NCT02560012 - Terminated(Loss of laboratory ... More >>performing molecular analysis) Less << - -
NCT03298451 Hepatocellular Carcinoma Phase 3 Recruiting January 29, 2021 -
NCT03499626 Advanced/ Metastatic Hepatocel... More >>lular Carcinoma Less << Phase 1 Phase 2 Recruiting May 5, 2021 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119228 Contact: Raghav Sundar    (65) 6779 5555    raghav_sundar@nuhs.edu.sg Less <<
NCT01190241 Advanced Solid Tumors ... More >> Inoperable Metastasis Less << Not Applicable Unknown - Netherlands ... More >> Medical Center Alkmaar Alkmaar, Netherlands, 1815 JD VU University Medical Center Amsterdam, Netherlands, 1081 HV Less <<
NCT01035229 - Completed - -
NCT01964235 Advanced Hepatocellular Carcin... More >>oma Less << Phase 2 Withdrawn(Study was cancelled ... More >>by Sponsor.) Less << July 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Mass General Hospital Boston, Massachusetts, United States, 02115 United States, Missouri Research Medical Center Onc Dept Kansas City, Missouri, United States, 64132 Australia, New South Wales Novartis Investigative Site Kogarah, New South Wales, Australia, 2217 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 France Novartis Investigative Site Clichy, France, 92110 Novartis Investigative Site LILLE Cedex, France, 59037 Novartis Investigative Site Montpellier Cedex 5, France, 34298 Novartis Investigative Site Nice Cedex 3, France, 06202 Germany Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Würzburg, Germany, 97080 Hong Kong Novartis Investigative Site Hong Kong SAR, Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Spain Novartis Investigative Site Cordoba, Andalucia, Spain, 14004 Switzerland Novartis Investigative Site Bern, Switzerland, 3010 Novartis Investigative Site Genève, Switzerland, 1211 Less <<
NCT02089763 Hepatocellular Carcinoma Phase 2 Terminated(Early termination f... More >>or futility) Less << - Hong Kong ... More >> Prince of Wales Hospital, the Chinese University of Hong Kong Hong Kong, Hong Kong Less <<
NCT01248247 Lung Cancer Phase 2 Active, not recruiting June 2019 United States, Connecticut ... More >> Yale Universtiy New Haven, Connecticut, United States, 06520 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01953406 Hepatocellular Carcinoma ... More >> Lung Metastasis Less << Phase 2 Withdrawn(No participants were... More >> enrolled. Therefore, we stop this study, prematurely.) Less << - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT02029157 Liver Cancer Phase 3 Completed - Japan ... More >> Cancer Centers in Japan Tokyo, Japan Less <<
NCT01449825 - Completed - -
NCT01035229 Carcinoma Phase 3 Completed - -
NCT03163992 Hepatocellular Carcinoma Phase 2 Recruiting December 2019 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Sung Ju Park    234106820       Principal Investigator: Jeeyun Lee, M.D., Ph.D. Less <<
NCT01620216 Acute Myeloid Leukemia Arising... More >> From Previous Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Less << Phase 2 Recruiting March 30, 2019 United States, Maryland ... More >> National Heart Lung and Blood Institute Not yet recruiting Bethesda, Maryland, United States, 20824 Contact: Christopher S. Hourigan    301-803-8029    hourigan@nih.gov    Principal Investigator: Christopher S. Hourigan          United States, Oregon OHSU Knight Cancer Institute Not yet recruiting Portland, Oregon, United States, 97239 Contact: Marc Loriaux    503-494-9383    loriauxm@ohsu.edu    Principal Investigator: Marc Loriaux          United States, Texas UT Southwestern/Simmons Cancer Center-Dallas Recruiting Dallas, Texas, United States, 75390 Contact: Robert H. Collins    214-648-4155    robert.collins@utsouthwestern.edu    Principal Investigator: Robert H. Collins          United States, Utah Huntsman Cancer Institute/University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84112 Contact: Tibor J. Kovacsovics    801-585-3229    tibor.kovacsovics@hci.utah.edu    Principal Investigator: Tibor J. Kovacsovics Less <<
NCT03563170 Hepatocellular Carcinoma Non-r... More >>esectable Hepatocellular Carcinoma Recurrent Less << Phase 1 Phase 2 Recruiting December 30, 2022 United States, California ... More >> Chan Soon-Shiong Institute for Medicine Recruiting El Segundo, California, United States, 90245 Less <<
NCT01246986 Carcinoma, Hepatocellular Phase 2 Active, not recruiting December 3, 2018 -
NCT01197170 Solid Tumors ... More >>Advanced Cancer Less << Phase 1 Active, not recruiting September 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01441388 Carcinoma, Renal Cell ... More >> Glioblastoma Carcinoma, Hepatocellular Less << Phase 1 Withdrawn(Business/Operational... More >> issues) Less << November 2013 -
NCT00791544 Liver Carcinoma Phase 1 Phase 2 Terminated(Company decision to... More >> discontinue the AVE1642 development program, not due to any safety or efficacy concerns) Less << - France ... More >> Sanofi-Aventis Administrative Office Paris, France Less <<
NCT02015728 Recurrent Childhood Brain Tumo... More >>r Less << Not Applicable Unknown December 2017 United States, Washington ... More >> Seattle Children's Seattle, Washington, United States, 98105 Less <<
NCT02973204 - Recruiting October 2020 Denmark ... More >> Department of Hepatology and Gastroenterology Recruiting Aarhus, Aarhus C, Denmark, 8000 Contact: Stine Karlsen, MD, Phd Student    +4522793193    stinkarl@rm.dk    Contact: Jens Kelsen, Consultant, PhD    +4530562682    jenskels@rm.dk    Principal Investigator: Stine Karlsen, MD, Phd student Less <<
NCT02372162 - Active, not recruiting July 2019 Germany ... More >> University Hospital Tuebingen, BW, Germany, D-72076 Less <<
NCT00900536 - Completed - United Kingdom ... More >> Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Less <<
NCT02115373 Carcinoma, Hepatocellular Phase 1 Phase 2 Completed - Germany ... More >> Please contact the Merck KGaA Communication Center located in Darmstadt, Germany Less <<
NCT01655693 Carcinoma, Hepatocellular Phase 3 Active, not recruiting January 2019 -
NCT01195649 - Completed - Taiwan ... More >> Many Locations, Taiwan Less <<
NCT00920816 Kidney Neoplasms Phase 3 Active, not recruiting May 30, 2021 -
NCT00829231 Liver Disease Phase 1 Completed - United States, Florida ... More >> Miami, Florida, United States, 33014 Orlando, Florida, United States, 32809 United States, Tennessee Knoxville, Tennessee, United States, 37920 Less <<
NCT00920816 - Active, not recruiting - -
NCT01582009 - Terminated(pts off study, PI l... More >>eft institute) Less << - -
NCT01582009 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << Phase 1 Phase 2 Terminated(pts off study, PI l... More >>eft institute) Less << - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT01209299 - Completed - -
NCT03630120 Thyroid Cancer ... More >> Thyroid Cancer, Medullary Differentiated Thyroid Cancer Papillary Thyroid Cancer Follicular Thyroid Cancer Poorly Differentiated Thyroid Gland Carcinoma Less << Phase 2 Recruiting December 2023 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Less <<
NCT01752933 Hepatocellular Carcinoma Phase 2 Completed - -
NCT02303444 - Active, not recruiting July 31, 2020 -
NCT03645980 Hepatocellular Carcinoma Phase 1 Phase 2 Recruiting August 31, 2022 Germany ... More >> Universitätsmedizin Mainz, I. Med. Klinik und Poliklinik Recruiting Mainz, Germany, 55131 Contact: Jens U Marquardt, Dr.med.    +49 6131 17 ext 6863    marquarj@uni-mainz.de Less <<
NCT03132454 Hematopoietic/Lymphoid Cancer ... More >> Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Less << Phase 1 Recruiting July 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       tkadia@mdanderson.org Less <<
NCT00979381 - Completed - Netherlands ... More >> University Medical Center Nijmegen st Radboud Nijmegen, Netherlands, 6525 GH Less <<
NCT02794337 Carcinoma, Hepatocellular Phase 2 Phase 3 Recruiting January 2022 India ... More >> Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre Recruiting Navi Mumbai, Maharashtra, India, 410210 Contact: Supriya Chopra, MD,DNB    022-27405000 ext 5510    schopra@actrec.gov.in    Advanced Centre of Treatment Research and Education In Cancer,Tata Memorial Centre Recruiting Navi Mumbai, Maharashtra, India, 410210 Contact: Dr Supriya Chopra, MD    91-22-27405000 ext 5491    schopra@actrec.gov.in    Principal Investigator: Supriya Chopra, MD Less <<
NCT01381614 - Completed - -
NCT00987935 Carcinoma, Hepatocellular Phase 2 Completed - Korea, Republic of ... More >> 1199.39.82001 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of 1199.39.82002 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of 1199.39.82003 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of 1199.39.82004 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of 1199.39.82005 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of 1199.39.82006 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of Taiwan 1199.39.88606 Boehringer Ingelheim Investigational Site Changhua, Taiwan 1199.39.88609 Boehringer Ingelheim Investigational Site Kaohsiung, Taiwan 1199.39.88610 Boehringer Ingelheim Investigational Site Kaohsiung, Taiwan 1199.39.88605 Boehringer Ingelheim Investigational Site Taichung, Taiwan 1199.39.88608 Boehringer Ingelheim Investigational Site Tainan City, Taiwan 1199.39.88602 Boehringer Ingelheim Investigational Site Tainan, Taiwan 1199.39.88601 Boehringer Ingelheim Investigational Site Taipei, Taiwan 1199.39.88603 Boehringer Ingelheim Investigational Site Taipei, Taiwan 1199.39.88604 Boehringer Ingelheim Investigational Site Taoyuan County, Taiwan 1199.39.88607 Boehringer Ingelheim Investigational Site Yunlin County, Taiwan Less <<
NCT01658878 Hepatocellular Carcinoma Phase 1 Phase 2 Active, not recruiting December 26, 2019 -
NCT01576185 - Completed - United States, California ... More >> Children's Oncology Group Monrovia, California, United States, 91006-3776 Less <<
NCT00110344 Carcinoma, Renal Cell Phase 2 Terminated - United States, Massachusetts ... More >> Boston, Massachusetts, United States, 02115-6084 Less <<
NCT01621906 Metastatic Breast Cancer to th... More >>e Brain Less << Not Applicable Recruiting June 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States Contact: Andrew Seidman, MD    646-888-5445       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Andrew Seidman, MD    646-888-5445       United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Andrew Seidman, MD    646-888-5445       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Andrew Seidman, MD    646-888-5445       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Andrew Seidman, MD    646-888-5445       Contact: Heiko Schoder, MD    212-639-2079       Principal Investigator: Andrew Seidman, MD          Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Andrew Seidman, MD    646-888-5445 Less <<
NCT00678392 Kidney Neoplasms Phase 3 Completed - -
NCT02220088 Hepatocellular Carcinoma Phase 2 Phase 3 Completed - China, Guangdong ... More >> Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT00987935 - Completed - -
NCT00543504 Advanced Cancer Phase 1 Active, not recruiting October 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01375569 Hepatocellular Carcinoma ... More >> Hepatocellular Cancer Carcinoma, Hepatocellular Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02406521 Metastatic Renal Cell Carcinom... More >>a Less << Phase 1 Active, not recruiting December 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01375569 - Completed - -
NCT02867891 - Completed - -
NCT02178358 Hepatocellular Carcinoma Phase 2 Active, not recruiting December 31, 2018 China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bengbu, China, 233004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changchun, China, 130012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China, 310016 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hefei, China, 230022 Hong Kong For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hong Kong, Hong Kong For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kowloon, Hong Kong Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Incheon, Korea, Republic of, 405-760 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 135 720 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gwei Shan Township, Taiwan, 333 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liouying/Tainan, Taiwan, 736 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Puzih City, Taiwan, 613 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan, 70403 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 11217 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taoyuan, Taiwan, 33378 Thailand For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bangkok, Thailand, 10330 Less <<
NCT01381601 - Completed - -
NCT02209441 - - - -
NCT03605706 Advanced Hepatocellular Carcin... More >>oma Less << Phase 3 Recruiting December 2021 China, Jiangsu ... More >> 81 Hospital Nanjing Recruiting Nanjing, Jiangsu, China, 210002 Contact: Shukui Qin, MD    +862580864542 Less <<
NCT00974896 Advanced Malignancy ... More >> Advanced Solid Tumors Cancer Solid Tumors Tumors Less << Phase 1 Completed - -
NCT00678392 - Completed - -
NCT01498952 Unresectable or Metastatic Hep... More >>atocellular Carcinoma (HCC) Less << Phase 1 Completed - United States, California ... More >> Research Site Oxnard, California, United States United States, Colorado Research Site Golden Springs, Colorado, United States United States, Nevada Research Site Las Vegas, Nevada, United States Less <<
NCT01191385 - Withdrawn(Study is officially ... More >>cancelled bevore FPFV.) Less << December 2013 -
NCT01636284 Hepatocellular Carinoma Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale, Arizona, United States, 85259 United States, Texas University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of Pusan National University Yangsan Hospital Yangsan, Korea, Republic of Spain University Clinic of Navarra Navarra, Spain Less <<
NCT01774344 Carcinoma, Hepatocellular Phase 3 Active, not recruiting February 28, 2019 -
NCT00673361 - Terminated - -
NCT03730675 Hepatocellular Carcinoma ... More >> Portal Vein Tumor Thrombosis Less << Not Applicable Not yet recruiting November 2021 -
NCT01774344 - Active, not recruiting - -
NCT01908426 Hepatocellular Carcinoma Phase 3 Active, not recruiting October 2018 -
NCT03389126 Carcinoma, Hepatocellular Phase 2 Recruiting March 31, 2020 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Kyung-Hun Lee, MD, PhD    82-2-2072-7207    kyunghunlee@snu.ac.kr Less <<
NCT00687596 Hepatocellular Carcinoma Phase 2 Terminated(Terminated due to s... More >>afety concerns) Less << - Italy ... More >> I.R.C.C.S. San Matteo University Hospital Golgi, Pavia, Italy, 27100 Less <<
NCT03275376 Overall Survival ... More >> Tumor Responses Less << Phase 2 Recruiting December 21, 2023 Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: Teng-Yu Lee, PhD    4-23592525 ext 3301    tylee@vghtc.gov.tw Less <<
NCT01140347 Hepatocellular Carcinoma Phase 3 Completed - -
NCT02436902 Hepatocellular Carcinoma Phase 3 Recruiting August 2019 China, Guangxi ... More >> Department of Hepatobilliary Surgery, Affiliated Tumor of Guangxi University Recruiting Nanning, Guangxi, China, 530021 Contact: Bang-De Xiang, MD,PhD    86-771-5330855    xiangbangde@163.com Less <<
NCT01140347 - Completed - -
NCT00811759 Melanoma (Skin) Phase 1 Phase 2 Unknown - France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT03008512 Carcinoma, Hepatocellular Phase 2 Recruiting October 2021 Korea, Republic of ... More >> Gachon University Gil Medical Center Recruiting Incheon, Korea, Republic of Contact: Young Saing Kim, MD    +82-32-460-3231    zoomboom@gilhospital.com Less <<
NCT00532064 - Terminated(Terminated per PI's... More >> request) Less << - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02939807 Carcinoma, Hepatocellular Phase 2 Recruiting May 2021 United States, South Carolina ... More >> Medical University of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: Lindsay Hunt    843-792-9321    hcc-clinical-trials@musc.edu    Principal Investigator: Carolyn Britten, MD Less <<
NCT00667589 Hand-foot Skin Reaction ... More >> Rash Less << Phase 2 Terminated(Study was halted du... More >>e to poor subject accrual.) Less << - United States, Illinois ... More >> Northwestern University Feinberg School of Medicine, Department of Dermatology Chicago, Illinois, United States, 60611 Less <<
NCT00673361 Melanoma Phase 2 Terminated - -
NCT01777594 Advanced Adult Hepatocellular ... More >>Carcinoma Less << Phase 2 Completed - United States, Texas ... More >> Mary Crowley Cancer Research Center Dallas, Texas, United States, 75230 Oncology Consultants, PA Houston, Texas, United States, 77030 University of Texas Health Sciences Center at Houston, Memorial Hermann Cancer Center Houston, Texas, United States, 77030 The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229-3900 Less <<
NCT00667589 - Terminated(Study was halted du... More >>e to poor subject accrual.) Less << - -
NCT00727233 Neurofibromatosis Type I ... More >> Plexiform Neurofibroma Less << Phase 1 Completed - United States, Alabama ... More >> Children's Hospital of Alabama Birmingham, Alabama, United States, 35233 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00801385 Lung Cancer Phase 2 Unknown - Korea, Republic of ... More >> Yonsei Cancer Center at Yonsei University Medical Center Recruiting Seoul, Korea, Republic of, 120-752 Contact: Joo-Hang Kim, MD    82-2-2228-8131    kjhang@yuhs.ac Less <<
NCT00108953 Carcinoma, Hepatocellular Phase 2 Completed - -
NCT00108953 - Completed - -
NCT00861419 Advanced Solid Tumors Phase 1 Completed - -
NCT00467025 Advanced Renal Cell Carcinoma Phase 2 Completed - -
NCT03468231 Hepatocellular Carcinoma Phase 3 Recruiting March 9, 2020 China, Guangdong ... More >> Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Wusheng Yu, MD    13827285010    yuwusheng1998@126.com    Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    86-2087343115    shiming@mail.sysu.edu.cn    Principal Investigator: Ming Shi, MD          The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Guosheng Tan, MD    13725254145    tgs1976@163.com    Guangzhou Twelfth People 's Hospital Recruiting Guangzhou, Guangdong, China, 510620 Contact: Yuanmin Zhou, MD    15521278919    13430288977@139.com    Principal Investigator: Jinghua Chen, MD          Kaiping Central Hospital Recruiting Kaiping, Guangdong, China, 529300 Contact: Shijie Zhang, MD    13717287622    Shijie_9262511@163.com    China, Hunan First Affiliated Hospital of University Of South China Recruiting Hengyang, Hunan, China, 421001 Contact: Xiaoping Wu, MD    13975486015    wxp19730806@sina.com    China, Shanxi The First Affiliated Hospital Of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710061 Contact: Xin Zheng, MD    13649265446    183421344@qq.com Less <<
NCT00111007 - Completed - -
NCT00493636 Breast Cancer Phase 2 Completed - -
NCT00493636 - Completed - -
NCT00672178 Renal Cell Carcinoma Phase 1 Phase 2 Terminated(Slow accrual) - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00672178 - Terminated(Slow accrual) - -
NCT00906373 Hepatocellular Carcinoma Phase 2 Completed - United States, Arizona ... More >> ImClone Investigational Site Scottsdale, Arizona, United States, 85259 United States, California ImClone Investigational Site Los Angeles, California, United States, 90095 United States, Illinois ImClone Investigational Site Chicago, Illinois, United States, 60611 United States, Louisiana ImClone Investigational Site Metairie, Louisiana, United States, 70006 United States, Massachusetts ImClone Investigational Site Burlington, Massachusetts, United States, 01805 United States, New York ImClone Investigational Site New York, New York, United States, 10032 United States, Pennsylvania ImClone Investigational Site Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00979329 - Completed - Netherlands ... More >> University Medical Center Nijmegen st Radboud Nijmegen, Netherlands, 6525 GH Less <<
NCT01357486 Hepatocellular Carcinoma ... More >> CHILD B Less << Phase 2 Completed - France ... More >> CH d'Abbeville Abbeville, France, 80142 CH Pays d'Aix Aix-en-provence, France, 13616 CH d'Auxerre Auxerre, France, 89011 CH de la Côte Basque Bayonne, France, 64109 AP-HP- Hôpital Jean-Verdier Bondy, France, 93143 CHU de Bordeaux Bordeaux, France, 33075 CH Duchenne Boulogne Sur Mer, France, 62321 CH de Béziers Béziers, France, 34525 AP-HP Hôpital Henri Mondor Creteil, France, 94010 CHU Le Bocage Dijon, France, 21079 CH Départemental Vendée La Roche-sur-yon, France, 85925 CH Le Mans Le Mans, France, 72037 CH de Bretagne Sud Lorient, France, 56100 Hôpital privé Jean Mermoz Lyon, France, 69008 AP-HM Hôpital de la Timone Marseille, France, 13385 CH de Meaux Meaux, France, 77104 CH Mont de Marsan Mont-de-marsan, France, 40024 CHU de Nancy Hôpital Brabois Nancy, France, 54511 CHU de Nantes Hôpital de l'Hotel Dieu Nantes, France, 44093 CHU Nîmes Nimes, France, 30029 CHR d'Orléans - Hôpital La Source Orleans, France, 45067 Groupe Hospitalier Paris Saint Joseph Paris, France, 75014 CH Perpignan Perpignan, France, 66046 CHU de Bordeaux, Hôpital du Haut Lévèque Pessac, France, 33604 CH de la Région d'Annecy Pringy, France, 74374 Centre Eugène Marquis Rennes, France, 35042 Clinique Mathilde Rouen, France, 76000 Clinique Armoricaine de Radiologie Saint Brieuc, France, 22015 CH Saint-Malo Saint Malo, France, 35400 Centre René Gauducheau CLCC Nantes Atlantique Saint-herblain, France, 44805 CH Gaston Ramon Sens, France, 89100 Centre Régional de Lutte contre le Cancer Centre Paul Strauss Strasbourg, France, 67065 Hôpitaux Universitaires de Strasbourg Hôpital civil Strasbourg, France, 67091 Hôpitaux Universitaires de Strasbourg, Hôpital Hautepierre Strasbourg, France, 67098 CHRU de Tours Tours, France, 37044 Less <<
NCT00492505 Melanoma (Skin) Phase 2 Unknown - United States, California ... More >> San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas Recruiting Encinitas, California, United States, 92024 Contact: Edward F. McClay, MD    760-452-3340    emcclay@pacificoncology.com Less <<
NCT00110994 Cancer Melano... More >>ma Less << Phase 2 Completed - United States, Arizona ... More >> Tucson, Arizona, United States, 85724 United States, Colorado Aurora, Colorado, United States, 80045 United States, Florida Lakeland, Florida, United States, 33805 United States, Illinois Park Ridge, Illinois, United States, 60068 United States, Massachusetts Boston, Massachusetts, United States, 02114 Boston, Massachusetts, United States, 02115-6084 Boston, Massachusetts, United States, 02215 United States, Missouri St. Louis, Missouri, United States, 63110-1093 United States, Nebraska Omaha, Nebraska, United States, 68114 United States, North Carolina Charlotte, North Carolina, United States, 28203 United States, Pennsylvania Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Hilton Head Island, South Carolina, United States, 29926-2739 United States, Tennessee Nashville, Tennessee, United States, 37232-6307 United States, Texas San Antonio, Texas, United States, 78229 Less <<
NCT00825955 Liver Cancer Phase 3 Terminated(Efficacy endpoint m... More >>et, however, overall experimental dosing regimen is not considered optimal to support further clinical development in this patient population) Less << - -
NCT00110994 - Completed - -
NCT00906373 - Completed - -
NCT00111007 Melanoma Phase 3 Completed - -
NCT02847468 Carcinoma, Hepatocellular Not Applicable Recruiting March 27, 2021 France ... More >> Emilie REDERSTORFF Recruiting Dijon, France, 21000 Contact: Emilie REDERSTORFF, PhD    0033 3 80 73 75 00 ext 3461    ERederstorff@cgfl.fr    Contact: Sandrine TIAGO    0033 3 80 73 75 00    stiago@cgfl.fr    Principal Investigator: Alexandre COCHET, MD Less <<
NCT01108705 Carcinoma, Hepatocellular Phase 3 Terminated - -
NCT03511703 Hepatocellular Carcinoma Phase 2 Not yet recruiting June 30, 2019 -
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT03318562 Triple Negative Breast Cancer ... More >> Hepatocellular Carcinoma Less << Phase 2 Terminated(The study was termi... More >>nated due to change in focus of the development program) Less << - United States, California ... More >> City of Hope Duarte, California, United States, 91010 United States, Missouri Kansas City Research Institute Kansas City, Missouri, United States, 64131 Less <<
NCT00698659 - Terminated - Singapore ... More >> National University Hospital Singapore, Singapore Less <<
NCT03768375 Cholangiocarcinoma of the Extr... More >>ahepatic Bile Duct Gallbladder Cancer Less << Phase 2 Recruiting December 30, 2021 China, Shanghai ... More >> Xinhua Hospital Recruiting Shanghai, Shanghai, China, 200092 Contact: Yingbin Liu, PHD    13918803900    laoniulyb@163.com    Principal Investigator: yingbin liu, PHD Less <<
NCT00498966 Kidney Cancer Phase 2 Completed - United States, Kentucky ... More >> Investigative Site Louisville, Kentucky, United States, 40202 United States, New Jersey Investigative Site Morristown, New Jersey, United States, 07962 United States, New York Investigative Site Armonk, New York, United States, 10504 Less <<
NCT03413176 - Completed - France ... More >> AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM. Paris, France, 75013 Less <<
NCT03251612 Colorectal Cancer Metastatic Phase 2 Recruiting December 2020 Denmark ... More >> Department of Oncology, Aalborg University Hospital Not yet recruiting Aalborg, Denmark Contact: Mette Yilmaz, MD       m.yilmaz@rn.dk    Department of Oncology, Rigshospitalet Not yet recruiting Copenhagen, Denmark Contact: Lone N Petersen, MD       Lone.Noergaard.Petersen@regionh.dk    Departmen of Oncology, Vejle Hospital Recruiting Vejle, Denmark Contact: Lars H Jensen, MD       lars.henrik.jensen@rsyd.dk    Germany Universitätsklinikum Hamburg - Eppendorf, Universitäres Cancer Center Hamburg (UCCH) Not yet recruiting Hamburg, Germany Contact: Andreas Block, MD       block@uke.de Less <<
NCT02135874 Acute Bilineal Leukemia ... More >> Acute Biphenotypic Leukemia Acute Leukemia of Ambiguous Lineage Acute Undifferentiated Leukemia Mixed Phenotype Acute Leukemia Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified Recurrent Mixed Phenotype Acute Leukemia Less << Phase 2 Recruiting October 30, 2019 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Elias Jabbour    713-792-4764       Principal Investigator: Elias Jabbour Less <<
NCT02111889 Disseminated Malignant Neoplas... More >>m Less << Not Applicable Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Noord-Holland, Netherlands, 1081 HV Less <<
NCT02086734 - Completed - Germany ... More >> Urologische Klinik und Poliklinik der Universität München München, Bavaria, Germany, 81377 Less <<
NCT03586973 Advanced Hepatocellular Carcin... More >>oma Less << Phase 2 Recruiting March 31, 2021 Japan ... More >> Aichi Cancer Center Hospital Recruiting Nagoya, Aichi, Japan National Cancer Center Hospital East Not yet recruiting Kashiwa, Chiba, Japan Iizuka Hospital Recruiting Iizuka, Fukuoka, Japan Kurume University Hospital Not yet recruiting Kurume, Fukuoka, Japan Sapporo-Kosei General Hospital Recruiting Sapporo, Hokkaido, Japan Kanazawa University Hospital Recruiting Kanazawa, Ishikawa, Japan Kanagawa Cancer Center Recruiting Yokohama, Kanagawa, Japan Yokohama City University Medical Center Not yet recruiting Yokohama, Kanagawa, Japan Kindai University Hospital Recruiting Osakasayama, Osaka, Japan National Cancer Center Hospital Recruiting Chuo-ku, Tokyo, Japan Kyorin University Hospital Recruiting Mitaka, Tokyo, Japan Japanese Red Cross Musashino Hospital Active, not recruiting Musashino, Tokyo, Japan Chiba University Hospital Recruiting Chiba, Japan Hiroshima University Hospital Active, not recruiting Hiroshima, Japan Okayama University Hospital Not yet recruiting Okayama, Japan Osaka City University Hospital Recruiting Osaka, Japan Osaka International Cancer Institute Not yet recruiting Osaka, Japan Less <<
NCT01810744 Metastatic Colorectal Cancer ... More >> Glioblastoma Bevacizumab Capillaroscopy Less << Not Applicable Active, not recruiting June 2018 France ... More >> Centre Georges François Leclerc Dijon, France, 21079 Less <<
NCT02452853 Hepatocellular Carcinoma Phase 2 Unknown May 2018 -
NCT02665065 Acute Myeloid Leukemia ... More >> Leukemia, Acute Myeloid Myeloid Leukemia, Acute Leukemia, Myeloid, Acute Acute Myelogenous Leukemia Leukemia, Acute Myelogenous Myelogenous Leukemia, Acute Less << Phase 3 Recruiting June 2020 United States, Arizona ... More >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States United States, Illinois Loyola University Medical Center Recruiting Maywood, Illinois, United States United States, Kansas The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Stony Brook University Recruiting Stony Brook, New York, United States United States, Ohio University Hospital of Cleveland Seidman Cancer Center Recruiting Cleveland, Ohio, United States The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States United States, Texas Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States MD Anderson Cancer Center Recruiting Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States Canada, Ontario University of Ottawa Recruiting Ottawa, Ontario, Canada Less <<
NCT01391962 Sarcoma, Alveolar Soft Part Phase 2 Recruiting December 15, 2019 United States, California ... More >> Santa Monica Oncology Center Recruiting Santa Monica, California, United States, 90403 Contact: Shivaani Kummar, M.D.    301-435-5402    kummars@mail.nih.gov    United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937       United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030-4096 Canada, Ontario Princess Margaret Cancer Center Recruiting Toronto, Ontario, Canada, M5G2M9 Less <<
NCT02426450 Hepatocellular Carcinoma Phase 2 Unknown April 2017 China, Guangdong ... More >> Zhen-Wei Peng Guangzhou, Guangdong, China, 510080 Less <<
NCT03017326 Hepatoblastoma ... More >> Carcinoma, Hepatocellular Less << Phase 3 Recruiting December 2022 United Kingdom ... More >> Royal Aberdeen Children's Hospital Recruiting Aberdeen, United Kingdom, AB25 2ZG Contact: Hugh Bishop, MBChB          Addenbrooke's Hospital Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: Amos Burke, MB ChB       amos.burke@addenbrookes.nhs.uk Less <<
NCT01381211 Hepatocellular Carcinoma Phase 2 Unknown December 2016 Belgium ... More >> University Hospital Ghent Recruiting Ghent, Belgium, 9000 Contact: L Defreyne, PhD, MD    (0)9/332 2938 ext +32    luc.defreyne@ugent.be    Principal Investigator: L Defreyne, PhD, MD Less <<
NCT03097601 - Active, not recruiting December 30, 2019 France ... More >> Centre Antoine LACASSAGNE Nice, France, 06189 Less <<
NCT01372813 - Terminated(Terminated for insu... More >>fficient accrual.) Less << - -
NCT03091465 - Completed - -
NCT02428543 Acute Myeloid Lukemia Phase 1 Phase 2 Recruiting September 2020 France ... More >> Dr Abdelaziz CHAIB Recruiting Aix-en-Provence, France, 13600 Contact: Abdelaziz CHAIB       achaib@ch-aix.fr    Principal Investigator: Abdelaziz CHAIB          Chu Amiens Recruiting Amiens, France, 80054 Contact: MAROLLEAU Jean Pierre          Principal Investigator: MAROLLEAU Jean Pierre          CHU d'Angers Recruiting Angers, France, 49033 Contact: Martine GARDEMBAS       Magardembas@chu-angers.fr    Principal Investigator: Martine GARDEMBAS          Hôpital VICTOR DUPOUY Recruiting Argenteuil, France, 95107 Contact: AL JIJAKLI Ahmad       ahmad.aljijakli@ch-argenteuil.fr    Principal Investigator: AL JIJAKLI Ahmad          Dr Edouard RANDIAMALALA Recruiting Bayonne, France, 64100 Contact: Edouard RANDIAMALALA       erandiamalala@ch-cotebasque.fr    Principal Investigator: Edouard RANDIAMALALA          CHU de Besançon Recruiting Besançon, France, 25030 Contact: Fabrice LAROSA       flarosa@chu-besançon.fr    Principal Investigator: Fabrice LAROSA          Dr Thorsten BRAUN Recruiting Bobigny, France, 93000 Contact: Thorsten BRAUN       thorsten.braun@aphp.fr    Principal Investigator: Thorsten BRAUN          CHU Boulogne Sur Mer Recruiting Boulogne Sur Mer cedex, France, 62321 Contact: CHOUFI Bachra       b.choufi@ch-boulogne.fr    Principal Investigator: CHOUFI Bachra          Chr Clemenceau Recruiting Caen Cedex, France, 14033 Contact: REMAN Oumédaly       reman-o@chu-caen.fr    Principal Investigator: REMAN Oumédaly          Hôpital d'Instruction des Armées PERCY Recruiting Clamart, France, 92141 Contact: Jean Valère MALFUSSON       jvmalf@free.fr    Principal Investigator: Jean Valère MALFUSSON          Dr Stéphanie HAÏAT Recruiting Corbeil-essonnes, France, 91100 Contact: Stéphanie HAÏAT          Principal Investigator: Stéphanie HAÏAT          Hôpital Henri Mondor Recruiting Créteil, France, 94010 Contact: PAUTAS Cécile       cecile.pautas@hmn.aphp.fr    Principal Investigator: PAUTAS Cécile          CHU de Dijon Not yet recruiting Dijon, France, 21079 Contact: CAILLOT Denis       denis.caillot@chu-dijon.fr    Principal Investigator: CAILLOT Denis          Centre hospitalier de Versailles Recruiting Le Chesnay cedex, France, 78157 Contact: Rousselot Philippe    003339638622    phrousselot@ch-versailles.fr    Principal Investigator: Rousselot Philippe          Hôpital Claude Huriez Recruiting Lille cedex, France, 59037 Contact: QUESNEL Bruno       bquesnel@chru-lille.fr    Principal Investigator: QUESNEL Bruno          CHRU Dupuytren Not yet recruiting Limoges cedex, France, 87042 Contact: TURLURE Pascal       pascal.turlure@chu-limoges.fr    Principal Investigator: TURLURE Pascal          Hôpital Edouard Herriot Recruiting Lyon cedex 03, France, 69437 Contact: THOMAS Xavier       xavier.thomas@chu-lyon.fr    Principal Investigator: THOMAS Xavier          Dr Regis COSTELLO Recruiting Marseille, France, 13000 Contact: Regis COSTELLO       regis.costello@ap-hm.fr    Principal Investigator: Regis COSTELLO          Centre Hospitalier de Meaux Recruiting Meaux, France, 77104 Contact: FRAYFER Jamilé       j-frayfer@ch-meaux.fr    Principal Investigator: FRAYFER Jamilé          Dr Mario OJEDA-URIBE Recruiting Mulhouse, France, 68000 Contact: Mario OJEDA-URIBE       ojedam@ch-mulhouse.fr    Principal Investigator: Mario OJEDA-URIBE          Dr Jacques DELAUNAY Recruiting Nantes, France, 44000 Contact: Jacques DELAUNAY       jacques.delaunay@chu-nantes.fr    Principal Investigator: Jacques DELAUNAY          CHU Nice, Hôpital Archet 1 Recruiting Nice cedex 3, France, 06202 Contact: MANNONE Lionel       mannone.l@chu-nice.fr    Principal Investigator: MANNONE Lionel          CHU de Nîmes Recruiting Nîmes, France, 30029 Contact: Eric JOURDAN       eric.jourdan@chu-nimes.fr    Principal Investigator: Eric Jourdan          Hôpital Saint Antoine Recruiting Paris cedex 12, France, 75751 Contact: ISNARD Françoise       francoise.isnard@sat.aphp.fr    Principal Investigator: ISNARD Françoise          Hôpital Necker Enfants Malades Recruiting Paris cedex 15, France, 75743 Contact: SUAREZ Felipe       felipe.suarez@nck.aphp.fr    Principal Investigator: SUAREZ Felipe          Hôpital Saint Louis Recruiting Paris, France, 75010 Contact: RAFFOUX Emmanuel       emmanuel.raffoux@sls.ap-hop-paris.fr    Principal Investigator: RAFFOUX Emmanuel          Hôpital La Pitié Salpêtrière Recruiting Paris, France, 75013 Contact: UZUNOV Madalina       madalina.uzunov@psl.aphp.fr    Principal Investigator: UZUNOV Madalina          Dr Laurence SANHES Suspended Perpignan, France, 66000 Dr Arnaud PIGNEUX Recruiting Pessac, France, 33604 Contact: Arnaud PIGNEUX       arnaud.pigneux@chu-bordeaux.fr    Principal Investigator: Arnaud PIGNEUX          Centre Hospitalier René Dubos Recruiting Pontoise Cedex, France, 95303 Contact: VAIDA Iona Dana       ioana.vaida@ch-pontoise.fr    Principal Investigator: VAIDA Iona Dana          Marc BERNARD Recruiting Rennes, France, 35000 Contact: Marc BERNARD       marc.bernard@chu-rennes.fr    Principal Investigator: Marc BERNARD          Dr Emilie LEMASLE Recruiting Rouen, France, 76000 Contact: Emilie LEMASLE       emilie.lemasle@chb.unicancer.fr    Principal Investigator: Emilie LEMASLE          Centre Hospitalier René Huguenin Suspended Saint Cloud, France, 92210 Institut de Cancérologie de la Loire Recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Emmanuelle TAVERNIER-TARDY       emmanuelle.tavernier@icloire.fr    Principal Investigator: Emmanuelle TAVERNIER-TARDY          Dr Réda GARIDI Recruiting Saint-Quentin, France, 02100 Contact: Réda GARIDI          Principal Investigator: Réda GARIDI          Dr Christian RECHER Recruiting Toulouse, France, 31000 Contact: Christian RECHER          Principal Investigator: Christian RECHER          Centre Hospitalier de Valenciennes Recruiting Valenciennes, France, 59322 Contact: FERNANDES José       fernandes-j@ch-valenciennes.fr    Principal Investigator: FERNANDES José Less <<
NCT01322477 - Unknown - Israel ... More >> Hadassah Hebrew University Medical Center Not yet recruiting Jerusalem, Israel Contact: Marina Orevi, MD    0508946211    marinaor@hadassah.org.il    Contact: Roland Chisin, MD       chisin@hadassah.org.il Less <<
NCT02847377 Carcinoma, Non-Small-Cell Lung Early Phase 1 Recruiting March 27, 2019 France ... More >> CGFL Recruiting Dijon, France, 21079 Less <<
NCT02711007 Osteosarcoma ... More >>Metastasis Less << Phase 2 Phase 3 Completed - China, Beijing ... More >> Peking University People's Hospital Beijing, Beijing, China, 100044 Less <<
NCT03630640 Hepatocellular Carcinoma Phase 2 Recruiting September 30, 2020 France ... More >> Hôpital Jean Verdier Recruiting Bondy, France, 93140 Contact: Pierre NAHON, MD,PhD    01 48 02 62 99 ext 0033    pierre.nahon@aphp.fr    Contact: Olivier SEROR, MD,PhD    01 48 02 58 68 ext 0033    olivier.seror@aphp.fr Less <<
NCT03322280 Hepatocellular Carcinoma ... More >> Portal Vein Occlusion Tumor Thrombus Less << Not Applicable Enrolling by invitation June 30, 2022 China, Guangdong ... More >> The 2nd Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China, 510260 Less <<
NCT02738697 Carcinoma, Hepatocellular Phase 3 Recruiting December 2021 China, Guangdong ... More >> SUN YAT-SEN University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Rong-Ping Guo, M.D.    00862087342266    guorp@sysucc.org.cn    Contact: Wei Wei, Ph.D. M.D.    00862087343790    weiwei@sysucc.org.cn Less <<
NCT01167374 Hepatocellular Carcinoma Not Applicable Recruiting August 2020 Germany ... More >> University Hospital of Heidelberg, Radiation Oncology Recruiting Heidelberg, Germany, 69120 Principal Investigator: Jürrgen Debus, MD PHD Less <<
NCT02056587 Metastatic Renal Cell Carcinom... More >>a Less << Phase 4 Completed - Russian Federation ... More >> Tatarstan Regional Cancer Center Kazan, Tatarstan, Russian Federation, 420029 Altai Regional Cancer Center Barnaul, Russian Federation N.N. Blokhin Russian Cancer Research Center Moscow, Russian Federation, 115478 Less <<
NCT02772029 Hepatocellular Carcinoma Phase 1 Phase 2 Unknown September 2017 -
NCT02877368 - Completed - France ... More >> Chu de Reims Reims, France, 51092 Less <<
NCT02857712 Salivary Gland Cancers Phase 2 Active, not recruiting June 2019 Italy ... More >> Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy, 20133 Less <<
NCT02448056 - Not yet recruiting May 2025 Taiwan ... More >> National Taiwn University Hospital Recruiting Taipei, Taiwan, 100 Contact: Ja-Der Liang, Master    886-2-23123456    jdliangntu@ntu.edu.tw Less <<
NCT01911000 Carcinoma. Hepatocellular Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT03229512 Hand Foot Skin Reaction Early Phase 1 Recruiting December 2018 United States, Illinois ... More >> Department of Dermatology, Northwestern University Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 Contact: Jennifer N Choi, MD    312-695-8106    jennifer.choi@northwestern.edu    Contact: Linda Serrano, MD    312-503-5903    linda.serrano@northwestern.edu    Principal Investigator: Jennifer N Choi, MD          Sub-Investigator: Linda Serrano, MD          Northwestern Memorial Hospital Recruiting Chicago, Illinois, United States, 60611 Contact: Jennifer N Choi, MD    312-695-8106    jennifer.choi@northwestern.edu    Contact: Linda Serrano, MD    312-503-5903    linda.serrano@northwestern.edu    Principal Investigator: Jennifer N Choi, MD          Sub-Investigator: Linda Serrano, MD Less <<
NCT00782275 - Completed - -
NCT00960167 Hepatocellular Carcinoma Phase 1 Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Jason Chia-Hsien Cheng, Ph.D.    886-2-2312-3456 ext 66696    jasoncheng@ntu.edu.tw Less <<
NCT00782275 Renal Cell Carcinoma ... More >> Kidney Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Tennessee Vanderbilt Univeristy Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00715182 Advanced/ Metastatic Renal Cel... More >>l Cancer Less << Phase 1 Completed - United States, California ... More >> Novartis Investigative Site San Francisco, California, United States United States, North Carolina Novartis Investigative Site Durham, North Carolina, United States, 27710 United States, Washington Novartis Investigative Site Seattle, Washington, United States, 98109-1023 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site München, Germany, 81675 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3075 EA Spain Novartis Investigative Site Madrid, Spain, 28041 Taiwan Novartis Investigative Site Taipei, Taiwan, ROC, Taiwan, 112 Novartis Investigative Site Taichung, Taiwan, 40705 Novartis Investigative Site Taipei, Taiwan, 10002 Less <<
NCT01538238 Locally Advanced or Metastatic... More >> Non-clear Cell Type Renal Cell Carcinoma Less << Phase 2 Completed - Korea, Republic of ... More >> Samsung medical Center Seoul, Korea, Republic of Less <<
NCT03359018 Progression-free Survival ... More >> Overall Survival Clinical Benefit Rate Toxicity Less << Phase 2 Active, not recruiting March 1, 2020 China ... More >> Musculoskeletal Tumor Center of Peking University People's Hospital Beijing, China, 100044 Peking University Shougang Hospital Beijing, China, 100144 Less <<
NCT02290977 Hepatocellular Carcinoma ... More >> Portal Vein Tumor Thrombosis Less << Phase 2 Unknown April 2016 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Yong Han Paik, MD, PhD       yh.paik@samsung.com    Principal Investigator: Yong-Han Paik, MD, PhD          Sub-Investigator: Hee Chul Park, MD, PhD          Sub-Investigator: Ju-Yeon Cho, MD          Sub-Investigator: Jeong Il Yu, MD Less <<
NCT02632864 Liver Neoplasm ... More >> Proton Therapy Less << Phase 2 Recruiting November 2022 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Joon Hyeok Lee, MD, PhD    82-2-3410-3409    gijhlee.lee@samsung.com    Contact: Hee Chul Park, MD, PhD    82-2-3410-2612    hee.ro.park@samsung.com    Sub-Investigator: Jeong Il Yu, MD Less <<
NCT01372813 Advanced Clear Cell Renal Carc... More >>inoma Less << Phase 2 Terminated(Terminated for insu... More >>fficient accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02571946 Liver Neoplasm ... More >> Portal Vein Tumor Thrombosis Proton Therapy Less << Not Applicable Recruiting September 2022 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Hee Chul Park, M.D., Ph.D.    82-2-3410-2612    hee.ro.park@samsung.com    Principal Investigator: Hee Chul Park, M.D., Ph.D.          Sub-Investigator: Doo Ho Choi, M.D., Ph.D.          Sub-Investigator: Jeong Il Yu, M.D.          Sub-Investigator: Won Ki Kang, M.D., Ph.D.          Sub-Investigator: Ho Yeong Lim, M.D., Ph.D.          Sub-Investigator: Young Suk Park, M.D., Ph.D.          Sub-Investigator: Joon Oh Park, M.D., Ph.D.          Sub-Investigator: Se Hoon Park, M.D., Ph.D.          Sub-Investigator: Jeeyun Lee, M.D., Ph.D. Less <<
NCT02716012 Hepatocellular Carcinoma ... More >> Liver Cancer Less << Phase 1 Recruiting December 2019 Singapore ... More >> National Cancer Centre Not yet recruiting Singapore, Singapore Principal Investigator: Dr Han Chong Toh          National University Hospital Not yet recruiting Singapore, Singapore Principal Investigator: Dr Cheng Ean Chee          Taiwan National Taiwan University Hospital Recruiting Taipei, Taiwan Principal Investigator: Professor Kai-Wen Huang          United Kingdom University Hospitals Birmingham NHS Foundation Trust Recruiting Birmingham, United Kingdom Principal Investigator: Dr yuk-Ting Ma          Cambridge University Hospitals NHS Trust Recruiting Cambridge, United Kingdom Principal Investigator: Dr Bristi Basu          The Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom Principal Investigator: Professor Jeff Evans          Clatterbridge Cancer Centre NHS Foundation Trust Recruiting Liverpool, United Kingdom Principal Investigator: Professor Daniel Palmer          Guy's and St. Thomas' NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Dr Debashis Sarker          Imperial College Healthcare NHS Trust Recruiting London, United Kingdom Principal Investigator: Professor Long R Jiao          University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Professor Tim Meyer          Newcastle upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle, United Kingdom Principal Investigator: Professor Ruth Plummer Less <<
NCT03048877 Differentiated Thyroid Cancer Phase 3 Recruiting December 2019 China, Jiangsu ... More >> Nanjing PLA 81 Hospital Recruiting Nanjing, Jiangsu, China Contact: Shukui Qin, Prof. M.D.    +86-26-84453932    qinsk@csco.org.cn    China Peking Union Medical College Hospital Recruiting Peking, China, 100730 Contact: Lin Yansong, MD    +86-10-69155610    linys@pumch.cn Less <<
NCT00936858 Thyroid Cancer Phase 2 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Mt. Sinai Medical Center New York, New York, United States, 10029 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01339962 - Completed - Denmark ... More >> University of Copenhagen Herlev Hospital Herlev, Denmark, 2730 Less <<
NCT00538772 - Withdrawn - Canada, British Columbia ... More >> BC Cancer Agency - Centre for Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 BC Cancer Agency - Vancouver Vancouver, British Columbia, Canada, V5Z 4E6 BC Cancer Agency - Vancouver Island Victoria, British Columbia, Canada, V8R 6V5 Less <<
NCT03066557 Hepatocellular Carcinoma Not Applicable Not yet recruiting December 31, 2018 -
NCT02558387 Recurrent or Metastatic Saliva... More >>ry Gland Cancer of the Head and Neck Less << Phase 2 Unknown January 2017 Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT02544737 Esophageal Cancer ... More >> Metastatic Esophageal Cancer Apatinib Less << Phase 2 Unknown December 2017 China, Zhejiang ... More >> Hangzhou Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Shixiu Wu, MD    +8657186826086    wushixiu@medmail.com.cn    Contact: Tao Song, Dr    +8657186826086    taosong01@hotmail.com Less <<
NCT03732547 Carcinoma, Hepatocellular Phase 2 Recruiting October 22, 2023 China, Zhejiang ... More >> The second affiliated hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Liang Wen, MD PhD    +8619967413613    11518214@zju.edu.cn Less <<
NCT01771458 Reccurent/Metastatic Solid Tum... More >>or Disease Less << Phase 2 Unknown December 2016 France ... More >> Centre régional de lutte contre le cancer de Bourgogne Georges François Leclerc Dijon, France, 21079 Centre Leon Berard Lyon, France, 69373 Institut Paoli Calmettes Marseille, France, 13009 Insitut Curie Paris, France, 75248 Institut Curie Hopital Rene Huguenin Saint-cloud, France, 92210 Institut de cancérologie de l'Ouest Centre René Gauducheau Saint-herblain, France, 44000 Institut Claudius Régaud Toulouse, France, 31052 Centre Alexis Vautrin Vandoeuvre Les Nancy, France, 54500 Less <<
NCT01545804 Liver Cancer Phase 2 Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT02702414 Hepatocellular Carcinoma Phase 2 Recruiting May 30, 2021 -
NCT03164057 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 2 Recruiting June 2027 United States, California ... More >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Weili Sun, MD,PhD    800-826-4673    weilisun@coh.org    Principal Investigator: Weili Sun, MD,PhD          Children's Hospital of Central California Recruiting Madera, California, United States, 93636 Contact: Faisal Razzaqi, MD    866-353-5437    frazzaqi@valleychildrens.org    Principal Investigator: Faisal Razzaqi, MD          Children's Hospital of Orange County Recruiting Orange, California, United States, 92968 Contact: Jamie Frediani, MD    714-509-4348    jfrediani@choc.org    Principal Investigator: Jamie Frediani, MD          Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD    650-497-8953    lacayon@stanford.edu    Principal Investigator: Norman J. Lacayo, MD          Rady Children's Hospital and Health Center Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD    858-966-5983    dschiff@chsd.org    Principal Investigator: Deborah Schiff, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD    866-278-5833    tanja.gruber@stjude.org    Contact: Referral Office    866-278-5833    referralinfo@stjude.org    Principal Investigator: Tanja A. Gruber, MD, PhD          United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD    682-885-4007    kenneth.heym@cookchildrens.org    Principal Investigator: Kenneth M. Heym, MD Less <<
NCT02942329 Gastric Cancer ... More >> Hepatocellular Carcinoma Less << Phase 1 Phase 2 Recruiting October 2018 China, Beijing ... More >> The Affiliated Hospital of the Chinese Academy of Military Medical Sciences Recruiting Beijing, Beijing, China, 100071 Contact: Jian-Ming Xu, M.D.    +861066947176    jmxu2003@yahoo.com    Principal Investigator: Jian-Ming Xu, M.D.          Sub-Investigator: Yun Zhang, M.D. Less <<
NCT02789137 - Recruiting October 30, 2018 Spain ... More >> Hospital Arquitecto Marcide de Ferrol Recruiting Ferrol, A Coruña, Spain, 15405 Hospital Asil de Granollers Recruiting Granollers, Barcelona, Spain, 08402 Hospital Parc Taulí Recruiting Sabadell, Barcelona, Spain, 08208 Hospital Galdakano Recruiting Usansolo, Bizkaia, Spain, 48960 Complejo Hospitalario la Mancha Centro Recruiting Alcazar de San Juan, Ciudad REAL, Spain, 13600 Hospital Universitari Son Espases Recruiting Palma, Mallorca, Spain, 07120 H. Universitario Infanta Cristina Recruiting Badajoz, Spain, 06006 Hospital Vall de Hebrón Recruiting Barcelona, Spain, 08035 Hospital Universitario Ciudad Real Recruiting Ciudad Real, Spain, 13005 H. Reina Sofía de Cordoba Recruiting Córdoba, Spain, 14004 Hospital de Cabueñes Not yet recruiting Gijón, Spain, 33394 ICO Girona (Hospital Dr.Josep Trueta) Recruiting Girona, Spain, 17007 Hospital Universitario de Guadalajara Not yet recruiting Guadalajara, Spain, 19002 Complejo Hospitalario de Jaén Recruiting Jaén, Spain, 23007 Complejo Hospitalario de León Recruiting León, Spain, 24071 Complejo Hospitalario Ourense. Hospital Santa María Nai Recruiting Ourense, Spain, 32005 Hospital General de Asturias Not yet recruiting Oviedo, Spain, 33011 Complejo Hospitalario de Navarra Recruiting Pamplona, Spain, 31008 Hospital Universitario Canarias Not yet recruiting Santa Cruz de Tenerife, Spain, 38320 Hospital de Sant Pau i Santa Tecla Recruiting Tarragona, Spain, 43003 Hospital Virgen de la Salud Recruiting Toledo, Spain, 45071 Hospital Clínico Universitario de Valencia Recruiting Valencia, Spain, 46011 H Clínico Zaragoza Recruiting Zaragoza, Spain, 50009 Less <<
NCT00923130 Renal Cell Carcinoma Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, South Carolina University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT01390519 - Completed - Norway ... More >> Novartis Investigative Site Kristiansand, Norway, 4615 Novartis Investigative Site Tromsø, Norway, 9038 Novartis Investigative Site Trondheim, Norway, 7006 Less <<
NCT01567930 Unresectable or Metastatic Hep... More >>atocellular Carcinoma Less << Phase 2 Unknown March 2013 United States, Tennessee ... More >> Boston Baskin Cancer Foundation Recruiting Memphis, Tennessee, United States, 38120 Less <<
NCT01798446 Renal Cell Carcinoma ... More >> Nonclear Cell Temsirolimus Resistance Less << Phase 2 Unknown December 2016 Korea, Republic of ... More >> Seou National University Hospital Recruiting Seoul, Korea, Republic of, 110744 Contact: Se-Hoon Lee, MD, PhD    82220722199    shlee119@snu.ac.kr    Principal Investigator: Se-Hoon Lee, MD, PhD          Sub-Investigator: Dae Seog Heo, MD, PhD          Sub-Investigator: Dong-Wan Kim, MD, PhD          Sub-Investigator: Tae Min Kim, MD, PhD          Sub-Investigator: Bhumsuk Keam, MD Less <<
NCT01949194 Metastatic Colorectal Cancer Phase 2 Active, not recruiting December 2018 Canada, New Brunswick ... More >> The Moncton Hospital (Horizon Health Network) Moncton, New Brunswick, Canada, E1C 6Z8 Canada, Quebec Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 St-Mary's Hospital Centre Montreal, Quebec, Canada, H3T 1M5 McGill University Health Centre Montréal, Quebec, Canada, H4A 3J1 Canada Hopital Maisonneuve-Rosemont Montreal, Canada, H1T 2M4 Less <<
NCT00923130 - Completed - -
NCT00448721 Renal Cell Carcinoma Phase 2 Completed - United States, California ... More >> Investigative Site Duarte, California, United States, 91010 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Pennsylvania Investigative Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Investigative Site Nashville, Tennessee, United States, 37232 Less <<
NCT02751827 - Recruiting February 2019 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Antoine ITALIANO, MD,PhD          Principal Investigator: Antoine ITALIANO, MD,PhD          Centre Léon Bérard Not yet recruiting Lyon Cedex 08, France, 69373 Contact: Jean-Yves BLAY, MD, PhD          Principal Investigator: Jean-Yves BLAY, MD, PhD Less <<
NCT00282048 - Completed - -
NCT00717756 Liver Cancer Phase 2 Completed - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467 United States, Rhode Island Memorial Hospital of Rhode island Pawtucket, Rhode Island, United States, 02860 Lifespan Hospitals Providence, Rhode Island, United States, 02903 Less <<
NCT00717756 - Completed - -
NCT00282048 Kidney Neoplasms ... More >> Carcinoma, Renal Cell Less << Phase 2 Completed - United States, Illinois ... More >> Pfizer Investigational Site Chicago, Illinois, United States, 60637 United States, New York Pfizer Investigational Site Bronx, New York, United States, 10466 United States, Ohio Pfizer Investigational Site Cleveland, Ohio, United States, 44195 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111-2497 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 Less <<
NCT02409524 Advanced Adult Hepatocellular ... More >>Carcinoma Less << Phase 2 Unknown August 2018 Thailand ... More >> National Cancer Institute of Thailand Address: 268/1 Rama Rd. Ratchathewi Recruiting Bangkok, Thailand, 10400 Contact: Wirote Lausoontornsiri, MD    081-373-7690    wlausoon@gmail.com    Contact: Nitiya Ritthidechratn    02-0260149    nitiya@immunovative.com    Principal Investigator: Wirote Lausoontornsiri, MD          Sub-Investigator: Somjin Chindavijak, MD          Sub-Investigator: Jesada Suvikrom, MD Less <<
NCT02338570 Renal Cell Carcinoma Phase 4 Terminated(Stopped on November... More >> 16th 2016, because of recruitment failure.) Less << - Italy ... More >> Spedali Civili Brescia, Italy Ospedale A Perrino Brindisi, Italy Istituto Europeo di Oncologia Milano, Italy Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale Napoli, Italy AOU Maggiore della Carità Novara, Italy Casa di Cura La Maddalena Palermo, Italy Unicampus Biomedico Roma, Italy AOU San Giovanni di Dio e Ruggi D'Aragona Salerno, Italy Less <<
NCT03648073 Hepatocellular Carcinoma Phase 1 Phase 2 Not yet recruiting December 3, 2019 -
NCT01498458 Metastatic Breast Cancer Phase 1 Completed - Germany ... More >> GBG Forschungs GmbH Neu-Isenburg, Germany, 63263 Less <<
NCT01498458 - Completed - -
NCT01265810 Oral Complaints ... More >> Renal Cell Carcinoma Hepatocellular Carcinoma Gastrointestinal Stromal Tumors Less << Phase 3 Completed - Netherlands ... More >> The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 CX Leiden University Medical Centre (LUMC) Leiden, Netherlands, 2300 RC Less <<
NCT02048371 Liposarcoma O... More >>steogenic Sarcoma Ewing/Ewing-like Sarcoma Rhabdomyosarcoma Less << Phase 2 Recruiting December 2020 United States, California ... More >> City of Hope National Medical Center Recruiting Duarte, California, United States, 91010 Contact: Torie Fechner    626-256-4673    tfechner@coh.org    Principal Investigator: Warren Chow, MD          Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Magnolia Manzano    323-361-8156    mmanzano@chla.usc.edu    Sarcoma Oncology Research Center Recruiting Santa Monica, California, United States, 90403 Contact: Victoria Chua    310-552-9999    vchua@sarcomaoncology.com    Principal Investigator: Sant Chawla, MD          Stanford University Recruiting Stanford, California, United States, 94305 Contact: Maria Ahern    650-725-6413    mahern@stanford.edu    Principal Investigator: Kristen Ganjoo, MD          United States, Florida Mayo Clinic - Florida Recruiting Jacksonville, Florida, United States, 32224 Contact: Steven Attia, DO    904-953-7292    Attia.Steven@mayo.edu    Principal Investigator: Steven Attia, DO          H. Lee Moffitt Terminated Tampa, Florida, United States, 33612 United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Rasima Cehic    312-695-2082    rasima.cehic@northwestern.edu    Principal Investigator: Mark Agulnik, MD          United States, Indiana Indiana University Recruiting Indianapolis, Indiana, United States, 46202 Contact: Michele Niland    317-278-0778    mniland@iupui.edu    Principal Investigator: Daniel Rushing, MD          United States, Massachusetts Dana Farber/Partners Cancer Care Terminated Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic - Minnesota Recruiting Rochester, Minnesota, United States, 55905 Contact: Elizabeth Smith    507-293-3817    Smith.Elizabeth6@mayo.edu    Principal Investigator: Scott Okuno, MD          United States, North Carolina Carolinas Healthcare System Recruiting Charlotte, North Carolina, United States, 28203 Contact: Michelle Treadwell    980-442-2332    Michelle.Treadwell@carolinashealthcare.org    Principal Investigator: Michael Livingston, MD          Duke University Recruiting Durham, North Carolina, United States, 27705 Contact: Colleen Piechocki    919-681-1883    colleen.piechocki@duke.edu    Principal Investigator: Richard Riedel, MD          United States, Ohio Ohio State University Recruiting Columbus, Ohio, United States, 43202 Contact: Comprehensive Cancer Center    800-293-5066    Jamesline@osumc.edu    Principal Investigator: David Liebner, MD          United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: David Boody-Alter    503-418-9655    boodyalt@ohsu.edu    Principal Investigator: Lara Davis, MD          United States, Tennessee Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232 Contact: Melissa Sindler    615-875-0060    melissa.m.sindler@vanderbilt.edu    Principal Investigator: Vicky Keedy, MD          United States, Utah Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Justin Parker    801-587-4702    justin.parker@hci.utah.edu    Principal Investigator: Jennifer Wright, MD          United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Roxanne Moore    206-288-6425    romoore@seattlecca.org    Principal Investigator: Elizabeth Loggers, MD, PhD Less <<
NCT01910909 Localized Non-Resectable Adult... More >> Hepatocellular Carcinoma Less << Not Applicable Recruiting October 2018 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Hee Chul Park, M.D., Ph.D.    82-2-3410-2612    hee.ro.park@samsung.com    Principal Investigator: Hee Chul Park, M.D., Ph.D. Less <<
NCT02910843 Rectal Cancer Phase 1 Recruiting December 2022 Switzerland ... More >> St. Claraspital Basel Recruiting Basel, Switzerland, 4016 Contact: Dieter Köberle, MD    +41 61 685 85 85    dieter.koeberle@claraspital.ch    Principal Investigator: Dieter Köberle, MD          Universitätsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Viviane Hess, Prof    +41 61 265 50 74    viviane.hess@usb.ch    Principal Investigator: Viviane Hess, Prof          Inselspital Bern Recruiting Bern, Switzerland, 3010 Contact: Martin D. Berger, MD    +41 31 632 41 14    martin.berger@insel.ch    Principal Investigator: Martin D. Berger, MD          Kantonsspital Graubünden Recruiting Chur, Switzerland, 7000 Contact: Ioannis Metaxas, MD    +41 81 256 66 46    ioannis.metaxas@ksgr.ch    Principal Investigator: Ioannis Metaxas, MD          Kantonsspital Luzern Recruiting Luzern, Switzerland, 6000 Contact: Ralph Winterhalder, MD    +41 41 205 58 75    ralph.winterhalder@ksl.ch    Principal Investigator: Ralph Winterhalder, MD          Kantonsspital St. Gallen Recruiting St. Gallen, Switzerland, 9007 Contact: Markus Jörger, MD    +41 71 494 29 22    markus.joerger@kssg.ch    Principal Investigator: Markus Jörger, MD          UniversitätsSpital Zürich Recruiting Zurich, Switzerland, 8091 Contact: Bernhard Pestalozzi, Prof    +41 (0)44 255 34 40    bernhard.pestalozzi@usz.ch    Principal Investigator: Bernhard Pestalozzi, Prof Less <<
NCT00314119 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01649180 Renal Cell Carcinoma Phase 2 Terminated(Closed due to prolo... More >>nged enrollment timelines) Less << - United States, Nebraska ... More >> Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68106 United States, Ohio Cleveland Clinic, Taussig Cancer Institute Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01649180 - Terminated(Closed due to prolo... More >>nged enrollment timelines) Less << - -
NCT02029001 Malignant Solid Neoplasms Phase 2 Recruiting October 2022 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Antoine ITALIANO    +335 56 33 33 33    a.italiano@bordeaux.unicancer.fr    Principal Investigator: Antoine ITALIANO          Sub-Investigator: Delphine GARBAY          Sub-Investigator: Maud TOULMONDE          Sub-Investigator: Sophie COUSIN          Sub-Investigator: Sylvestre LE MOULEC          Sub-Investigator: Mathilde CABART          Sub-Investigator: Guilhem ROUBAUD          Centre Jean Perrin Not yet recruiting Clermont-Ferrand, France, 63011 Contact: Xavier DURANDO    04 73 27 81 31    xavier.durando@cjp.fr    Principal Investigator: Xavier DURANDO          Sub-Investigator: Pierre DALLOZ          Sub-Investigator: Anne-Françoise DILLIES-LEGRAIN          Sub-Investigator: Pascale DUBRAY-LONGERAS          Sub-Investigator: Hakim MAHAMMEDI          Sub-Investigator: Marie-Ange MOURET-REYNIER          Sub-Investigator: Isabelle VAN PRAAGH DOREAU          Institut Daniel Hollard Not yet recruiting Grenoble, France, 38028 Contact: Cécile LEYRONNAS    04 76 70 73 33    c.leyronnas@ghm-grenoble.fr    Principal Investigator: Cécile LEYRONNAS, MD          Sub-Investigator: Claire GARNIER-TIXIDRE, MD          Sub-Investigator: Laurence LANCRY-LECOMTE, MD          Sub-Investigator: Jérôme LONG, MD          Sub-Investigator: Christine REBISCHUNG, MD          Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Jean-Yves BLAY    +33478785126    jean-yves.blay@lyon.unicancer.fr    Principal Investigator: Jean-Yves BLAY, MD          Sub-Investigator: Virginie AVRILLON          Sub-Investigator: Thomas BACHELOT          Sub-Investigator: Christophe BERGERON          Sub-Investigator: Pierre BIRON          Sub-Investigator: Helen BOYLE          Sub-Investigator: Philippe CASSIER          Sub-Investigator: Patrick COMBEMALE          Sub-Investigator: Maria CHELGHOUM          Sub-Investigator: Françoise DESSEIGNE          Sub-Investigator: Cécile FAURE-CONTER          Sub-Investigator: Jérome FAYETTE          Sub-Investigator: Aude FLECHON          Sub-Investigator: Christelle DE LA FOUCHARDIERE          Sub-Investigator: Didier FRAPPAZ          Sub-Investigator: Pierre GUIBERT          Sub-Investigator: Pierre-Etienne HEUDEL          Sub-Investigator: Eve-Marie NEIDHARDT          Sub-Investigator: Maurice PEROL          Sub-Investigator: Isabelle RAY-COQUARD          Sub-Investigator: Paul REBATTU          Sub-Investigator: Pierre SAINTIGNY          Sub-Investigator: Catherine TERRET          Sub-Investigator: Olivier TREDAN          Sub-Investigator: Olivia BALLY          Sub-Investigator: Stéphane DEPIL          Sub-Investigator: Olfa DERBEL          Sub-Investigator: Nathalie MARQUES          Sub-Investigator: Philippe TOUSSAINT          Sub-Investigator: Mehdi BRAHMI          Sub-Investigator: Matthieu SARABI          Sub-Investigator: Alice BONNEVILLE-LEVARD          Sub-Investigator: Nadège CORRADINI          Sub-Investigator: Louis DOUBLET          Sub-Investigator: Armelle DUFRESNE          Sub-Investigator: Lauriane EBERST          Sub-Investigator: Sylvie NEGRIER          Sub-Investigator: Katell MICHAUX          Sub-Investigator: Anne-Sophie MICHALLET          Sub-Investigator: Guillaume MAURICEAU          Sub-Investigator: Juliette REURE          Sub-Investigator: Pauline ROCHEFORT          Hopital Edouard Herriot Not yet recruiting Lyon, France, 69437 Contact: Julien FORESTIER, MD    +33472119738    julien.forestier@chu-lyon.fr    Principal Investigator: Julien FORESTIER          Sub-Investigator: Catherine LOMBARD BOHAS          Sub-Investigator: Thomas WALTER          Sub-Investigator: Yann MOLIN          Sub-Investigator: Noura BEN SLAMA          Institut Paoli Calmettes Recruiting Marseille, France, 13273 Contact: François BERTUCCI    +334 91 22 35 37    bertuccif@ipc.unicancer.fr    Principal Investigator: François BERTUCCI          Sub-Investigator: Jean-Marc EXTRA          Sub-Investigator: Anthony GONCALVES          Sub-Investigator: Gwenaêlle GRAVIS-MESCAM          Sub-Investigator: Anne MADROSZYK-FLANDIN          Sub-Investigator: Jean-Luc RAOUL          Sub-Investigator: Delphine PERROT          Sub-Investigator: Magali PROVENSAL          Sub-Investigator: Carole TARPIN          Sub-Investigator: Frédéric VIRET          Sub-Investigator: Louis TASSY          Sub-Investigator: Maria Antonietta CAPPIELLO          Sub-Investigator: Slimane DERMECHE          Sub-Investigator: Simon LAUNAY          Sub-Investigator: Frederique ROUSSEAU          Sub-Investigator: Nicolas MEYER          Sub-Investigator: Loïc MOUREY          Sub-Investigator: Elisabeth MOYAL          Sub-Investigator: Roxana Maria RADUT          Sub-Investigator: Henri ROCHE          Sub-Investigator: Thibaud VALENTIN          Sub-Investigator: Sarah ZAHI          Institut Curie Recruiting Paris, France, 75248 Contact: Christophe LE TOURNEAU, MD    +33144324672    Christophe.letourneau@curie.fr    Principal Investigator: Christophe LE TOURNEAU, MD          Sub-Investigator: Philippe BEUZEBOC          Sub-Investigator: François-Clément BIDARD          Sub-Investigator: Bruno BUECHER          Sub-Investigator: Paul-Henri COTTU          Sub-Investigator: Catherine DANIEL          Sub-Investigator: Véronique DIERAS          Sub-Investigator: Valérie LAURENCE          Sub-Investigator: Alain LIVARTOWSKI          Sub-Investigator: Jean-Yves PIERGA          Sub-Investigator: Marie ALT          Sub-Investigator: Delphine LOIRAT          Sub-Investigator: Marie-Paule SABLIN          Sub-Investigator: Mustapha ZOUBIR          Sub-Investigator: Francesco RICCI          Sub-Investigator: Emanuela ROMANO          Sub-Investigator: Olivier COLLARD          Centre Hospitalier Lyon Sud Recruiting Pierre-Bénite, France, 69495 Contact: Benoit YOU, MD    +33478864319    benoit.you@chu-lyon.fr    Principal Investigator: Benoit YOU, MD          Sub-Investigator: Nathalie BONNIN          Sub-Investigator: Gilles FREYER          Sub-Investigator: Salima HAMIZI          Sub-Investigator: Sophie TARTAS          Sub-Investigator: Véronique TRILLET-LENOIR          Sub-Investigator: Marion CHAUVENET          Sub-Investigator: Denis MAILLET          Sub-Investigator: Julien PERON          Sub-Investigator: Claire FALANDRY          Sub-Investigator: Olivia LE SAUX          Institut de cancérologie LUCIEN NEUWIRTH Not yet recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Olivier COLLARD, MD    04 77 91 70 34    olivier.collard@icloire.fr    Principal Investigator: Olivier COLLARD, MD          Sub-Investigator: Claire BOSACKI, MD          Sub-Investigator: Pierre FOURNEL, MD          Sub-Investigator: Aline GUILLOT, MD          Sub-Investigator: Jean-Philippe JACQUIN, MD          Sub-Investigator: Thierry MURON, MD          Sub-Investigator: Léa SABAN-ROCHE, MD          Institut Claudius Regaud Recruiting Toulouse, France, 31059 Contact: Carlos-Alberto GOMEZ-ROCA    05 31 15 51 01    Gomez-roca.carlos@iuct-oncopole.fr    Principal Investigator: Carlos-Alberto GOMEZ-ROCA          Sub-Investigator: Christine CHEVREAU          Sub-Investigator: Ewa-Anna COTTURA          Sub-Investigator: Florence DALENC          Sub-Investigator: Jean-Pierre DELORD          Sub-Investigator: Marion DESLANDRES          Sub-Investigator: Cécile GANDY          Sub-Investigator: Laurence GLADIEFF          Sub-Investigator: Eleonora MAIO D'ESPOSITO          Sub-Investigator: Nicolas MEYER          Sub-Investigator: Loïc MOUREY          Sub-Investigator: Elisabeth MOYAL          Sub-Investigator: Henri ROCHE          Sub-Investigator: Thibaud VALENTIN          Sub-Investigator: Sarah ZAHI          Sub-Investigator: Roxana Maria RADUT Less <<
NCT02638428 Relapsed Pediatric Solid Tumor... More >> Refractory Pediatric Solid Tumor Relapsed Pediatric AML Refractory Pediatric AML Less << Phase 2 Recruiting December 2023 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung    82-2-3410-3529    kwsped@skku.edu    Principal Investigator: Ki Woong Sung Less <<
NCT01507740 - Terminated(Study was stopped 0... More >>4.10.2014 prematurly after recruitment of HCC and RCC patients. NSCLC (2 of 10 patients planned) and CRC patients recruitment was stopped) Less << - Austria ... More >> University Hospital Innsbruck, Internal Medicine V, Hematology Oncology Innsbruck, Austria, A-6020 Less <<
NCT02071719 - Terminated October 2017 Netherlands ... More >> VU Medical Center Amsterdam, Noord Holland, Netherlands, 1081 HV Less <<
NCT01871766 Rhabdomyosarcoma Phase 2 Recruiting June 2024 United States, Florida ... More >> University of Florida Proton Therapy Institute Active, not recruiting Jacksonville, Florida, United States, 32206 Nemours Children's Clinic Active, not recruiting Jacksonville, Florida, United States, 32207 United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Matthew J. Krasin, MD    866-278-5833    referralInfo@stjude.org    Principal Investigator: Matthew J. Krasin, MD          United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Karen Albritton, MD    682-885-2103    karen.albritton@cookchildrens.org    Principal Investigator: Karen Albritton, MD Less <<
NCT02423239 Hepatocellular Carcinoma ... More >> Pancreatic Cancer Less << Phase 1 Unknown December 2016 Germany ... More >> University Hospital Bonn, Study Center Bonn (SZB) Clinical Study Core Unit Institute of Clinical Chemistry and Clinical Pharmacology University Hospital Bonn, Sigmund-Freud-Str. 25 Bonn, Germany, D-53127 Universitätsklinikum Hamburg-Eppendorf II. Medizinischen Klinik Martinistr. 52 Hamburg, Germany, 20246 Klinikum der Ruhr-Universitaet Bochum, Medizinische Klinik III - Hämatologie/Onkologie Marien Hospital Herne Universitätsklinikum der Ruhr-Universität Bochum Hölkeskampring 40 Herne, Germany, 44625 Klinikum der Universität München, Universitätsklinikum Großhadern Medizinische Klinik und Poliklinik III AG Onkologie Marchioninistr. 15 München, Germany, 81377 UNIFONTIS Praxis fur Integrative Onkologie, Hoppe-Seyler-Straße 6, Tübingen, Germany, 72076 Poland Osrodek Medyczny SAMARYTANIN, ul. Kazimierza Pużaka 11 Opole, Poland, 45-272 Wojewodzki Szpital Zespolony w Toruniu, ul. Św. Józefa 53-59 Toruń, Poland, 87-100 Spain Hospital Universitario Virgen de la Victoria, Servicio de Oncología Médica Campus de Teatinos, Málaga, Malaga, Spain, 29010 START MADRID-FJD, Hospital Fundación Jiménez Díaz, Av Reyes Católicos 2, Floor 1 28040 Madrid, Spain, 28040 Hospital Universitario Virgen del Rocio, Hospital Universitario Virgen del Rocío Oncología Médica Avda. Manuel Siurot, Sevilla, Spain, 41013 United Kingdom Beatson West of Scotland Cancer Centre, 1053 Great Western Rd, Glasgow, United Kingdom, G12 0YN St James's Hospital, Cancer Research UK Clinical Centre/Section of Oncology, Beckett St, Leeds, United Kingdom, LS9 7TF Freeman Hospital, Sir Bobby Robson Cancer Trials Research Centre, Freeman Road, High Heaton, Newcastle upon Tyne, United Kingdom, NE7 7DN Less <<
NCT01946529 Desmoplastic Small Round Cell ... More >>Tumor Ewing Sarcoma of Bone or Soft Tissue Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Less << Phase 2 Active, not recruiting July 2026 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT03316872 Hepatocellular Carcinoma Phase 2 Recruiting April 2, 2022 Canada, Ontario ... More >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Jennifer J. Knox, M.D.    416-946-2399       Principal Investigator: Jennifer J. Knox, M.D. Less <<
NCT01747642 Quality of Life Phase 2 Phase 3 Unknown June 2014 Bangladesh ... More >> Farabi General Hospital Recruiting Dhaka, Bangladesh, 1215 Contact: Mamun A Mahtab, MD, FACG    +8801711567275    shwapnil@agni.com    Contact: Helal Uddin, BSc    +880-1819251514    crobangladesh@gmail.com    Principal Investigator: Mamun A Mahtab, MD, FACG          Sub-Investigator: Lovely Begum, BPharm Less <<
NCT01946529 - Active, not recruiting - -
NCT01911273 Carcinoma, Hepatocellular Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Japan National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 Kinki University Hospital, Department of Gastroenterology and Hepatology Osaka-Sayama, Osaka, Japan, 589-8511 National Cancer Center Hospital Chuo-ku, Tokyo, Japan, 104-0045 Less <<
NCT01224730 Cancer Phase 1 Completed - United States, Texas ... More >> Dallas, Texas, United States, 75230 Houston, Texas, United States, 77030 Less <<
NCT01911273 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01446224 - Completed - -
NCT01628640 Advanced Malignant Solid Neopl... More >>asm Hepatocellular Carcinoma Less << Phase 1 Suspended(for evaluation of 3 ... More >>patients enrolled on DL3A) Less << June 2025 United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01101906 Advanced Hepatocellular Carcin... More >>oma (HCC) Less << Phase 2 Terminated(Company decided not... More >> to pursue the development of this drug in this patient population at this time) Less << - -
NCT02412475 Leukemia, Acute Myeloid Phase 1 Active, not recruiting February 2019 United States, Minnesota ... More >> Children's Hospitals and Clinics of Minnesota Minneapolis, Minnesota, United States, 55404 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT03516071 Hepatocellular Carcinoma (HCC) Phase 2 Recruiting May 10, 2019 China, Anhui ... More >> Anhui Provincial Hospital Recruiting Hefei, Anhui, China Contact: Yueyin Pan          China, Guangdong Nanfang Hospital Recruiting Guangzhou, Guangdong, China Contact: Jinlin Hou          Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China Contact: Li Xu          China, Heilongjiang Harbin Medical University Cancer Hospital Recruiting Harbin, Heilongjiang, China Contact: Yuxian Bai          China, Henan Henan Cancer Hospital Recruiting Zhengzhou, Henan, China Contact: Xinfang Hou          China, Hunan Hunan Cancer Hospital Recruiting Changsha, Hunan, China Contact: Shanzhi Gu          China, Jiangsu China PLA 81st hospital Recruiting Nanjing, Jiangsu, China Contact: Shukui Qin          China, Jilin The first Hospital of Jilin University Recruiting Changchun, Jilin, China Contact: Wei Li          China, Liaoning Army General Hospital of Shenyang military region Recruiting Shenyang, Liaoning, China Contact: Zhendong Zheng          China, Shanghai Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China Contact: Zhiqiang Meng          Zhongshan Hospital Recruiting Shanghai, Shanghai, China Contact: Zhenggang Ren          China, Shanxi Tangdu Hospital Recruiting Xi'an, Shanxi, China Contact: Helong Zhang          China, Sichuan West China Hospital West China School of Medicine Sichuan University Recruiting Chengdu, Sichuan, China Contact: Hong Zhu          China, Tianjin Tianjin Medical University Cancer Institute & Hospital Recruiting Tianjin, Tianjin, China Contact: Tianqiang Song          China, Zhejiang Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China Contact: Jieer Ying Less <<
NCT01205828 Hepatocellular Carcinoma Phase 2 Terminated(Lack of efficacy) - United States, District of Col... More >>umbia Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington, District of Columbia, United States, 20007 Less <<
NCT01700699 - Unknown October 2013 Italy ... More >> Department of Medicine and Surgery, Univeristy of Salerno Recruiting Baronissi, Salerno, Italy, 84081 Contact: Mario Vitale, MD    +39 089672539    mavitale@unisa.it    Principal Investigator: Mario Vitale, MD Less <<
NCT01205828 - Terminated(Lack of efficacy) - -
NCT02435433 Hepatocellular Carcinoma Phase 3 Recruiting June 2020 -
NCT01180959 Liver Cancer Phase 2 Active, not recruiting April 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01246817 Renal Cell Cancer Phase 2 Unknown - Netherlands ... More >> University Medical Centre Nijmegen Recruiting Nijmegen, Gelderland, Netherlands, 6500 HB Principal Investigator: C.M.L. van Herpen, Md PhD Less <<
NCT01758575 - Terminated - Netherlands ... More >> VU University Medical Center Amsterdam, Netherlands, 1081HV Less <<
NCT02551718 Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker    206-616-1589    pbecker@u.washington.edu    Principal Investigator: Pamela S. Becker Less <<
NCT00610012 - Active, not recruiting August 2020 Germany ... More >> iOMEDICO Freiburg, Germany Less <<
NCT01387503 Carcinoma, Hepatocellular ... More >> Cirrhosis Less << Phase 2 Phase 3 Unknown January 2014 Italy ... More >> Ospedali Riuniti di Bergamo Recruiting Bergamo, Italy, 24125 Ospedale Maggiore di Milano Policlinico Recruiting Milano, Italy, 20122 Istituto Nazionale Tumori Recruiting Milano, Italy, 20133 Azienda Ospedaliera Ospedale Niguarda Ca' Granda Recruiting Milano, Italy, 20162 Azienda Ospedaliera Universitaria di Padova Recruiting Padova, Italy, 35128 Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT) Recruiting Palermo, Italy, 90133 Policlinico Tor Vergata Recruiting Roma, Italy, 00133 Ospedale "Lazzaro Spallanzani" Recruiting Roma, Italy, 00149 Ospedale Umberto Iº Policlinico di Roma Recruiting Roma, Italy, 00161 Ospedale Universitario Molinette S. Giovanni Battista di Torino Recruiting Torino, Italy, 10126 Less <<
NCT02776644 - Completed - -
NCT03419572 - Recruiting January 5, 2021 -
NCT00986661 Cancer Metastatic to the Liver... More >> Hepatocellular Carcinoma Less << Phase 1 Recruiting February 2020 United States, California ... More >> Sharp Memorial Hospital Recruiting San Diego, California, United States, 92123 Contact: Amy King    858-939-5052    Amy.King@sharp.com    Principal Investigator: Kristin Rice, M.D.          United States, Florida Florida Hospital Tampa Recruiting Tampa, Florida, United States, 33613 Contact: Heather Bingaman, BS    813-615-7068    heather.bingaman@ahss.org    Principal Investigator: Alexander Rosemurgy, M.D.          United States, Pennsylvania St Luke's University Health Network Recruiting Bethlehem, Pennsylvania, United States, 18015 Contact: Alyse M LaLiberte, MPH    484-503-4151    Alyse.LaLiberte@sluhn.org    Contact: Robyn Rex, RN, OCN, CCRP    484-503-4152    robyn.rex@sluhn.org    Principal Investigator: Sanjiv Agarwala, MD          United States, Tennessee Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Rhonda Combs, LPN    615-322-2260    rhonda.j.combs@vanderbilt.edu    Contact: Melissa Ford, MSN, PhD, RN    615-875-7143    melissa.b.ford@vanderbilt.edu    Principal Investigator: Daniel Brown, MD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Gener Balmes, RN, CCRP    713-794-4153    gcbalmes@mdanderson.org    Principal Investigator: Sapna Patel, MD Less <<
NCT03338166 - Not yet recruiting December 2018 -
NCT01009801 Liver Cancer Phase 1 Phase 2 Terminated(due to slow patient... More >> recruitement.) Less << - Switzerland ... More >> Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Graubuenden Chur, Switzerland, 7000 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Clinica Luganese di Moncucco Lugano, Switzerland, 6903 Institut Central des Hopitaux Valaisans / Hôpital de Sion Sion, Switzerland, CH-1951 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT00601120 Renal Cell Carcinoma Not Applicable Withdrawn(This protocol was ne... More >>ver officially opened and no patients were recruited.) Less << - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Less <<
NCT01827254 - Completed - France ... More >> CHU de la Timone Marseille, Cedex 5, France, 13335 Hopital albert Michalon Grenoble, Cedex 9, France, 38043 Centre Paul Papin Angers, France, 49100 Hôpital Saint-André Bordeaux Cedex, France, 33075 Centre Catalan Urologie Andrologie Cabestany, France, 66330 Centre Oscar Lambret - Cancérologie Urologie Digestive Lille Cedex, France, 59020 clinique de la Louvière Lille Cedex, France, 59042 Hopital Dupuytren - Oncologie Medicale Limoges Cedex, France, 87042 Centre Leon Berard, Service d'Oncologie Medicale Lyon Cedex 08, France, 69373 Institut Paoli-Calmettes / Hôpital de jour Marseille Cedex 9, France, 13273 Cedex 9 Hopital Timone Adultes Marseille Cedex, France, 13385 Hopital Europeen Georges Pompidou Paris Cedex 15, France, 75908 Centre Eugene Marquis Rennes, France, 35042 CHU Charles Nicolle ROUEN Cedex, France, 76031 Departement d'Oncologie Medicale-Institut de Cancerologie de la Loire Saint Priest en Jarez Cedex, France, 42271 Centre Rene Gauducheau - Service Oncologie Medicale St Herblain Cedex, France, 44805 Institut Claudius Regaud Toulouse, France, 31000 Centre Alexis Vautrin Vandoeuvre les Nancy, France, 54511 Less <<
NCT02829840 Leukemia FLT3... More >>-Mutated Acute Myeloid Leukemia FLT3-Mutated High-Risk Myelodysplastic Syndrome Less << Phase 1 Phase 2 Withdrawn - -
NCT01827254 - Completed - -
NCT01703910 Adenocarcinoma of Colon ... More >> Adenocarcinoma of Rectum Metastatic Disease Less << Phase 2 Completed - Spain ... More >> Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain, 28950 Hospital Madrid Norte Sanchinarro Madrid, Spain, 28050 Less <<
NCT00811993 Neoplasms Phase 1 Terminated - United States, Arizona ... More >> Tucson, Arizona, United States, 85724 United States, California San Francisco, California, United States, 94115 Santa Monica, California, United States, 90025 United States, District of Columbia Washington, District of Columbia, United States, 20007 United States, Illinois Chicago, Illinois, United States, 60637 United States, Minnesota Rochester, Minnesota, United States, 55905 United States, North Carolina Chapel Hill, North Carolina, United States, 27514 United States, Texas Houston, Texas, United States, 77030 Less <<
NCT03680677 Leukemia, Acute ... More >> MDS Less << Not Applicable Not yet recruiting November 2025 United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01636908 Cancer Advanc... More >>ed Solid Tumors Less << Not Applicable Active, not recruiting - Netherlands ... More >> VUMedical Center Amsterdam, Netherlands, 1081 HV Less <<
NCT02645149 Melanoma Phase 4 Not yet recruiting August 2021 Australia, New South Wales ... More >> Royal Prince Alfred Hospital Not yet recruiting Camperdown, New South Wales, Australia, 2050 Contact: Maria Gonzalez    612 9911 7200    maria.gonzalez@melanoma.org.au    Principal Investigator: John Thompson          Westmead Hospital Westmead, New South Wales, Australia, 2145 Melanoma Institute Australia Not yet recruiting Wollstonecraft, New South Wales, Australia, 2065 Contact: Maria Gonzalez    +612 9911 7200    maria.gonzalez@melanoma.org.au    Contact: Alex Menzies    +612 9911 7200    info@melanoma.org.au    Sub-Investigator: Georgina Long          Principal Investigator: Alex Menzies Less <<
NCT03520257 Hepatocellular Carcinoma Phase 2 Not yet recruiting June 30, 2019 -
NCT02836847 Cholangiocarcinoma of the Extr... More >>ahepatic Bile Duct Gallbladder Cancer Less << Phase 2 Recruiting December 2020 China, Shanghai ... More >> Xinhua Hospital Recruiting Shanghai, Shanghai, China, 200092 Contact: yingbin liu    13918803900    laoniulyb@163.com Less <<
NCT01105364 Kidney Cancer ... More >> Metastatic Cancer Less << Not Applicable Unknown - France ... More >> Centre Hospitalier Universitaire Bretonneau de Tours Recruiting Tours, France, 37044 Contact: Contact Person    33-2-4747-4776 Less <<
NCT00265798 Gastrointestinal Stromal Tumor PHASE2 ACTIVE_NOT_RECRUITING 2025-03-08 City of Hope Comprehensive Can... More >>cer Center, Duarte, California, 91010, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, 60637, United States|Decatur Memorial Hospital, Decatur, Illinois, 62526, United States|Central Illinois Hematology Oncology Center, Springfield, Illinois, 62702, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.57mL

0.31mL

0.16mL

7.85mL

1.57mL

0.78mL

15.70mL

3.14mL

1.57mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories